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ABSTRACT
In recent years, the advancement in high-throughput next-generation sequencing technologies
have revolutionized the way for genomic studies. The rapid progress of these technologies has
resulted in an ever-increasing number of high-dimensional gene expression datasets available for
analysis. However, due to the genetic complexity and high cost of such experiments, the number
of replicates employed in an experiment is typically small. This introduces the so-called “small
n, large p” problem, where n refers to the sample size and p refers to the number of genes, in
which case the power of statistical inference is limited after adjusting multiple testing errors. This
dissertation presents novel statistical methods for gene expression experiments based on sequencing
data, including sample size calculation and methods that allow borrow information across genes
for identifying differential expressed (DE) genes, detecting gene expression heterosis, and assessing
differential translation across treatments.
Chapter 2 proposes a one-time simulation based sample size calculation method while controlling
false discovery rate (FDR) for RNA-sequencing (RNA-seq) experimental design. Our procedure is
based on the weighted linear model analysis facilitated by the voom method, which has been shown
to have competitive performance in terms of power and FDR control for RNA-seq differential
expression analysis. We derive a method that approximates the average power across the DE
genes, and then calculate the sample size to achieve a desired average power while controlling
FDR. Simulation results demonstrate that the actual power of several popularly applied tests for
differential expression is achieved and is close to the desired power for RNA-seq data with sample
size calculated based on our method.
Chapter 3 develops a semi-parametric Bayesian approach for DE analysis in RNA-seq data.
More specifically, we model the count data from RNA-seq experiments with a Poisson-Gamma
mixture model, and propose a Bayesian mixture modeling procedure with a Dirichlet process as
xvi
the prior model for the distribution of fold changes between the two treatment means. We develop
Markov chain Monte Carlo (MCMC) posterior simulation using Metropolis Hastings algorithm
to generate posterior samples for differential expression analysis while controlling FDR. Simula-
tion study results suggest that our proposed method outperforms other popular methods used for
detecting DE genes.
In Chapter 4, we extend the idea of Chapter 3 by proposing a powerful test to detect gene
expression heterosis while controlling FDR. We use the similar Poisson-Gamma mixture model for
RNA-seq count data, and propose a Bayesian mixture modeling procedure with a Dirichlet process
as the prior for the distribution of fold changes between each parental line versus the hybrid offspring
respectively. The MCMC sampling scheme with Gibbs algorithm is utilized to provide posterior
inference to detect heterosis genes while controlling false discovery rate. The effectiveness of our
approach is demonstrated through simulation studies.
Chapter 5 addresses another gene expression analysis challenge with ribosome profiling data. It
explores a new a statistical framework, RiboZIP, to identify differentially translated genes (DTGs).
We model the ribosome profiling data with a zero-inflated Poisson (ZIP) model, and propose a
Bayesian hierarchical modeling procedure to assess differential translation while taking the paring
information between mRNA and RPFs samples into account. The MCMC sampling scheme is
employed for posterior inference to detect DTGs while controlling FDR. We investigate the per-
formance of our method and compare it with several existing methods used for ribosome profiling
data. The analysis results show that our RiboZIP method generally provides a better ranking for
genes as well as higher number of true significant results, while still adequately controlling FDR.
In summary, this dissertation raised and coped with several statistical problems under transcrip-
tome data analysis. All proposed methods are evaluated through simulation studies and applied to
real data analysis with fruitful results.
1CHAPTER 1. GENERAL INTRODUCTION
1.1 Next-generation Sequencing Technology
Next-generation sequencing (NGS) refers to a series of sequencing technologies developed since
2005. Compared with Sanger sequencing, the first generation sequencing technologies, NGS tech-
nologies simplify the library preparation, and significantly improve the sequencing throughput by
utilizing massively parallel sequencing. This allows millions of fragments to be sequenced in a single
run versus Sanger sequencing which only produces one forward and reverse read. During the past
decade, NGS technologies have revolutionized genomic studies, and tremendous development has
been made in terms of throughput, scalability, speed and sequencing cost.
1.1.1 RNA-seq
Many applications arise based on NGS technologies. RNA-Sequencing (RNA-seq), also called
Whole Transcriptome Shotgun Sequencing (WTSS), is a technology that uses the capabilities of
NGS to study the entire transcriptome through the sequencing of RNA molecules. In a typical
RNA-seq experiment, messenger RNA (mRNA) molecules are extracted from samples, fragmented,
and reverse transcribed to double-stranded complementary DNA (cDNA). The cDNA fragments
are then sequenced on a high-throughput platform, such as HiSeq by Illumina or SOLiD by Applied
Biosystems. After sequencing, millions of DNA fragment sequences, called reads, are recorded and
aligned to a reference genome. The number of reads mapped to each gene measures the expression
level for that gene.
Compared with microarray technologies that used to be the major tool for transcriptome studies,
RNA-seq technologies have several advantages including a larger dynamic range of expression levels,
less noise, higher throughput, and more power to detect gene fusions, single nucleotide variants and
2novel transcripts. Hence, RNA-seq technologies have been popularly applied in transcriptomic
studies.
1.1.2 Ribo-seq
Ribosome profiling (Ribo-seq), also named Ribosome footprinting, is a method based on NGS
technologies that uses deep sequencing of ribosome-protected mRNA fragments (RPFs) to deter-
mine what proteins are being actively translated in a cell.
It is a modification of RNA-seq that allows one to essentially detect the position and amount of
every translating (80S) ribosome on every mRNA in the sample. Briefly, a translation-arrested cell
lysate is digested with RNase to degrade all mRNA that is not protected by a translating ribosome.
The resulting RPFs, along with randomly fragmented total RNA from the same initial lysate to
be used for normalization, are sequenced by Illumina sequencing, then mapped to the reference
genome or transcriptome. RPFs represent the mRNA region occupied by the translating ribosome
(Ingolia et al., 2009). The positions and numbers of RPFs on each mRNA indicate the abundance
of ribosomes at each position in each mRNA. Highly translated mRNAs and ribosome pause sites
generate more RPFs. Therefore, the number of RPFs mapped on the coding region of an mRNA
species has been frequently used as a measurement of the level of translation.
1.2 False Discovery Rate
Both RNA-seq and Ribo-seq technologies measure tens of thousands of genes. A major goal in
the analysis of gene expression is to identify genes that are of interest, such as genes whose expression
levels change across conditions, or whose translational efficiency changes across conditions. Thus
multiple testing procedures that control the number of false significant results while simultaneously
testing a large number of hypotheses is essential. Assume there are m genes in total and each gene
is tested of a hypothesis. Among the m tests, suppose m0 of the null hypotheses are true and m1 of
the null hypotheses are false. We denote the m null hypotheses as H10 , . . . ,H
m
0 , and let p1, . . . , pm
3represent the p-values correspond to the m tests. Also, we denote p(1), . . . , p(m) as the ordered
p-values from smallest to largest.
We reject H i0 if pi ≤ c and fail to reject H i0 if pi > c, where the cutoff value c is chosen in order
to control some type of error rate. Table 1.1 summarizes the various outcomes that occur when
testing m hypotheses, where V is the number of false positives, R is the number of rejections.
Table 1.1 Outcomes when testing m hypotheses.
Accept Null Reject Null Total
True Nulls U V m0
False Nulls T S m1
Total W R m
False discovery rate (FDR), defined by Benjamini and Hochberg (1995), is the expected pro-
portion of false positives among the rejected hypothesis,
FDR = E
(
V
R
∣∣∣∣R > 0)Pr(R > 0),
has been the choice of error criterion in genomic studies. There are several well known and com-
monly used methods for controlling FDR (choosing c).
1.2.1 Benjamini and Hochberg Method
Benjamini and Hochberg (1995) proposed a method for controlling FDR at level α by finding
the largest integer k such that
p(k) ≤
kα
m
, (1.1)
and setting c = p(k). If no such k exists, then set c = 0 and no hypotheses testings are rejected.
Notice that the Benjamini and Hochberg (1995) method controls FDR at level α(m0/m) rather
than α.
41.2.2 The q-value Procedure
An improved method for controlling FDR at level α would be to replace the quantity m with
m0 in 1.1, but m0 needs to be estimated since it is unknown. Storey (2002) proposed a method to
estimate quantity m0 with mˆ0, and defined the q-value as
q(j) = min
{
p(r)mˆ0
r
: r = j, . . . ,m
}
,
where q(j) is the q-value corresponds to the gene with the j
th smallest p-value, and qj corresponds to
the q-value of jth hypothesis testing. The q-value converts the p-value from a significance measure
of the Type I error rate of a single hypothesis test to a significance measure of the FDR for a family
of m hypothesis tests.
1.2.3 Bayesian FDR
The Bayesian version of FDR is an alternative way to estimate the FDR within the Bayesian
framework. It has been proposed and discussed by several authors including Genovese and Wasser-
man (2003) and Newton et al. (2004). The Bayesian FDR can be obtained by using posterior
probabilities of the null hypotheses. More specifically, for each hypothesis i, i = 1, . . . ,m, we de-
note the posterior probability that ith null hypothesis is true by vi. vi can be estimated by the
proportion of the posterior samples for some parameters or some function of parameters that falls
into the null set ∆0. We reject H
i
0 if the estimated posterior probability vˆi is smaller than a critical
value c∗. The critical value c∗ is chosen based on controlling the FDR below a target level α, for
example, 0.05, i.e.,
c∗ = sup{c : F̂DR(c) < α},
where
F̂DR(c) =
∑m
i=1 vˆiI(vˆi < c)∑m
i=1 I(vˆi < c)
.
So the Bayesian FDR controlled at level α can be calculated by
B̂FDR(α) =
∑m
i=1 vˆiI(vˆi < c
∗)∑m
i=1 I(vˆi < c
∗)
.
51.3 Bayesian Hierarchical Modeling
For genomic studies, tens of thousands of genes are simultaneously measured for their expression
levels. However, due to the genetic complexity and high-dimensionality of the resulting datasets,
in addition to the cost of experimental materials and sequencing, many experiments only employ a
small number of replicates. This introduces the “small n, large p” problem, where n refers to the
sample size and p refers to the number of variables, in which cases the power of statistical inference
is limited after adjusting multiple testing errors. Therefore, in order to mitigate the effects of
small sample sizes during estimation, Bayesian hierarchical modeling approach has been proposed
in terms of borrowing information across genes, and is becoming increasingly popular in statistical
genomics (Do et al., 2005; Hardcastle and Kelly, 2010; Wu et al., 2012).
1.4 Dissertation Organization
In the rest of this dissertation, each chapter addresses one challenge related to RNA-seq or Ribo-
seq analysis. In Chapter 2, we propose a procedure for sample size calculation while controlling
FDR for RNA-seq experimental design. Chapter 3 extends Liu et al. (2015) idea, and develops a
semi-parametric Bayesian approach for differential expression analysis of RNA-seq data. Chapter
4 uses the method introduced in Liu et al. (2015) and Chapter 3, and proposes a semi-parametric
Bayesian approach for detection of gene expression heterosis while controlling FDR. In Chapter 5,
we utilize a zero-inflated Poisson (ZIP) model and adopt a Bayesian hierarchical modeling pipeline
to assess differential translations with ribosome profiling data.
6Bibliography
Benjamini, Y., Hochberg, Y.(1995). Controlling the false discovery rate: a practical and powerful
approach to multiple testing. J. R. Stat. Soc. B, 57, 289–300.
Do, K. A. , Muller, P., Tang, F. (2005). A Bayesian Mixture Model For Differential Gene. Journal
of the Royal Statistical Society, Series C (Applied Statistics), 54, 627–644.
Genovese, C., Wasserman, L. (2003). Bayesian and Frequentist Multiple Testing. Bayesian Statis-
tics, 7, 145–161.
Hardcastle, T. J., Kelly, K. A. (2010). baySeq: Empirical Bayesian Methods for Identifying Differ-
ential Expression in Sequence Count Data. BMC Bioinformatics, 11, 422.
Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. S., Weissman, J. S.(2009). Genome-wide analysis
in vivo of translation with nucleotide resolution using ribosome profiling. Science, 324, 218–23.
Liu, F., Wang, C., Liu, P. (2015). A Semi-parametric Bayesian Approach for Differential Expression
Analysis of RNA-seq Data. J Agric Biol Environ Stat, 20 (4), 555–576.
Newton, M. A., Noueiry, A., Sarkar, D., Ahlquist, P. (2004). Detecting Differential Gene Expression
with a Semiparametric Hierarchical Mixture Method. Biostatistics, 5, 155–176.
Storey, J. D. (2002). A Direct Approach to False Discovery Rates. Journal of the Royal Statistical
Society, Series B, 64, 479–498.
Wu, H., Wang, C., Wu, Z. (2012). A new shrinkage estimator for dispersion improves differential
expression detection in RNA-seq data. Biostatistics, 1 (1), 1–24.
7CHAPTER 2. SAMPLE SIZE CALCULATION WHILE CONTROLLING
FALSE DISCOVERY RATE FOR DIFFERENTIAL EXPRESSION
ANALYSIS WITH RNA-SEQUENCING EXPERIMENTS
Published in BMC Bioinformatics 2016, 17 :146
Ran Bi, Peng Liu
Abstract
Background: RNA-Sequencing (RNA-seq) experiments have been popularly applied to transcrip-
tome studies in recent years. Such experiments are still relatively costly. As a result, RNA-seq
experiments often employ a small number of replicates. Power analysis and sample size calculation
are challenging in the context of differential expression analysis with RNA-seq data. One challenge
is that there are no closed-form formulae to calculate power for the popularly applied tests for
differential expression analysis. In addition, false discovery rate (FDR), instead of family-wise type
I error rate, is controlled for the multiple testing error in RNA-seq data analysis. So far, there are
very few proposals on sample size calculation for RNA-seq experiments.
Results: In this paper, we propose a procedure for sample size calculation while controlling FDR
for RNA-seq experimental design. Our procedure is based on the weighted linear model analysis
facilitated by the voom method which has been shown to have competitive performance in terms
of power and FDR control for RNA-seq differential expression analysis. We derive a method that
approximates the average power across the differentially expressed genes, and then calculate the
sample size to achieve a desired average power while controlling FDR. Simulation results demon-
strate that the actual power of several popularly applied tests for differential expression is achieved
and is close to the desired power for RNA-seq data with sample size calculated based on our method.
8Conclusions: Our proposed method provides an efficient algorithm to calculate sample size while
controlling FDR for RNA-seq experimental design. We also provide an R package ssizeRNA that
implements our proposed method and can be downloaded from the Comprehensive R Archive
Network (http://cran.r-project.org).
Keywords: RNA-seq; FDR; Experimental design; Sample size calculation; Power analysis.
2.1 Introduction
During the past decade, next generation sequencing (NGS) technology has revolutionized ge-
nomic studies, and tremendous development has been made in terms of throughput, scalability,
speed and sequencing cost. RNA-Sequencing (RNA-seq), also called Whole Transcriptome Shot-
gun Sequencing (WTSS), is a technology that uses the capabilities of NGS to study the entire
transcriptome. Compared with microarray technologies that used to be the major tool for tran-
scriptome studies, RNA-seq technologies have several advantages including a larger dynamic range
of expression levels, less noise, higher throughput, and more power to detect gene fusions, single nu-
cleotide variants and novel transcripts. Hence, RNA-seq technologies have been popularly applied
in transcriptomic studies.
In a typical RNA-seq experiment, messenger RNA (mRNA) molecules are extracted from sam-
ples, fragmented, and reverse transcribed to double-stranded complementary DNA (cDNA). The
cDNA fragments are then sequenced on a high-throughput platform, such as HiSeq by Illumina
or SOLiD by Applied Biosystems. After sequencing, millions of DNA fragment sequences, called
reads, are recorded and aligned to a reference genome. The number of reads mapped to each gene
measures the expression level for that gene. Thus, RNA-seq provides discrete count data serving as
measurements of mRNA expression levels, which is different from the fluorescence intensity mea-
surements from microarray technologies that have been considered as continuous variables after
transformation. As a result of high frequency of low integers, the statistical methods developed for
analyzing microarray data are not directly applicable for RNA-seq data.
9In the statistical analysis of RNA-seq data, identifying differentially expressed (DE) genes across
treatments or conditions is a major step or main focus. A gene is considered to be DE across
treatments or conditions if the mean read counts differ across treatment groups. Otherwise, we
say the gene is equivalently expressed (EE). Many statistical methods have been proposed for the
detection of DE genes with RNA-seq data. Some popular methods, including edgeR (Robinson and
Smyth, 2007, 2008; Robinson et al., 2010; McCarthy et al., 2012), DESeq (Anders and Huber, 2010)
and DESeq2 (Love et al., 2014), are based on the negative binomial (NB) distribution. QuasiSeq
(Lund et al., 2012) presented quasi-likelihood methods with shrunken dispersion estimates. A more
recently proposed method by the Smyth group (Law et al., 2014) works with log-transformed count
data and captures the mean-variance relationship of the log-count data through a precision weight
for each observation (using a function called voom in their R package) and then applies the limma
method (Smyth, 2004) for differential expression analysis.
Due to the genetic complexity and high-dimensionality of the resulting datasets, RNA-seq ex-
periments require complicated bioinformatic and statistical analysis in addition to the cost of ex-
perimental materials and sequencing. Many experiments only employ a small number of replicates,
in which cases the power of statistical inference is limited. However, if the sample size is too large
(which is rare), it is also a waste of experimental materials and manpower. For these reasons, one
of the principal questions in designing an RNA-seq experiment is: how many biological replicates
should be used to achieve a desired power? In other words, how large of the sample size do we
need?
To answer this question, we need to determine a sample size that is required to achieve a desired
power while controlling an appropriate error rate. When calculating sample size for a single test,
type I error rate is commonly used. Fang and Cui (2011) discussed a sample size formula for a single
gene based on likelihood ratio test or Wald test. Hart et al. (2013) and their associated R package
RNASeqPower (Therneau et al., 2015) proposed a sample size calculation method for any single
gene based on score test while controlling type I error rate. However, for RNA-seq data analysis,
tens of thousands of genes are simultaneously tested for differential expression, which requires the
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correction of multiple testing error, and false discovery rate (FDR) (Benjamini and Hochberg, 1995)
has been the choice of error criterion in RNA-seq data analysis.
Several sample size calculation methods while controlling FDR have been proposed in microarray
experiments. For example, Liu and Hwang (2007) developed a method to calculate sample size given
a desired power and a controlled level of FDR by finding the rejection region for the test procedure
and hence power for each sample size. Hereafter, we call this sample size calculation method the LH
method. Orr and Liu (2009) assembled the ssize.fdr R package which implements the LH method.
However, sample size calculation for RNA-seq data analysis while controlling FDR is underde-
veloped. Some earlier studies performed sample size and power estimation for RNA-seq experiments
under Poisson distribution (Chen et al., 2011; Busby et al., 2013; Li et al., 2013), but the addi-
tional biological variation across RNA-seq samples yields overdispersion, which means the equal
mean-variance relationship for the Poisson distribution does not adapt to the variability present in
RNA-seq data. To account for overdispersion, the negative binomial distribution is more flexible
to use. Li et al. (2013) proposed a sample size determination method while controlling FDR based
on the exact test implemented in edgeR that tests for genes differentially expressed between two
treatments or conditions. This method calculates a sample size based on the minimum fold change
of DE genes, the minimum average read counts of DE genes in the control group, and the maximum
dispersion of DE genes under negative binomial models. As expected, such a method would be very
conservative and not practically informative. The RnaSeqSampleSize R package (Zhao et al., 2015)
provides an estimation of sample size based on single read count and dispersion which implements
Li et al. (2013) method. Also, instead of using the minimum average read counts and the maxi-
mum dispersion, RnaSeqSampleSize gives an estimation of sample size based on the read count and
dispersion distributions estimated from real data, together with the minimum fold change, which
is much better than Li et al. (2013) method, but would still be conservative due to the usage of
the minimum fold change. The LH method is applicable as long as we can compute the power and
type I error rate given a rejection region. However, there are no closed-form formulae for power
for the popularly applied NB based methods. Then we have to rely on a lot of simulation to figure
11
out quantities such as power and type I error rate for each sample size and each simulation setting
(Fang and Cui, 2011). Ching et al. (2014) provided a power analysis tool that calculates the power
for a given budget constraint for each size of samples, and then determined the sample size for
a desired power. Wu et al. (2015) introduced the concepts of stratified targeted power and false
discovery cost, and estimated sample size by the evaluation of statistical power over a range of
sample sizes based on simulation studies. Both Ching et al. (2014) and Wu et al. (2015) methods
are simulation-based, thus we need to do a lot of simulations for power assessment for each sample
size, which is time-consuming.
In this paper, we propose a much less computationally intensive method, which only demands
one-time simulation, for sample size calculation in designing RNA-seq experiments. First, we use
the voom method to model the mean-variance relationship of the log-count data of RNA-seq and
produce a precision weight for each observation. Second, based on the normalized log-counts and
associated precision weights, we estimate the distribution of weighted residual standard deviation
of expression levels. Then for two-sample experiments, we derive a formula of the t test statistic
in the weighted least squares setting and estimate the distribution of effect size for differential
expression. Next, we apply the LH method to calculate the required sample size for a given desired
power and a controlled FDR level. Our simulation demonstrates that the desired power is reached
for data with the sample size calculated from our method for several popular tests for differential
expression.
The article is organized as follows. The Methods section (Section 2.2) describes our proposed
method illustrated with the two-sample t-test. In the Results and Discussion section (Section 2.3),
we present four simulation studies based on either negative binomial distributions or real RNA-seq
dataset, and our method provide reliable sample sizes for all simulation studies. The Conclustions
section (Section 2.4) discusses our results and some future work.
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2.2 Methods
In this section, we first review the voom method (Law et al., 2014) and the LH method of sample
size calculation. Then, we introduce our approach for calculating sample size while controlling FDR
in designing RNA-seq experiments.
2.2.1 The voom Method
Suppose that an RNA-seq experiment includes a total of N samples. Each sample has been
sequenced, and the resulting reads are aligned with a reference genome. The number of reads
mapped to each reference gene is recorded. The RNA-seq data then consist of a matrix of read
counts rgij , where g = 1, 2, . . . , G denotes gene g, i = 1, 2 denotes group where i = 1 is for the
control group and i = 2 is for the treatment group, and j = 1, 2, . . . , ni denotes replicates in each
group with N = n1 + n2. The idea of the voom method proposed by Law et al. (2014) is to use
precision weights to account for the mean-variance relationship and apply weighted least square
analysis to RNA-seq data.
The method of voom starts from transforming the RNA-seq count data to the log-counts per
million (log-cpm) value calculated by
ygij = log2
(
rgij + 0.5
Rij + 1
× 106
)
,
where Rij =
∑G
g=1 rgij is the library size for the ith treatment and jth replicate. As has been done
in Smyth (2004), Law et al. (2014) then fit a linear model to the transformed data according to
the experimental design. For each gene g, the following linear model
yg = Xβg + εg
is fitted to yg = (yg11, . . . , yg1n1 , yg21, . . . , yg2n2)
′, the vector of log-cpm values, where X is the
design matrix with rows xTij , βg is a vector of parameters that may be parameterized to include
log2-fold changes between experimental conditions, and εg is the error term with E(εg) = 0.
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Assuming that E(ygij) = µgij = x
T
ijβg, then by ordinary least squares, the above linear model
is fitted for each gene g, which yields regression coefficient estimates βˆg, fitted values µˆgij = x
T
ijβˆg,
residual standard deviations ηg and fitted log2-read counts
lˆgij = µˆgij + log2(Rij + 1)− log2(106).
To obtain a smooth mean-variance trend, Law et al. (2014) fit a LOWESS curve to the square
root of residual standard deviations η
1/2
g as a function of average log-counts r˜g, where r˜g = y¯g +
log2(R˜ + 1) − log2(106) with y¯g being the average log-cpm value for each gene g and R˜ being the
geometric mean of library sizes. Then for each observation ygij , the predicted square root residual
standard deviation ηˆ
1/2
gij is obtained to be the LOWESS fitted value corresponding to lˆgij .
Finally, the voom precision weights are defined as the inverse variances wgij =
1
ηˆ2gij
. Law et al.
(2014) recommended analyzing the log-cpm data with weighted least squares, and the weights
(wgij) are used to account for the mean-variance relationship in the log-cpm values. Assuming
normal distribution for residual errors (εg), methods such as t-tests or moderated t-tests can then
be applied for differential expression analysis.
2.2.2 The LH Method of Sample Size Calculation
In genomic studies, we simultaneously test a large number of hypotheses, each relating to a
gene. Hence, multiple testing is commonly used in the analysis. Assume there are G genes in total
and each gene is tested for the significance of differential expression. Table 2.1 summarizes the
various outcomes that occur when testing G hypotheses, where V is the number of false positives,
R is the number of rejections among the G tests, and pi0 is the proportion of non-differentially
expressed genes.
Table 2.1 Outcomes when testing G hypotheses.
Accept Null Reject Null Total
True Nulls U V pi0G
False Nulls T S (1− pi0)G
Total W R G
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False discovery rate (FDR), defined by Benjamini and Hochberg (1995), is the expected pro-
portion of false positives among the rejected hypothesis:
FDR = E
(
V
R
∣∣∣∣R > 0)Pr(R > 0),
while positive FDR (pFDR), proposed by Storey Storey (2002), is defined to be
pFDR = E
(
V
R
∣∣∣∣R > 0) .
Both FDR and pFDR are widely used error rates to control in multiple testing encounted in genomic
studies. In RNA-seq experiments, most often we end up detecting DE genes, i.e. R > 0. Hence, in
this paper, we do not differentiate between FDR and pFDR.
Liu and Hwang (2007) proposed a method for a quick sample size calculation for microarray
experiments while controlling FDR. Let H = 0 represent no differential expression (null hypothesis
is true) and H = 1 represent differential expression (null hypothesis is false). Based on the definition
of pFDR and assumptions in Storey (2002) (all tests are identical, independent and Bernoulli
distributed with Pr(H = 0) = pi0, where pi0 is the proportion of EE genes), they derived that
α
1− α
1− pi0
pi0
≥ Pr(T ∈ Γ|H = 0)
Pr(T ∈ Γ|H = 1) , (2.1)
where α is the controlled level of FDR, T denotes the test statistic and Γ denotes the rejection region
of the test. Then for each comparison, the LH method calculates the sample size as follows. First,
for a fixed proportion of non-differentially expressed genes, pi0, and the level of FDR to control, α,
they find a rejection region Γ that satisfy (2.1) for each sample size. Then for the selected rejection
region Γ for each sample size, the power is calculated by Pr(T ∈ Γ|H = 1). According to the
desired power, a sample size is determined.
The rejection region depends on the test applied for differential expression, and the method
based on (2.1) can be applied to any multiple testing procedure where the same rejection region is
used. This LH method can be implemented using an R package, ssize.fdr, developed by Orr and Liu
(2009), and applied for designing one-sample, two-sample, or multi-sample microarray experiments.
The method would be applicable to RNA-seq experiments if we can calculate power and type I error
rate given a rejection region.
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2.2.3 Proposed Method for RNA-seq Experiments with Two-sample Comparison
For the popularly applied tests in RNA-seq differential expression analysis such as edgeR and
DESeq, there are no closed-form expressions to calculate the two quantities Pr(T ∈ Γ|H = 0)
and Pr(T ∈ Γ|H = 1). Hence, the LH method cannot be directly applicable to these methods.
However, the recently proposed voom and limma analysis for RNA-seq data (Law et al., 2014;
Ritchie et al., 2015) is based on weighted linear models and we can obtain tractable formulae for
power and type I error rate. In this paper, our idea is to derive formulae to calculate power and
type I error rate based on voom and weighted linear model analysis, and then apply the LH method
for sample size calculation. We will use two-sample t-tests to illustrate our idea. Similar methods
can be derived for other designs such as paired-sample or multiple treatments comparison.
Suppose our interest is to identify the differentially expressed (DE) genes between a treatment
and a control group. Assuming that for gene g, group i and replicates j, we observe the RNA-seq
data read counts rgij , where the mean for gene g in group i is λgij = dijγgi. Here, dij stands for
a normalization factor or effective library size that adjusts the sequencing depth for sample j in
group i, γgi stands for the normalized mean expression level of gene g in group i. Then for each
gene g, to test for differential expression means to test the hypothesis:
Hg0 : γg1 = γg2 vs. H
g
1 : γg1 6= γg2.
As reviewed in the first part of the Methods section, when applying the voom method, the
RNA-seq read counts rgij are transformed to log-cpm values ygij with associated weights wgij and
mean µgi for each sample j in group i. With this parameterization, testing for DE means testing
Hg0 : µg1 = µg2 vs. H
g
1 : µg1 6= µg2,
where µg1 and µg2 are the expectation of log-cpm values of gth gene for control and treatment
group, respectively.
For each individual gene g, the weighted linear model
yg = Xβg + σgW
− 1
2
g 
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can be fitted to log-cpm values
yg = (yg11, . . . , yg1n1 , yg21, . . . , yg2n2)
with design matrix
X =

1 0
...
...
1 0
1 1
...
...
1 1

,
coefficients vector
βg =
 βg1
βg2
 ,
unknown gene-specific standard deviation σg, and associated voom precision weights
Wg = diag(wg11, · · · , wg1n1 , wg21, · · · , wg2n2).
Assuming  ∼MVN(0, In1+n2), where MVN stands for multivariate normal distribution, the t-test
statistic for gene g is
Tg =
βˆg2
S.E.(βˆg2)
, (2.2)
where the estimated log2-fold change between treatment and control group βˆg2 and its standard
error S.E.(βˆg2) could be obtained through weighted least squares estimation.
To make the t-test based method more straightforward to apply, we reparameterize the formula
(2.2) to
Tg =
∆g
sg
√
1
n1
+ 1n2
, (2.3)
where
sg =
√
(yg −Xβg)′Wg(yg −Xβg)
n1 + n2 − 2
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can be viewed as the pooled sample standard deviation, which is an estimator of σg, and
∆g ≡ βˆg2
√
w¯g1·w¯g2·
w¯g··
(2.4)
can be viewed as the scaled effect size which is defined by weighted mean difference of log-cpm
values. Here, w¯g1· = 1n1
∑n1
j=1wg1j , w¯g2· =
1
n2
∑n2
j=1wg2j and w¯g·· =
1
n1+n2
∑2
i=1
∑ni
j=1wgij . Details
of the derivation for (2.3) is provided in the Appendix A (2.5.1).
After generating the effect size ∆g, and the standard deviation σg for each gene g, we could
assume, as in Liu and Hwang (2007), that the effect size follows a normal distribution
∆g ∼ N(µ∆, σ2∆),
and the variance of log-cpm values for each gene follows an inverse gamma distribution
σ2g ∼ Inv −Gamma(a, b)
with mean ba−1 . Then we apply the LH method to calculate the optimal sample size given desired
power and controlled FDR level. See Appendix B for a brief review of the calculations in the LH
method involving in choosing the rejection region Γ safisfying formula (2.1).
Our proposed method requires the estimation of hyperparameters µ∆, σ∆, a, and b. If a
relatively large pilot dataset is available, these parameters can be estimated based on the pilot
data. Otherwise, we can simulate data to obtain the values for these hyperparameters. It has been
shown that the NB model fits real RNA-seq data well (Anders and Huber, 2010). In addition,
many popularly applied tests for differential expression analysis of RNA-seq data are based on NB
models. Hence, we suggest to simulate data according to NB models, and then use such simulated
data to obtain the estimates of µ∆, σ∆, a, and b, which are then used to calculate sample size. We
outline our proposed procedure for sample size calculation as follows:
1. For a given RNA-seq experiment, specify the following parameters:
G: total number of genes for testing;
pi0: proportion of non-DE genes;
α: FDR level to control;
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pow: desired average power to achieve;
λg: average read count for gene g = 1, . . . , G in control group (without loss of generality, we
assume that the normalization factors dij are equal to 1 for all samples);
φg: dispersion parameter for gene g;
δg: fold change for gene g.
Note that λg and φg could be estimated from real data using methods such as edgeR.
2. Simulate RNA-seq read count data from a NB distribution with given parameters in step 1.
3. Use the voom and limma method to obtain the log-cpm value and the associated precision
weight for each count, and then estimate effect size ∆g according to (2.4) for each gene g and
parameters a, b for the prior of σg.
4. Estimate µ∆ and σ∆ by fitting
∆g ∼ N(µ∆, σ2∆).
5. Use the LH method to determine the sample size n to achieve desired power and controlled
FDR level.
2.3 Results and Discussion
In this section, we present four simulation studies to evaluate our proposed method for sample
size calculation for RNA-seq experiments. In the first three simulation studies, we set the total
number of genes to be G = 10, 000 and the desired average power to be 80%. The last simulation
is real data-based.
2.3.1 Simulation1. Same Set of Parameters
We start from the simplest simulation setting where all genes share the same set of parameters
for the NB distribution. Although such cases are unrealistic, they allow the method of Li et al.
(2013) to perform best because this method uses a single set of NB parameters (mean, dispersion,
fold change) when calculating sample size. Hence, we use this simulation setting to study the
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performance of our method and compare it to the method of Li et al. (2013). We refer to the
parameter settings from Table 1 in Li et al. (2013), and compare the resulting sample size and
power calculated by both Li et al. (2013) method and our proposed method.
In the main manuscript, we present results for one of those parameter settings as an example:
the proportion of non-DE genes pi0 = 0.99, the mean read counts for control group λ = 5 with
normalization factors dij = 1, dispersion parameter φ = 0.1, FDR controlling at level 0.05, and
fold change δ = 2 for differentially expressed genes. Suppose rgij denotes the read count for gene
g, group i and replicate j = 1, 2, . . . , ni in each group with n1 = n2 = n. Then, for EE genes, both
rg1j and rg2j were drawn from NB(5, 0.1); for DE genes, rg1j were drawn from NB(5, 0.1) and rg2j
were drawn from NB(10, 0.1) or NB(2.5, 0.1).
After setting these simulation parameters in step 1, we follow steps 2-4 to simulate data and
obtain the values of hyperparameters. To investigate the effect of this simulation step, we tried
different sizes of simulated data, m = 50, 100, 200, 500, 1000, where m is the sample size for each
group in step 2 of our procedure. For each m, we generated read counts rg1j (control group) and rg2j
(treatment group) from independent NB distributions for every gene g and sample j, g = 1, . . . , G,
j = 1, . . . ,m. After using voom and lmFit in the R package limma (Smyth, 2004) to produce
weights wgij for each observation, we then obtained effect size ∆g for each gene and parameters
a, b for the prior distribution of σ2g . The fitted inverse gamma distributions of σ
2
g for each m are
shown as in Figure 2.1, with vertical lines indicating the modes. It seems that the mode doesn’t
change much, and the distribution of σ2g shrinks towards the center as sample size gets larger.
After obtaining the fitted parameters, we calculated sample size according to our proposed
method described in the third part of the Methods section to achieve a desired power of 80%. We
then simulated data according to each calculated sample size and checked whether the desired power
was achieved. In Table 2.2, the first three columns listed our simulation results corresponding to
this simulation setting. As m increased from 50 to 100 to 1000, the calculated sample size dropped
from 35 to 34 and 32, respectively. This decrease is expected because the parameters were estimated
more precisely with larger m. For example, the distribution of σ2g shrank as m increased as shown
20
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Figure 2.1 Fitted inverse gamma distributions of σ2g for sample size m = 50, 100, 200, 500,
1000 for simulation 1.
in Figure 2.1. The effect on the resulting sample size is not big, at most with a difference of 3 (35
vs. 32).
We now choose a sample size n = 32 and demonstrate this sample size indeed reaches the
desired power 0.8. At n = 32, we simulated 100 datasets and performed several popularly applied
tests such as the edgeR exact test, the voom and limma method, DESeq, DESeq2 and QuasiSeq
using the corresponding R packages. Desired power (0.8) was achieved for all testing methods when
controlling FDR at 0.05 using q-value procedure Storey et al. (2004), and the observed FDR was
controlled successfully under all the five methods. The results are shown in Figure 2.2. For the
voom and limma pipeline method, the observed power curves while FDR was controlled using the
Benjamini and Hochberg (1995) method and the q-value procedure (Storey et al., 2004) and the
power curve based on our calculation are shown in Figure 2.3. The observed power was obtained
by averaging actual power over 100 simulated datasets for each sample size. The observed power
and the power calculated by our method are close with our calculation being a little conservative.
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Figure 2.2 Results from simulation 1. Data were simulated with sample size n = 32.
(a) Observed average power from different methods of differential expression
analysis is plotted against the nominal FDR level controlled using the q-value
procedure. (b) The actual FDR level versus the nominal FDR level for different
methods.
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Hence, our proposed method provides an accurate estimate of power, and the sample size calculated
by our method is reliable.
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Figure 2.3 Anticipated power curve calculated by ssizeRNA and observed power curves
using voom and limma while FDR was controlled using either the Benjamini
and Hochberg method (BH) or the q-value procedure by Storey and Tibshirani
(ST) for simulation 1.
Finally we would like to compare our method with other existing sample size calculation meth-
ods, including Li et al. (2013); Zhao et al. (2015) approach and Wu et al. (2015) approach. Li et al.
(2013) proposed to calculate the sample size by “using a common ρ∗ = argming∈M1{|log2(ρg)|}
minimum fold change”, where ρg in their paper denotes the fold change and is equivalent to δg in
this paper. However, we found that the direction of fold change does matter when applying their
code. If we set ρg = 2, the sample size calculated by their method is n = 20, as presented in their
Table 1. The plot of average power vs. nominal FDR for their method is shown in Figure 2.4, from
which we notice that the desired power (0.8) is not achieved at sample size n = 20 when controlling
FDR at 0.05. In fact, the observed power is 0.6166 when using the edgeR exact test based on
which they derived their method. When applying the the voom and limma pipeline, the observed
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power is 0.4608 for sample size 20. If we set ρg = 0.5, then the sample size will be 32, the same as
our proposed method, and we get power of 0.8988 using the edgeR exact test and 0.8149 using the
voom and limma pipeline for differential expression analysis. Wu et al. (2015) (PROPER) provided
a simulation-based power evaluation tool, which requires a lot of simulations to assess the power
for each sample size. Table 2.3 presents the computation time needed for the calculation. It took
PROPER 6.5 hours to get the resulting sample size while the other two methods only needed sec-
onds. PROPER is more than 1,300 fold time-consuming than our proposed method. The resulting
sample size from PROPER is 25, less than our proposed method. This is because PROPER is
based on edgeR exact test, which tends to be more powerful than the voom and limma pipeline.
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Figure 2.4 Observed average power vs. nominal FDR for five methods at sample size
n = 20 calculated by Li et al. (2013) method for simulation 1.
Results for other parameter settings under m = 200 are presented in the Additional file 1, with
Li et al. (2013) results in the first row, and our results in the second row.
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2.3.2 Simulation 2. Gene-specific Mean and Dispersion with Fixed Fold Change
In the second simulation setting, we used a real RNA-seq dataset to generate gene-specific mean
and dispersion parameters. A maize dataset was obtained from a study by Tausta et al. (2014),
who compared gene expression between bundle sheath and mesophyll cells of corn plants.
Similar to simulation 1, we generated 10,000 genes from NB(λg, φg), with fold change δ = 2 for
DE genes, λg and φg from the means and dispersions estimated for each gene in the maize dataset.
For EE genes, both rg1j and rg2j were drawn from NB(λg, φg); for DE genes, rg1j were drawn from
NB(λg, φg) and rg2j were drawn from NB(2λg, φg) or NB(0.5λg, φg). The proportion of non-DE
genes was pi0 = 0.8.
The fitted inverse gamma distributions of σ2g for m = 50 and 1000 are very similar, as shown
as in Figure 2.5, where vertical lines indicate the modes. The middle three columns in Table 2.2
give the sample size and average power calculated by our ssizeRNA package. As shown in Table
2.2, the resulting sample sizes are all 13 when m ranges from 50 to 1000. This is expected because
Figure 2.5 indicates that the estimated distributions of σ2g are very close using different m values
for this dataset.
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Figure 2.5 Fitted inverse gamma distributions of σ2g for sample size m = 50 and 1000 for
simulation 2.
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At n = 13, we checked the plots of average power vs. nominal FDR and true FDR vs. nominal
FDR, and the results were similar to those obtained in simulation 1. More specifically, the desired
power (0.8) was achieved, and FDR was controlled successfully. Actually, the desired power can
be reached at sample size n = 11. Figure 2.6(a) gives the power curve calculated by our method
based on hyperparameters estimated at m = 1000 together with observed power curves with FDR
controlled by the Benjamini and Hochberg’s method and the q-value procedure, respectively. The
anticipated power curve based on m = 1000 is close to the other two observed power curves.
The RnaSeqSampleSize R package (Zhao et al., 2015) could give an estimation of sample size
and power by prior real data. They first use user-specified number of genes to estimate the gene
read count and dispersion distribution, then sample size distribution and est power distribution
functions will be used to determine sample size and actual power. When we used the same real
dataset as our simulation setting 2, the sample size calculated by their method was 7, with actual
power 0.774, which did not reach the desired power 0.8. We also tried to apply their method using
our simulated data (with different m), the resulting sample size is larger (n = 9). The power
estimated by their method at n = 9 are shown in Table 2.2, and all their estimated power were
actually smaller than 0.8. PROPER started from an estimation of mean and dispersion parameters,
which is similar to our method. The sample size calculated by their method is 10, with power 0.804
based on DE detection method edgeR. The comparison results of our proposed method and these
three approaches are shown in the middle three columns of Table 4.2. Still, PROPER is much more
time-consuming than the other two methods.
2.3.3 Simulation 3. Gene-specific Mean and Dispersion with Different Fold Change
In this simulation, the setting is the same as the second simulation study, except that the
fold change δg was simulated from a log-normal distribution for differentially expressed genes. For
EE genes, both rg1j and rg2j were drawn from NB(λg, φg); for DE genes, rg1j were drawn from
NB(λg, φg) and rg2j were drawn from NB(λgδg, φg) or NB(λg/δg, φg) where
δg ∼ log − normal(log(2), 0.5log(2)).
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Figure 2.6 Anticipated power curve calculated by ssizeRNA and observed power curves
using voom and limma while FDR was controlled using either the Benjamini
and Hochberg method (BH) or the q-value procedure by Storey and Tibshirani
(ST) for simulation 2 (in (a)) and 3 (in (b)).
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The last three columns in Table 2.2 give the sample size and power calculated by our method.
As in simulation 2, varying the size of simulated data (m) did not result in different sample sizes.
Anticipated and observed power curves are presented in Figure 2.6(b), from which we notice that the
three curves are almost indistinguishable after power reaches 60%. This more realistic simulation
demonstrates that our proposed method provides accurate power and sample size.
We also applied RnaSeqSampleSize to this simulation setting. Since their method is based
on minimum fold change, such results will be conservative due to the variability of fold change,
especially as in this case, the minimum fold change is close to 1. When we used the 10th percentile of
fold change of DE genes as the “minimum” fold change, the sample size calculated by their method
was 74, which is still much larger than what we actually need, but the power calculated by their
method based on the “minimum” fold change was less than the desired power 0.8. PROPER gave
a result of sample size 19 with power 0.805 based on DE detection method edgeR. The comparison
results of our proposed method and these three approaches are shown in the last three columns of
Table 4.2.
Based on results from simulations, our proposed method and RnaSeqSampleSize provided an-
swers much faster than PROPER, and our proposed method and PROPER provided good sample
size estimation. Overall, our proposed method worked the best while both accuracy and computa-
tion time are considered.
2.3.4 Simulation 4. Real Data-based Simulation
Our method involves simulating data based on negative binomial distributions. To check the
robustness of our method, we conducted a simulation based on a real RNA-seq dataset from Pickrell
et al. (2010), which was upon an RNA-seq experiment that sequenced 69 lymphoblastoid cell lines
(LCL) derived from unrelated Nigerian individuals. We used the genes with minimum read counts
across all individuals larger than 10, which results in 9154 genes. First, we estimated the mean and
dispersion across all 69 individuals for each gene. Assume that fold change comes from a log-normal
distribution as in simulation 3,
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δg ∼ log − normal(log(2), 0.5log(2)),
the proportion of non-DE genes being 80%, to reach a desired power 0.8 while controlling FDR at
0.05, the sample size calculated by our method is 12 at m = 200.
To check whether desired power can be achieved at the calculated sample size, we simulated
100 datasets. For each simulation, we randomly picked 24 out of the 69 individuals and randomly
assigned 12 individuals to the control group and the remaining 12 individuals to the treatment
group. Consider all 9154 genes among the 24 individuals as EE since the samples were randomly
selected from the same population. Then we randomly generated 20% of the 9154 genes to be
DE, and their counts in the treatment group were multiplied by fold change δg which were drawn
from a log−normal(log(2), 0.5log(2)) distribution. The scaled counts were rounded to the nearest
integers. This strategy likely results in more realistic data because all counts come from real
dataset and no distributional assumptions were imposed. The plot of average power vs. nominal
FDR at n = 12 is shown in Figure 2.7(a), where desired power (0.8) was achieved for most testing
methods, including edgeR, DESeq2, QuasiSeq, voom and limma methods, when controlling FDR
at 0.05 using q-value procedure. Figure 2.7(b) gives the power calculated by our method based on
hyperparameters estimated at m = 200. It also presents the observed average power curves when
FDR was controlled by either the Benjamini and Hochberg’s method or the q-value procedure.
The anticipated power curve based on m = 200 is close to the other two observed power curves.
Hence, our proposed method also provides a reliable estimation of sample size and power in the
most realistic simulation study.
2.4 Conclusions
In recent years, RNA-seq technology has become a major platform to study gene expression.
With large sample size, RNA-seq experiments would be rather costly; while insufficient sample size
may result in unreliable statistical inference. Thus sample size calculation is a crucial issue when
designing an RNA-seq experiment. Although we could use a lot of simulations for each sample size
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Figure 2.7 Results from simulation 4. (a) Observed average power from different methods
of differential expression analysis is plotted against the nominal FDR level
controlled using the q-value procedure at sample size n = 12. (b) Anticipated
power curve calculated by ssizeRNA and observed power curves using voom
and limma while FDR was controlled using either the Benjamini and Hochberg
method (BH) or the q-value procedure by Storey and Tibshirani (ST).
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and determine the one that reach our desired power as suggested in Fang and Cui (2011); Ching
et al. (2014); Wu et al. (2015), this requires generous calculation and lacks efficiency. Our method
provides a quick calculation for sample size, which only demands one-time simulation. From the
simulation studies in the section of Results and Discussion, we demonstrate that our proposed
method offers a reliable approach for sample size calculation for RNA-seq experiments.
For each gene g, when we use a two-sample t-test to do differential expression analysis, the
effect size ∆g in formula (2.4) depends on the simulated sample size m. Larger m may lead to
better estimation of the prior distributions and hence a more accurate sample size. Based on our
simulation studies, the effect of m on the resulting sample size is not big, and m = 200 should be
enough for providing a relatively precise sample size.
The ordinary t-test instead of the moderated t-test Smyth (2004) was used in ssizeRNA R
package. Because the ordinary t-test is a bit less powerful than the moderated t-test, it tends to
overestimate the sample size which might be the reason why our calculated sample size in simulation
2 is a little bit larger than what we actually need according to the observed power curves using
voom and limma. However, the overestimation is not dramatic and far less than the method Li
et al. (2013).
In this article, we illustrate our idea using a method for two-sample comparison with the t-test,
because detecting differentially expressed genes between two treatment groups is the most common
case in RNA-seq analysis. Our idea could be applied to multi-sample comparison with an F-test
or tests for linear contrasts of treatment means as well.
The R package ssizeRNA implements our proposed sample size calculation method for RNA-seq
experiments and it is freely available on the Comprehensive R Archive Network (http://cran.r-
project.org). To install this package, start R and enter:
source(“http://bioconductor.org/biocLite.R”)
biocLite(“ssizeRNA”)
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2.5 Appendices
2.5.1 Appendix A: Derivation of Equation (2.3)
For each individual gene g, the weighted linear model
yg = Xβg + σgW
− 1
2
g 
can be fitted to log-cpm values
yg = (yg11, . . . , yg1n1 , yg21, . . . , yg2n2)
′
with design matrix
X =

1 0
...
...
1 0
1 1
...
...
1 1

,
coefficients vector
βg =
 βg1
βg2
 ,
unknown gene-specific standard deviation σg, associated voom precision weights
Wg = diag(wg11, · · · , wg1n1 , wg21, · · · , wg2n2),
and error
 ∼MVN(0, In1+n2).
Thus we could obtain the coefficient estimators
βˆg = (X
TWgX)
−1XTWgyg
with variance-covariance matrix
V ar(βˆg) = σ
2
g(X
TWgX)
−1,
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where σ2g is estimated by s
2
g
s2g =
(yg −Xβg)′Wg(yg −Xβg)
n− p
with
p = rank(X) = 2.
Let vgk be the kth diagonal element of (X
TWgX)
−1, where
(XTWgX)
−1
=
 ∑2i=1∑nij=1wgij ∑n2j=1wg2j∑n2
j=1wg2j
∑n2
j=1wg2j

−1
=
 ∑n2j=1wg2j −∑n2j=1wg2j
−∑n2j=1wg2j ∑2i=1∑nij=1wgij

∑n1
j=1wg1j
∑n2
j=1wg2j
.
Under the assumptions as made in Smyth (2004),
βˆgk|βgk, σ2g ∼ N(βgk, vgkσ2g)
and
s2g|σ2g ∼
σ2g
dg
χ2dg ,
where dg is the residual degrees of freedom for the linear model of gene g, the ordinary t-test
statistic will be
tgk =
βˆgk
sg
√
vgk
,
which follows an approximate t-distribution with dg degrees of freedom.
Assuming equal variance between treatment and control group, then the statistic for testing
Hg0 : µg1 = µg2 vs. H
g
1 : µg1 6= µg2
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for the gth gene is
Tg =
βˆg2
S.E.(βˆg2)
=
βˆg2
sg
√
vg2
=
βˆg2
sg
√ ∑2
i=1
∑ni
j=1 wgij∑n1
j=1 wg1j
∑n2
j=1 wg2j
=
βˆg2
√
1
n1
+ 1n2
√∑n1
j=1 wg1j
∑n2
j=1 wg2j∑2
i=1
∑ni
j=1 wgij
sg
√
1
n1
+ 1n2
=
βˆg2
√∑n1
j=1 wg1j/n1
∑n2
j=1 wg2j/n2∑2
i=1
∑ni
j=1 wgij/(n1+n2)
sg
√
1
n1
+ 1n2
=
βˆg2
√
w¯g1·w¯g2·
w¯g··
sg
√
1
n1
+ 1n2
≡ ∆g
sg
√
1
n1
+ 1n2
,
where
∆g ≡ βˆg2
√
w¯g1·w¯g2·
w¯g··
with w¯g1· = 1n1
∑n1
j=1wg1j , w¯g2· =
1
n2
∑n2
j=1wg2j and w¯g·· =
1
n1+n2
∑2
i=1
∑ni
j=1wgij .
2.5.2 Appendix B: Choice of Rejection Region Γ Satisfying Formula (2.1)
For the two-sample comparison with t-test statistics Tg as in equation (2.3), we assume as in
LH method that the effect size follows a normal distribution
∆g ∼ N(µ∆, σ2∆),
and the variance of log-cpm values for each gene follows an inverse gamma distribution
σ2g ∼ Inv −Gamma(a, b)
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with mean ba−1 , then formula (2.1) becomes
α
1− α
1− pi0
pi0
≥Pr(T ∈ Γ|H = 0)
Pr(T ∈ Γ|H = 1)
=
Pr(T ∈ Γ|H = 0)∫ ∫
Pr(T ∈ Γ|H = 1,∆g, σg)pi1(∆g)pi2(σg)d∆gdσg
=
Pr(|Tg| > c|H = 0)∫ ∫
Pr(|Tg| > c|H = 1,∆g, σg)pi1(∆g)pi2(σg)d∆gdσg , (2.5)
where pi1(∆g) and pi2(σg) denote the probability distribution function (p.d.f.) of ∆g and σg respec-
tively. The numerator in (2.5) equals
2 · Tn1+n2−2(−c),
where Td (·) denotes the cumulative distribution function (c.d.f.) of a central t-distribution with d
degrees of freedom, and the denominator in (2.5) equals
1−
∫ ∫
Tn1+n2−2 (c|θg)pi1(∆g)pi2(σg)d∆gdσg
+
∫ ∫
Tn1+n2−2 (−c|θg)pi1(∆g)pi2(σg)d∆gdσg. (2.6)
Here, Td (·|θg) denotes the c.d.f. of a non-central t-distribution with d degrees of freedom and
non-centrality parameter
θg =
∆g
σg
√
1
n1
+ 1n2
.
The integration in (2.6) with respect to ∆g could be avoided through mathematical derivation,
and the integration with respect to σg is approximated using static quadrature rules, which allows a
stable calculation to get the root of c. Details of derivation could be found in Appendix B (Section
2.5.2) of Liu and Hwang (2007).
Once the choice of c has been made for each sample size, power would be calculated accordingly
by integrating over the prior distributions on effect size and residual variance. Hence based on the
desired power, sample size is finally determined.
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CHAPTER 3. A SEMI-PARAMETRIC BAYESIAN APPROACH, iSBA,
FOR DIFFERENTIAL EXPRESSION ANALYSIS OF RNA-SEQ DATA
Submitted to PLOS ONE
Ran Bi, Peng Liu
Abstract
RNA sequencing (RNA-seq) technologies have been popularly applied to study gene expression in
recent years. Identifying differentially expressed (DE) genes across treatments is one of the major
steps in RNA-seq data analysis. Most differential expression analysis methods rely on parametric
assumptions, and it is not guaranteed that these assumptions are appropriate for real data analysis.
In this paper, we develop a semi-parametric Bayesian approach for differential expression analysis.
More specifically, we model the RNA-seq count data with a Poisson-Gamma mixture model, and
propose a Bayesian mixture modeling procedure with a Dirichlet process as the prior model for the
distribution of fold changes between the two treatment means. We develop Markov chain Monte
Carlo (MCMC) posterior simulation using Metropolis Hastings algorithm to generate posterior
samples for differential expression analysis while controlling false discovery rate. Simulation results
demonstrate that our proposed method outperforms other popular methods used for detecting DE
genes.
Keywords: Bayesian mixture modeling; RNA-seq; Differential expression; Dirichlet process; Pos-
terior probability; MCMC.
3.1 Introduction
During the past decade, RNA sequencing (RNA-seq) technologies have revolutionized transcrip-
tomic studies. In a typical RNA-seq experiment, messenger RNA (mRNA) molecules are extracted
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from samples, fragmented, and converted to a library of complementary DNA (cDNA) fragments.
The cDNA fragments are then amplified and sequenced on a high-throughput platform, such as
HiSeq by Illumina or SOLiD by Applied Biosystems. Millions of DNA fragment sequences, called
reads, are obtained for each sample and mapped to a reference genome. The number of reads
aligned to a given gene measures the expression level for that gene. Thus, RNA-seq generates
discrete count data rather than continuous data serving as measurements of mRNA expression
levels.
In the statistical analysis of RNA-seq data, detecting differentially expressed (DE) genes across
treatments or conditions is one of the major steps and often the main goal. A gene is considered
to be DE if the expression levels change across treatment groups. Otherwise, the gene is said to be
equivalently expressed (EE). Generally, negative binomial (NB) distribution is used for modeling
RNA-seq count data. Many statistical methods based on the NB distribution have been proposed
for detecting DE genes with RNA-seq data, including edgeR (Robinson and Smyth, 2007, 2008;
Robinson et al., 2010; McCarthy et al., 2012), DESeq (Anders and Huber, 2010) and DESeq2
(Love et al., 2014). Methods that do not assume NB models typically involves transformation of
the count data to continuous scale, such as the Voom and limma pipeline (Law et al., 2014), which
models the mean-variance relationship of the log-transformed count data and produces a precision
weight for each observation, then applies the limma method based on normal distributions (Smyth,
2004) for the detection of DE genes.
The comparison among all the popular methods for RNA-seq data analysis mentioned above has
been done through simulation studies (Kvam et al., 2012; Soneson and Delorenzi, 2013). However,
the optimality of these existing testing procedures is inadequately studied. Si and Liu (2013)
developed an optimal test for RNA-seq data anaysis while controlling FDR, where optimal tests
were defined as tests that achieve the maximum of the power averaged across all genes for which null
hypotheses are false. Furthermore, Si and Liu (2013) proposed an approximation to the optimal test,
where hyper distributions were estimated with mixture distributions, and such a test is called the
approximated most average powerful (AMAP) test. In the two-treatment comparison problem, Si
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and Liu (2013) modeled the gene-specific treatment means by the overall geometric mean expression
level across both treatments and the ratio of the two treatment means, i.e., fold change ρg. They
used a K-component mixture Gamma-Normal (MGN) distribution to model the joint distribution
of the overall geometric mean expression level and the logarithm of the fold change. However, there
are several limitations of using MGN distribution, such as difficulty in selecting an appropriate
number of components K, and challenges in modeling the empirical distribution of all genes by
parametric models.
Bayesian nonparametric modeling is a more flexible way for distribution estimation and is often
applied to avoid critical dependence on parametric assumptions. The most popular Bayesian non-
parametric methods adopt Dirichlet process (DP) mixture modeling, and such modeling framework
has been utilized for DE analyses. For instance, (Do et al., 2005) chose DP mixtures to model the
population of genes under two different conditions and applied to a microarray dataset. Liu et al.
(2015) used the DP prior for modeling the distribution of fold changes between two treatments,
with a mixture of a point mass at one and a Gamma distribution as the base distribution in the
DP prior. In the method proposed by Liu et al. (2015), one treatment condition was set as the
reference condition (i.e., baseline) and they used DP as the prior for the distribution of fold changes
of the other condition versus the reference. When they changed the reference treatment group, the
declared differential expression status were not exactly the same for all genes.
To address this issue that the model is not invariant to the choice of reference condition, we
propose a method using a mixture of three components as the base distribution in the DP prior for
the distribution of the fold changes between two treatment conditions. The three components are
a point mass at one, a Gamma, and an inverse-Gamma distribution, so that the model becomes
invariant no matter which treatment group is set to be the reference. In addition, we model RNA-
seq count data via a Poisson-Gamma mixture model, which is equivalent to a NB model. Similar
to Liu et al. (2015), this paper shows how our mixture modeling procedure can be accommodated
to provide meaningful posterior probabilities of simple or composite null hypothesis. Also, we show
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that the posterior inference can be viewed as an approximation for the optimal test in Si and Liu
(2013), thus our approach is an approximated optimal test.
The article is organized as follows. Section 3.2 describes our proposed Bayesian mixture mod-
eling pipeline and the prior models. In Section 3.3, we present the MCMC algorithm for posterior
inference and FDR estimation. In Section 3.4, we generate several simulation studies based on
NB distributions, and compare our proposed method to some popular methods for DE analysis.
In Section 3.5, we analyze a real dataset using our proposed method. Section 3.6 summarizes our
results and provides some discussion.
3.2 Bayesian Mixture Modeling
In this section, we first describe the framework of our mixture modeling, and then introduce
the prior models employed in our method.
3.2.1 A Poisson-Gamma Mixture Model
Suppose that an RNA-seq experiment measures G genes. Let Ygij denote the number of reads
mapped to gene g from biological replicate j of treatment i, where g = 1, . . . , G, i = 1, 2, j =
1, . . . , ni, and ni is the number of biological replicates in treatment i. As we mentioned in the
introduction section, NB distribution has been popularly applied to such data. In the development
of our modeling framework, we use a Poisson-Gamma mixture model parameterization instead of
the NB model directly, where the RNA-seq read counts follow a Poisson distribution conditioning
on the true expression mean, and the true gene abundances follow a Gamma distribution between
replicate RNA samples. Then read count data Ygij can be modeled as below,
Ygij |λgij ∼ Poisson(Sijλgij),
λg1j |αg, βg ∼ Gamma(αg, βg), and
λg2j |αg, βg, ρg ∼ Gamma(αg, βgρg), (3.1)
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where Sij is a normalization factor that accounts for sequencing depth variation and nuisance
technical effects across the replicates, λgij is the normalized expression mean of jth replicate of ith
treatment in gene g, αg is the shape parameter which stands for the reciprocal of the dispersion
parameter for gene g, βg is the rate parameter for the first treatment, and the product of βg and ρg
is the rate parameter for the second treatment. So the marginal expression mean for treatment 1 is
αg/βg, while for treatment 2 is αg/(βgρgi). Therefore, the mean ratio of treatment 1 over treatment
2 is ρg, which refers to the fold change between treatment 1 versus treatment 2.
The goal of differential expression analysis is to test
Hg0 : ρg ∈ ∆0 vs. Hg1 : ρg ∈ ∆1, (3.2)
for each gene g, where ∆0 represents the null set of values for ρg, while ∆1 represents the alternative
set. ∆0 and ∆1 are assumed to be a partition of the positive real line R+ (∆0
⋃
∆1 = R+,
∆0
⋂
∆1 = ∅). The null space ∆0 can be defined in different ways depending on the biological
problems of interest. For example, if we are interested in identifying DE genes across the two
treatments, we set ∆0 = {1}. If we are interested in whether the mean expression level in the
first treatment is greater than the second treatment, we set ∆0 = (0, 1]. If we are interested in
genes whose expression changes are large enough, for instance, the fold changes are greater than
1.5 (Peart et al., 2005), we set ∆0 = [1/1.5, 1.5].
3.2.2 Prior Specification
Since our main focus is to test the hypothesis about the fold change parameter ρg in (3.2)
for each gene, specifying an appropriate prior distribution for ρg is very crucial. The empirical
distribution of the fold change of all genes could be very irregular and differs between various
studies. To provide maximal flexibility, Bayesian nonparametric modeling with DP is a common
way for distribution estimation. DP is a stochastic process whose realizations are probability
distributions, i.e., each draw from a DP is itself a distribution. The formal definition of DP is as
follows. Given a measurable set Ω, a base probability distribution F0 and a positive real number
M called the concentration parameter, a random probability distribution F is generated by a DP
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if for any measurable partition A1, . . . , Ak of Ω, the distribution of (F (A1), . . . , F (Ak)) is Dirichlet
D(M ·F0(A1), . . . ,M ·F0(Ak)). We denote this by F ∼ DP (M,F0). The parameters F0 and M play
intuitive roles in the definition of the DP. For any measurable subset B of Ω, the base distribution
F0 is the mean of the DP, i.e., E[F (B)] = F0(B). Besides, the concentration parameter M defines
the variance as V ar[F (B)] = F0(B)(1−F0(B))/(M+1). The larger M is, the smaller the variance,
and the DP will concentrate more of its mass around the mean.
Throughout our mixture modeling procedure, we use a DP to model the fold change parameters
(ρ1, . . . , ρG). Different from Liu et al. (2015), we use a mixture of a point mass at one, a Gamma
and an inverse-Gamma distribution as the base distribution in the DP prior for the distribution of
the fold change parameters, so that our modeling is invariant to the specification of the reference
condition, and we call it iSBA (where SBA stands for semiparametric Bayesian approach). Details
of the proof of reference level invariance are provided in the first part of Appendices (Section 3.7.1).
Therefore, the DP prior for gene g, g = 1, . . . , G, can be expressed as
ρg|F i.i.d.∼ F,
F ∼ DP (M,F0),
F0 ∼ p0δ{1} +
1
2
(1− p0)Gamma(α0, β0) (3.3)
+
1
2
(1− p0)Inv-Gamma(α0, β0),
where p0 is the proportion of EE genes, and δ{x} denotes a point mass at x. In this paper, we set
p0 = 0.5 to give no prior preference to either DE or EE. The concentration parameter M in the
DP priors is fixed as M = 1, which is a common choice used in application (Do et al., 2005; Green
and Richardson, 2001; Kalli et al., 2011). Throughout our paper, the simple null hypothesis of our
great interest is Hg0 : ρg = 1.
Following Liu et al. (2015), we use a Gamma distribution as the prior distribution for βg
due to its conjugacy, and an exponential distribution as the prior for αg in order to reduce the
computational complexity of the posterior distribution,
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αg ∼ Exp(r), (3.4)
βg ∼ Gamma(a0, b0), (3.5)
where r, a0, b0, in addition to α0 and β0 in (3.3), are hyperparameters. We set r = 0.01, a0 = 0.1,
b0 = 0.1, α0 = 0.1, β0 = 0.1 so that the priors are non-informative and the inference for αg and βg
mainly relies on the observed data. For computational simplicity, we set the priors for αg’s, βg’s,
and ρg’s to be independent.
3.3 Posterior Inference
Posterior inference based on our proposed model is implemented by using Markov chain Monte
Carlo (MCMC) algorithm (Tierney, 1994). MCMC methods are usually employed to generate
samples from the posterior distribution by constructing a Markov chain that has the target posterior
distribution as its equilibrium distribution. We use an MCMC-based sampling method in our
proposed Bayesian mixture models. Gibbs sampling is the most frequently used tool to perform
MCMC algorithm for Bayesian hierarchical models when dealing with conjugate priors. However,
for addressing non-conjugate priors, the simplest way is by using the Metropolis-Hastings algorithm
(Hastings, 1970).
3.3.1 Markov Chain Monte Carlo Simulation
The Metropolis-Hastings algorithm simulates samples from a target distribution pi(x) using a
proposal distribution g(x∗|x), and updates the state x as follows. Generate a candidate state x∗
from the distribution g(x∗|x), then compute the acceptance probability
a(x∗|x) = min
[
1,
g(x|x∗)pi(x∗)
g(x∗|x)pi(x)
]
.
Set the new state x′ to x∗ with probability a(x∗|x). Otherwise, reject the candidate x∗ and let x′
be the same as x.
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To simplify the use of DP prior, when F is integrated over its prior distribution (3.3), the
sequence of ρg’s follows a Polya urn scheme (Blackwell and MacQueen, 1973; Escobar, 1994), that
is,
ρg|ρ−g ∼
1
G− 1 +M
∑
k 6=g
δ{ρk} +
M
G− 1 +MF0, (3.6)
where ρ−g is the vector of (ρ1, . . . , ρG) after deleting ρg.
Then the most direct approach to sample for our model is to perform Metropolis-Hastings
update for each of the ρg. However, this algorithm may not be very efficient since it cannot change
the ρg for more than one gene simultaneously. A change to the ρg values occurs only when they are
reallocated to new components. Thus it may take long time to converge to the posterior distribution
(Neal, 2000). In order to improve the efficiency of the MCMC algorithm, a modified Metropolis-
Hastings updates and partial Gibbs sampling method has been proposed by (Neal, 2000) (Algorithm
7). Suppose K is the number of distinct values in the vector (ρ1, . . . , ρG) and the distinct values
are denoted as ρ∗1, . . . , ρ∗K , respectively. Let ξ = (ξ1, . . . , ξG) be the configuration indicators defined
by
ξg = k if and only if ρg = ρ
∗
k = ρ
∗
ξg .
Therefore, we reparameterize the prior model for ρg’s with ρ
∗
k’s and ξg’s as follows,
ρ∗k
i.i.d.∼ F0,
F0 ∼ p0δ{1} +
1
2
(1− p0)Gamma(α0, β0)
+
1
2
(1− p0)Inv-Gamma(α0, β0),
(ξ1, . . . , ξG)|M ∼ CRP(M),
where the prior models for ρ∗k’s and ξg’s are independent and CRP stands for Chinese Restaurant
Process. CRP is a random distribution and the full conditional distribution for ξg’s can be written
as
ξg|ξl,M ∼
K(−g)∑
k=1
n
(−g)
k
G− 1 +M δ{k} +
M
G− 1 +M δ{K(−g)+1},
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where K(−g) denotes the number of distinct values in the vector (ρ1, . . . , ρG) after deleting ρg, and
n
(−g)
k denotes the number of (ρ1, . . . , ρG) who equal ρ
∗
k after deleting ρg.
The MCMC sampling scheme uses the modified Metropolis-Hastings updates and partial Gibbs
sampling method to repeatedly sample the following parameters step by step. The procedure for
generating the full conditionals of all parameters and how we apply Metropolis-Hastings algorithm
are shown in the second part of Appendices (Section 3.7.2).
(1) Draw samples of λgij ’s from their full condition distributions,
λg1j |· ∼ Gamma(Yg1j + αg, S1j + βg),
λg2j |· ∼ Gamma(Yg2j + αg, S2j + βgρg).
(2) Draw samples of βg’s from their full conditional distributions,
βg|· ∼ Gamma
(
αg(n1 + n2) + a0,
n1∑
j=1
λg1j +
n2∑
j=1
λg2jρg + b0
)
.
(3) There is no closed-form full conditional distribution for αg’s. Since the conditional posterior
distribution for each gene g is a log-concave function with respect to αg, we could draw
posterior samples based on adaptive rejection sampling method (Gilks, 1992).
(4) Obtain posterior samples for ρg’s by getting the Markov chain for (ξ1, . . . , ξG) and (ρ
∗
1, . . . , ρ
∗
K)
as follows:
(i) Update the configuration vector (ξ1, . . . , ξG).
• For g = 1, . . . , G, repeat the following: If ξg = ξl for some l 6= g, let ξ∗g be a newly
created component, with ρ∗ξ∗g drawn from F0. Set ξg to ξ
∗
g with probability
a(ξ∗g , ξg) = min
[
1,
M
G− 1 · e
−βg
∑n2
i=1 λg2j(ρ
∗
ξ∗g−ρ
∗
ξg
)
(ρ∗ξ∗g
ρ∗ξg
)n2αg]
.
Otherwise, if ξg 6= ξl for all l 6= g, draw ξ∗g from ξ−g, choosing ξ∗g = ξ with probability
n
(−g)
ξ
G−1 . Set the new ξg to this ξ
∗
g with probability
a(ξ∗g , ξg) = min
[
1,
G− 1
M
· e−βg
∑n2
j=2 λg2j(ρ
∗
ξ∗g−ρ
∗
ξg
)
(ρ∗ξ∗g
ρ∗ξg
)n2αg]
.
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• For g = 1, . . . , G, if ξg 6= ξl for all l 6= g, do nothing. Otherwise, choose a new value
for ξg from {ξ1, . . . , ξG} with probabilities
p(ξg = ξ|ξ−g, rest) = b ·
n
(−g)
ξ
G− 1
n2∏
j=1
λ
αg−1
g2j e
−βgρ∗ξλg2j (βgρ∗ξ)
αg
Γ(αg)
,
where b is the appropriate normalizing constant.
(ii) Update (ρ∗1, . . . , ρ∗K). For k = 1, . . . ,K, repeat the following: Draw ρ
∗∗
k from F0. Set the
new value of ρ∗k to ρ
∗∗
k with the probability
a(ρ∗∗k , ρ
∗
k) = min
[
1, e
∑
{g:ξg=k}
∑n2
j=1 βgλg2j(ρ
∗∗
k −ρ∗k) ·
(ρ∗∗k
ρ∗k
)∑
{g:ξg=k} n2αg
]
.
Otherwise, let the new ρ∗k be the same as the old value. If we have duplicated ρ
∗
k, delete
it and combine ξg.
3.3.2 Bayesian FDR Control
In genomic studies, tens of thousands of hypotheses are simultaneously tested, each relating
to a gene. Thus multiple testing procedures that control the number of false significant results
are commonly used in the analysis. False discovery rate (FDR) (Benjamini and Hochberg, 1995),
defined as the expected proportion of false positives among the rejected hypotheses, has been
the choice of error criterion in RNA-seq data analysis. Within the Bayesian framework, one can
estimate the FDR with Bayesian FDR (Genovese and Wasserman, 2003; Newton et al., 2004) by
using posterior probability.
For each gene g, g = 1, . . . , G, the posterior probability that gth null hypothesis is true is denoted
by P (ρg ∈ ∆0|Yg). If we are interested in detecting DE genes, with ∆0 = {1}, P (ρg ∈ ∆0|Yg) is
the posterior probability that gene g is EE. P (ρg ∈ ∆0|Yg) can be estimated by the proportion of
the posterior samples obtained from MCMC for gene g that fall into the null set ∆0, i.e.,
vˆg = Pˆ (ρg ∈ ∆0|Yg) = 1
N
N∑
m=1
I(ρmg ∈ ∆0|Yg),
where N is the number of posterior samples. We reject Hg0 if the estimated posterior probability
vˆg is smaller than a critical value c
∗. The critical value c∗ is chosen based on controlling the FDR
at a target level γ, for example, 0.05, i.e.,
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c∗ = sup{c : F̂DR(c) < γ},
where
F̂DR(c) =
∑G
g=1 vˆgI(vˆg < c)∑G
g=1 I(vˆg < c)
.
So the Bayesian FDR controlled at level γ can be calculated by
B̂FDR(γ) =
∑G
g=1 vˆgI(vˆg < c
∗)∑G
g=1 I(vˆg < c
∗)
.
3.4 Simulation
In this section, we adopt the simulation settings in Liu et al. (2015) to assess the performance of
our proposed method (iSBA), and compare to their semi-parametric Bayesian (SBA) method along
with other popular methods for differential expression analysis of RNA-seq data, such as edgeR
(Robinson et al., 2010), voom and limma pipeline (Law et al., 2014), and DESeq (Anders and Huber,
2010). To mimic the distributions of real RNA-seq count data, we sampled gene-specific mean and
dispersion parameters from the estimated values based on a maize study (Tausta et al., 2014) that
compared gene expression between bundle sheath and mesophyll cells of corn plants. Following Liu
et al. (2015), we conducted the same two sets of simulation studies (A and B). For each simulation
study, 32 independent RNA-seq datasets were simulated from NB distributions with given mean and
dispersion parameters, each dataset contains 10,000 genes, 2 treatment groups, and n replicates per
treatment group, where n = 3 or 6. For our proposed method, we generated 5000 posterior samples
after 3000 iterations burn-in, to calculate the estimated posterior probabilities. Convergence was
checked via Gelman-Rubin criteria (Gelman and Rubin, 1992). The test performances of different
methods are evaluated by averaging the 32 datasets.
3.4.1 Simulation A
We used the maize dataset published by Tausta et al. (2014) to estimate the gene-specific mean
for one treatment group and the dispersion parameters, and randomly sampled 10,000 pairs of
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mean and dispersion parameters out of all 27,819 pairs without replacement, which would be used
as the true mean expression level for the control group (µg) and the true dispersion parameter (φg)
for gene g = 1, . . . , 10000. Given the number of replicates per treatment group, n = 3 or 6, the
RNA-seq read count data for the control group were generated from NB(µg, φg) for gene g. Then
we randomly selected 5000 out of the 10,000 genes to be EE, whose count data for the treatment
group were also drawn from NB(µg, φg). The remaining 5000 genes were simulated to be DE genes,
with fold change (ρg) set to be 4, 8, 0.25 and 0.125. Thus we had 1250 genes for each ρg value,
whose count data for the treatment group were drawn from NB(µgρg, φg).
3.4.2 Simulation B
Similar to Simulation A, we generated 10,000 genes from NB(µg, φg), with fold change ρg for
5000 DE genes. Instead of setting ρg to be 4, 8, 0.25 or 0.125, we simulated ρg from a two-component
mixture of lognormal distributions,
log(ρg) ∼ 0.5Normal(log(4), 1) + 0.5Normal(−log(4), 1).
3.4.3 Simulation Results for Testing DE Genes
In order to avoid the impact on test performance with different normalization procedures, we
applied the same normalization steps for all the methods under comparison. Specifically, we set all
normalization factors to be 1 for both Simulations A and B.
The receiver operating characteristic (ROC) curves that plot the true positive rate (TPR) versus
false positive rate (FPR) resulting from Simulations A and B with number of replicates per group
n = 3 or 6 are shown in Figure 3.1. These curves were generated based on either the posterior
probabilities or p−values for each method. For each level of FPR, the TPRs were averaged over
the 32 simulated datasets. We plotted the curves over the FPR values in the range of 0 and 0.1
because we are most interested in small FPR values. We also calculated the area under the curve
(AUC) values as the percentages of 0.1, which is the total area in the range of FPR < 0.1. The
average values and standard deviations of the AUC across the 32 simulated datasets are reported in
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the legends of Figure 3.1. Figure 3.1 shows that our iSBA method and the SBA method proposed
by Liu et al. (2015) generated the highest ROC curves and largest AUC values among all tests
under all simulation settings, indicating that iSBA and SBA methods outperformed other methods
in terms of ranking DE genes.
Figure 3.1 ROC curves resulting from Simulations A and B. For each level of FPR, the
TPRs were averaged over the 32 simulated datasets. The percentage reported
in the legend is the average AUC for each method, representing the percentage
of 0.1, which is the total area in the range of FPR < 0.1, and the percentage
in each set of parentheses is the standard deviation of the estimated AUC.
We also checked the false discovery (FD) plot as in Liu et al. (2015), which is the plot of the
number of false positives versus the number of top ranked genes selected as DE. Genes were ranked
based on either posterior probabilities or p−values for each method. A better performing method
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would have a lower FD curve. The FD plots for Simulations A and B with n = 3 or 6 are shown
in Figure 3.2. The number of false positives decreased when sample size increased from 3 to 6 for
all methods, as expected. Our iSBA method and the SBA method provided the lowest FD curves
under all simulation settings, indicating that our iSBA method and the SBA method produced less
false positives than others, when we declared the same number of DE genes for all methods.
Figure 3.2 False discovery curves resulting from Simulations A and B. For each number of
top ranked genes selected as DE, the number of false positives were averaged
across the 32 simulated datasets. Genes were ranked based on either posterior
probabilities or p−values.
In addition, we evaluated the estimation of FDR based on subsection 3.3.2 for our method
and SBA method. For other non-Bayesian methods, we applied the Benjamini and Hochberg
(Benjamini and Hochberg, 1995) procedure to adjust p−values for multiple comparisons. FDR
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plots for Simulations A and B with n = 3 or 6 are presented in Figure 3.3. Our iSBA method
controlled FDR well, the SBA method performed the second, while other methods provide more
conservative results.
Figure 3.3 Plots of the actual FDR versus the nominal level of FDR resulting from Sim-
ulations A and B. The dashed lines correspond to the Y = X line. A well
performing method would control the FDR below or close to the dashed line.
Based on results from these simulations, our iSBA method and the SBA method generated the
highest ROC curves and the least false positives, comparing with other popularly applied RNA-seq
DE analysis methods. Furthermore, the iSBA method controlled FDR the best, hence provided
reliable lists of declared DE genes. All in all, our proposed iSBA method worked the best or among
the best under all simulation settings.
56
3.4.4 Simulation Results for Testing: |logFC| ≤ log1.5
In addition to the simple hypothesis testing problem introduced in the last subsection, we could
also apply our method to do other types of hypothesis testing, for example, testing whether the
fold change falls into a certain interval or not. In practice, biologists often want to detect genes
whose fold-changes are big enough and biologically meaningful. This subsection shows the results
for testing: |logFC| ≤ log1.5 for Simulation B.
We applied our iSBA method and the SBA method directly to do this hypothesis testing
problem. For other methods including edgeR, voom and limma pipeline, and DESeq, we adopted
the two-step procedure described in Si and Liu (2013). More specifically, in the first step, ρg = 1
was tested for each gene, and a list of DE genes was identified while controlling FDR at a given
level. In the second step, among those DE genes declared in the first step, genes with large enough
fold changes (|logFC| > log1.5) were selected.
The ROC curves for testing |logFC| ≤ log1.5 for Simulation B are shown in the upper panel of
Figure 3.4. The iSBA method and the SBA method outperformed all other methods. The lower
panel of Figure 3.4 provides the FDR plots, from which we could notice that our iSBA method
controlled FDR well in the range of FDR smaller than 0.1.
3.4.5 Simulation Results for Swapping Treatments
As we discussed in the introduction (Section 3.1), the semi-parametric Bayesian (SBA) method
(Liu et al., 2015) set one treatment group as reference condition. If the choice of a reference
condition is not obvious based on the experimental design, the declared differential expression
status may vary depending on which group is set to be baseline. However, the model we proposed
is invariant no matter which group is set to be the reference condition. The proportion of genes
remaining the same declared differential expression status between two analyses that swapped the
treatment and control groups were calculated when controlling FDR at 0.05, with average values
and standard deviation of the percentage across the 32 simulated datasets reported in Table 3.1. It
turned out that our iSBA method had higher overlap and more consistency in declared differential
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Figure 3.4 Results for testing |logFC| ≤ log1.5 from Simulation B. The upper panel shows
the ROC curves. For each level of FPR, the TPRs were averaged over the 32
simulated datasets. The percentage reported in the legend is the average AUC
for each method, representing the percentage of 0.1, which is the total area
in the range of FPR < 0.1, and the percentage in each set of parentheses is
the standard deviation of the estimated AUC. The lower panel plots the actual
FDR versus the nominal level of FDR. The dashed lines correspond to the
Y = X line.
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expression status than SBA method when swapping the treatment and control groups, for all
simulation settings.
Table 3.1 Proportion of genes remaining the same declared differential expression status
between two analyses that swapped the treatment and control groups for Simu-
lations A and B, when controlling FDR at 0.05. The proportions were averaged
across the 32 simulated datasets, and the percentage in each set of parentheses
is the standard deviation of the estimated proportion.
Simulation setting SBA iSBA
Simulation A, n = 3 91.43% (2.21%) 92.43% (0.33%)
Simulation A, n = 6 93.12% (5.55%) 94.87% (0.48%)
Simulation B, n = 3 91.42% (4.80%) 93.78% (0.84%)
Simulation B, n = 6 93.98% (2.23%) 94.83% (0.39%)
3.5 Real Data Analysis
In this subsection, we analyze a real RNA-seq dataset published by Li et al. (2010). The dataset
measures the transcript abundance of two cell types, bundle sheath and mesophyll, for different
leaf sections. Each cell type has two biological replicates. The objective of the analysis is to detect
genes that are DE between cell types or between different leaf sections. We analyzed leaf section 4
to detect DE genes between the two cell types in this section.
After deleting genes that have zero counts for both replicates in either cell type, 28,407 out of
33,743 genes were retained for analysis. We assumed NB models for the count data observed for
each gene, and performed our proposed iSBA method, together with SBA method and edgeR. We
also controlled FDR as described in subsection 3.3.2 for SBA and iSBA, and applied the Benjamini
and Hochberg (Benjamini and Hochberg, 1995) procedure for edgeR.
The numbers of DE genes detected by different methods while controlling FDR at different levels
are shown in Figure 3.5. For example, when we controlled FDR at 0.05, 6040 genes were detected
by all three methods. The majority of genes identified by our iSBA method were overlapped with
SBA. 2703 genes were detected by both iSBA and SBA, but not by edgeR, which may due to the
conservative control of FDR based on our simulation studies.
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Figure 3.5 The numbers of DE genes between two cell types for leaf section 4. The Venn
diagram on the left shows the number of overlapping identified DE genes from
our iSBA method, SBA method, and edgeR while controlling FDR at 1%; the
Venn diagram on the right shows the corresponding results while controlling
FDR at 5%.
The proportions of genes remaining the same declared differential expression status between
two analyses that swapped the two treatment groups when controlling FDR at 0.05 for our iSBA
method is 93.47%, while the SBA method is 89.28%.
3.6 Discussion
In this paper, we proposed a Bayesian mixture modeling procedure for DE analysis of RNA-seq
count data, and employed the MCMC sampling scheme to generate posterior samples for further
inference. Simulation results demonstrate that our method outperformed other commonly used
methods, such as edgeR, voom and limma pipeline, and DESeq, in terms of both ranking DE genes
and FDR control.
A common choice of the concentration parameter M in the DP priors that are widely used in
application is M = 1 (Do et al., 2005). We check the simulation results with different M values
(M being 0.2, 0.5, 2, 5, 10 or 20), and the results remain almost the same for various values of M .
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In our proposed method, the DP prior we choose guarantees that our modeling is invariant
regardless of which treatment group is set to be the reference condition. According to the simulation
results on two analyses that swapped the treatment and control groups, it is worth noticing that
even for our iSBA method, the declared differential expression status are still not 100% the same.
Part of the reason is due to the randomness of MCMC, if we run another MCMC using different
seed, the overlap between the two MCMCs is about 97%. Since we generated 5000 posterior samples
to calculate the estimated posterior probabilities after 3000 iterations burn-in, whether the Markov
chains are long enough to get accurate results is also a potential problem. We checked the effective
sample size for each gene, genes that had the same declared DE status after swapping treatments
had effective sample sizes about 500 or larger, but genes that had different declared DE status
overlapped had effective sample sizes around only 100. Effective sample size around 400 can be
regarded as large enough, so for those genes with low effective sample size, we may need to run
longer MCMC. Based on simulation checking, running the Markov chains longer do increase the
percentage of overlapping genes, as expected. For example, for simulation A with n = 6, if we
doubled the length of chain, the overlap for iSBA increased to 95.28%. However, running longer
chains is more time consuming, and it only benefits a small proportion of genes while results for
most genes would not change. Therefore, it is a tradeoff between efficiency and accuracy, and we
will let the users decide which one is more important for a practical application.
As indicated in subsection 3.3.2, the estimated posterior probability vˆg is used as a test statistic
and a decision Dg is based on whether vˆg is small enough. And the AMAP test by Si and Liu (2013)
is based on a similar test statistic except that the prior models are different. In fact, the MAP
test statistic derived in Si and Liu (2013) can be viewed as the posterior probability of being null
given the distribution of gene-specific parameters under the null hypothesis and the distribution of
these parameters under the alternative hypothesis. Assuming the distributions of the gene-specific
parameters (fold changes and other parameters) follow approximately the prior distribution we use,
our estimated posterior probability using MCMC is an AMAP test statistic.
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3.7 Appendices
3.7.1 Proof of Model Invariance
Here we give a brief proof that the model for the distribution of fold change parameters
(ρ1, . . . , ρG) we proposed does not depend on which group is set to be the reference condition.
Suppose we set the first treatment group as baseline, then our model can be expressed as
Ygij |λgij ∼ Poisson(Sijλgij),
λg1j |αg, βg ∼ Gamma(αg, βg),
λg2j |αg, βg, ρg ∼ Gamma(αg, βgρg),
ρg|F i.i.d.∼ F,
F ∼ DP (M,F0),
F0 ∼ p0δ{1} +
1
2
(1− p0)Gamma(α0, β0)
+
1
2
(1− p0)Inv-Gamma(α0, β0).
If we set the second treatment group as baseline, then our model can be expressed as
Ygij |λgij ∼ Poisson(Sijλgij),
λg1j |α′g, β′g, ρ′g ∼ Gamma(α′g, β′gρ′g),
λg2j |α′g, β′g ∼ Gamma(α′g, β′g),
α′g = αg,
β′g = βgρg,
ρ′g =
1
ρg
.
It is obvious that if the distribution of ρ′g is the same as ρg, then our model structure will be
invariant no matter which treatment group is set to be baseline. Suppose X ∼ F0, Y = 1X , where
F0 ∼ p0δ{1} +
1
2
(1− p0)Gamma(α0, β0)
+
1
2
(1− p0)Inv-Gamma(α0, β0).
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The characteristic function of Y is
φY (t) = E(e
itY )
=
∫ ∞
−∞
eityfY (y)dy
= −
∫ ∞
−∞
eityfX
(1
y
) 1
y2
dy
= −
∫ ∞
−∞
eit
1
x fX(x)x
2d
1
x
=
∫ ∞
−∞
eit
1
x fX(x)dx
= E(eit
1
X )
=
∫ ∞
−∞
eit
1
x
(
p0 · fX1(x) +
1
2
(1− p0)fX2(x) +
1
2
(1− p0)fX3(x)
)
dx
= p0E(e
it 1
X1 ) +
1
2
(1− p0)E(eit
1
X2 ) +
1
2
(1− p0)E(eit
1
X3 )
where X1 ∼ δ{1}, X2 ∼ Gamma(α0, β0), X3 ∼ Inv-Gamma(α0, β0), thus 1X1 ∼ δ{1}, 1X2 ∼
Inv-Gamma(α0, β0),
1
X3
∼ Gamma(α0, β0). Therefore, the characteristic function of Y is
φY (t) = p0E(e
it 1
X1 ) +
1
2
(1− p0)E(eit
1
X2 ) +
1
2
(1− p0)E(eit
1
X3 )
= p0E(e
itX1) +
1
2
(1− p0)E(eitX3) + 1
2
(1− p0)E(eitX2)
= φX(t),
i.e., Y = 1X ∼ F0. Thus swapping treatments won’t change the model structure.
3.7.2 Detailed MCMC Sampling Scheme
Details on how we generate the full conditionals for all parameters and how we apply Metropolis-
Hastings algorithm.
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(1) Obtain draws of λgij ’s from their full condition distributions.
p(λg1j |·) ∝ p(Yg1j |λg1j)p(λg1j |αg, βg)
∝ e−S1jλg1j (S1jλg1j)Yg1jλαg−1g1j e−(λg1jβg)
∝ λ(Yg1j+αg−1)g1j e−λg1j(S1j+βg)
p(λg2j |·) ∝ p(Yg2j |λg2j)p(λg2j |αg, βg, ρg)
∝ e−S2jλg2j (S2jλg2j)Yg2jλαg−1g2j e−(λg2jβgρg)
∝ λ(Yg2j+αg−1)g2j e−λg2j(S2j+βgρg)
Thus,
λg1j |· ∼ Gamma(Yg1j + αg, S1j + βg),
λg2j |· ∼ Gamma(Yg2j + αg, S2j + βgρg).
(2) Draw Sample of βg’s from their full conditional distributions.
p(βg|·) ∝ pi(βg)
n1∏
j=1
p(λg1j |αg, βg)
n2∏
j=1
p(λg2j |αg, βg, ρg)
∝ βa0−1g e−βgb0 ·
n1∏
j=1
e−λg1jβgβαgg ·
n2∏
j=1
e−λg2jβgρg(βgρg)αg
∝ βn1αg+n2αg+a0−1g e−βg(
∑n1
j=1 λg1j+
∑n2
j=1 λg2jρg+b0)
Thus,
βg|· ∼ Gamma
(
αg(n1 + n2) + a0,
n1∑
j=1
λg1j +
n2∑
j=1
λg2jρg + b0
)
(3) Draw sample of αg’s.
p(αg|·) ∝ pi(αg)
n1∏
j=1
p(λg1j |αg, βg)
n2∏
j=1
p(λg2j |αg, βg, ρg)
∝ e−rαg ·
n1∏
j=1
λ
αg−1
g1j β
αg
g
Γ(αg)
·
n2∏
j=1
λ
αg−1
g2j (βgρg)
αg
Γ(αg)
∝ e−rαg · β
αg(n1+n2)
g ρ
αgn2
g
[Γ(αg)]n1+n2
·
2∏
i=1
ni∏
j=1
λ
αg−1
gij
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There is no closed-form full conditional distribution for αg. If p(αg|·) is a log-concave function
with respect to αg, then we could draw posterior samples based on adaptive rejection sampling
method (Gilks, 1992).
log p(αg|·) =− rαg + αg(n1 + n2)log(βg) + αgn2log(ρg)
− (n1 + n2)log Γ(αg) +
2∑
i=1
ni∑
j=1
(αg − 1)log(λgij),
then the first derivative of log p(αg|·) is
∂ log p(α|·)
∂ αg
=− r + (n1 + n2)log(βg) + n2log(ρg)
− (n1 + n2)∂ log Γ(αg)
∂ αg
+
2∑
i=1
ni∑
j=1
log(λgij),
the second derivative of log p(αg|·) is
∂2 log p(αg|·)
∂ α2g
= −(n1 + n2)∂
2 log Γ(αg)
∂ α2g
.
Denote the first derivative of log-Gamma function
d logΓ(x)
dx
=
Γ′(x)
Γ(x)
, ψ(x).
Since
Γ(x+ 1) = Γ(x) · x
⇒ Γ′(x+ 1) = Γ′(x) · x+ Γ(x)
⇒ Γ
′(x+ 1)
Γ(x)
= 1 + x · Γ
′(x)
Γ(x)
⇒ Γ
′(x+ 1)
Γ(x+ 1)/x
= 1 + x · Γ
′(x)
Γ(x)
⇒ ψ(x+ 1) = 1
x
+ ψ(x)
⇒ ψ(n+ 1) = −r +
n∑
k=1
1
k
,
where −r = ψ(1), n = 0, 1, 2, . . .
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Also by Stirling’s formula,
log Γ(x+ 1) = log x! ∼ x log x− x+ 1
2
· log 2pix as n→∞
⇒ ψ(x+ 1) ∼ log x+ 1
2x
as n→∞
⇒ r = limn→∞
( n∑
k=1
1
k
− log n
)
Then we have
ψ(x+ n) =
n−1∑
k=0
1
x+ k
+ ψ(x),
and
ψ(n+ 1) = −r +
n∑
k=1
1
k
,
subtract the second formula from the first one, we could obtain
ψ(x+ n)− ψ(n+ 1) =
n−1∑
k=0
( 1
x+ k
− 1
k + 1
)
+ r + ψ(x).
Let n→∞, then
ψ(x) = limn→∞
[
ψ(x+ n)− ψ(n+ 1)−
n−1∑
k=0
( 1
x+ k
− 1
k + 1
)
− r
]
= limn→∞
[
log
(x+ n− 1
n
)
+
1
2(x+ n− 1) −
1
2n
−
n−1∑
k=0
( 1
x+ k
− 1
k + 1
)
− r
]
= −r −
∞∑
k=0
( 1
x+ k
− 1
k + 1
)
.
Thus
d2 log Γ(x)
d2x
=
∞∑
k=0
1
(x+ k)2
> 0.
Therefore,
∂2 log p(αg|·)
∂ α2g
< 0,
i.e., p(αg|·) is log-concave.
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(4) Obtain posterior samples for ρg’s by getting the Markov chain for (ξ1, . . . , ξG) and (ρ
∗
1, . . . , ρ
∗
K)
as follows:
(i) Update the configuration vector (ξ1, . . . , ξG).
• If ξ = ξl for some l 6= g,
p(ξg = ξ|ξ−g, rest) = c · n(−g)ξ · F (λg2j , ρ∗ξ)
= c · n(−g)ξ
n2∏
j=1
p(λg2j |αg, βg, ρ∗ξ)
= c · n(−g)ξ
n2∏
j=1
λ
αg−1
g2j e
−βgρ∗ξλg2j (βgρ∗ξ)
αg
Γ(αg)
.
• Otherwise, if ξ 6= ξl for all l 6= g,
p(ξg 6= ξl for all l 6= g|ξ−g, rest)
= cM
∫
F (λg2j , ρ)dF0(ρ)
= cM
∫ n2∏
j=1
p(λg2j |αg, βg, ρ) · f0(ρ) dρ
= cM
∫ ∞
0
n2∏
j=1
λ
αg−1
g2j e
−βgρλg2j (βgρ)αg
Γ(αg)
· p0δ{1}dρ
+ cM
∫ ∞
0
n2∏
j=1
λ
αg−1
g2j e
−βgρλg2j (βgρ)αg
Γ(αg)
· 1− p0
2
ρα0−1e−β0ρβα00
Γ(α0)
dρ
+ cM
∫ ∞
0
n2∏
j=1
λ
αg−1
g2j e
−βgρλg2j (βgρ)αg
Γ(αg)
· 1− p0
2
ρ−α0−1e−β0/ρβα00
Γ(α0)
dρ
= cMp0
n2∏
j=1
{ βαgg
Γ(αg)
λ
αg−1
g2j e
−βgλg2j
}
+
1
2
cM(1− p0) β
α0
0
Γ(α0)
β
n2αg
g
[Γ(αg)]n2
n2∏
j=1
λ
αg−1
g2j ·
Γ(n2αg + α0)(
βg
∑n2
j=1 λg2j + β0
)n2αg+α0
+
1
2
cM(1− p0) β
α0
0
Γ(α0)
β
n2αg
g
[Γ(αg)]n2
n2∏
j=1
λ
αg−1
g2j
·
∫ ∞
0
ρn2αg−α0−1e−(βg
∑n2
j=1 λg2j ·ρ+
β0
ρ
)
dρ
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Here c is the common proportionality constant to ensure that the probabilities add up
to 1. K is the number of distinct values of the configuration vector (ξ1, . . . , ξG), as a
result, K is automatically updated.
The third part of the above formula is not integrable, thus we use Metropolis-Hastings
to update ξ1, . . . , ξG:
• For g = 1, . . . , G, repeat the following: If ξg is not a singleton (i.e. ξg = ξl for some
l 6= g), let ξ∗g be a newly created component, with ρ∗ξ∗g drawn from F0. Set ξg to ξ∗g
with probability
a(ξ∗g , ξg) = min
[
1,
M
G− 1 ·
F (λg2j , ρ
∗
ξ∗g
)
F (λg2j , ρ∗ξg)
]
= min
[
1,
M
G− 1 · e
−βg
∑n2
i=1 λg2j(ρ
∗
ξ∗g−ρ
∗
ξg
)
(ρ∗ξ∗g
ρ∗ξg
)n2αg]
.
Otherwise, if ξg is a singleton (i.e., ξg 6= ξl for all l 6= g), draw ξ∗g from ξ−g, choosing
ξ∗g = ξ with probability
n
(−g)
ξ
G−1 . Set the new ξg to this ξ
∗
g with probability
a(ξ∗g , ξg) = min
[
1,
G− 1
M
·
F (λg2j , ρ
∗
ξ∗g
)
F (λg2j , ρ∗ξg)
]
= min
[
1,
G− 1
M
· e−βg
∑n2
j=2 λg2j(ρ
∗
ξ∗g−ρ
∗
ξg
)
(ρ∗ξ∗g
ρ∗ξg
)n2αg]
.
• For g = 1, . . . , G, if ξg is a singleton, do nothing. Otherwise, choose a new value for
ξ from {ξ1, . . . , ξG} with probabilities
p(ξg = ξ|ξ−g, rest) = b ·
n
(−g)
ξ
G− 1F (λg2j , ρ
∗
ξ)
= b · n
(−g)
ξ
G− 1
n2∏
j=1
λ
αg−1
g2j e
−βgρ∗ξλg2j (βgρ∗ξ)
αg
Γ(αg)
,
where b is the appropriate normalizing constant.
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(ii) Update (ρ∗1, . . . , ρ∗K).
p(ρ∗k|·) ∝
∏
{g:ξg=k}
n2∏
j=1
p(λg2j |αg, βg, ρg) · F0(ρ∗k)
∝
∏
{g:ξg=k}
n2∏
j=1
p(λg2j |αg, βg, ρ∗g) · F0(ρ∗k)
∝
∏
{g:ξg=k}
n2∏
j=1
λ
αg−1
g2j e
−βgρ∗kλg2j (βgρ∗k)
αg
Γ(αg)
×
{
p0δ{1} +
1− p0
2
· (ρ
∗
k)
α0−1e−β0ρ∗kβα00
Γ(α0)
+
1− p0
2
· (ρ
∗
k)
−α0−1e−β0/ρ∗kβα00
Γ(α0)
}
∝ p0e−
∑
{g:ξg=k}
∑n2
j=1 βgλg2j
{ ∏
{g:ξg=k}
n2∏
j=1
λ
αg−1
g2j β
αg
g
Γ(αg)
}
δ{1}
+
1− p0
2
(ρ∗k)
∑
{g:ξg=k}
∑n2
j=1 αg+α0−1e−
(∑
{g:ξg=k}
∑n2
j=1 βgλg2j+β0
)
ρ∗k
·
{ ∏
{g:ξg=k}
n2∏
j=1
λ
αg−1
g2j β
αg
g
Γ(αg)
}
· β
α0
0
Γ(α0)
+
1− p0
2
(ρ∗k)
∑
{g:ξg=k}
∑n2
j=1 αg−α0−1e
−
(∑
{g:ξg=k}
∑n2
j=1 βgλg2j ·ρ∗k+
β0
ρ∗
k
)
·
{ ∏
{g:ξg=k}
n2∏
j=1
λ
αg−1
g2j β
αg
g
Γ(αg)
}
· β
α0
0
Γ(α0)
∝ c1 · δ{1} + c2 ·Gamma
(
n2 ·
∑
{g:ξg=k}
αg + α0,
∑
{g:ξg=k}
n2∑
j=1
βgλg2j + β0
)
+ c3 · (ρ∗k)
∑
{g:ξg=k}
∑n2
j=1 αg−α0−1e
−
(∑
{g:ξg=k}
∑n2
j=1 βgλg2j ·ρ∗k+
β0
ρ∗
k
)
Here c1, c2 and c3 are proportionality constants to ensure that the probabilities add up
to 1.
The third part of the above formula has no obvious distribution, thus we use Metropolis-
Hastings to update (ρ∗1, . . . , ρ∗K). For k = 1, . . . ,K, repeat the following: Draw ρ
∗∗
k from
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F0. Use F0 as proposal, compute the acceptance probability
a(ρ∗∗k , ρ
∗
k) = min
[
1,
g(ρ∗k|ρ∗∗k )
g(ρ∗∗k |ρ∗k)
· pi(ρ
∗∗
k )
pi(ρ∗k)
]
= min
[
1,
F0(ρ
∗
k)
F0(ρ∗∗k )
· F (λg2j , ρ
∗∗
k )F0(ρ
∗∗
k )
F (λg2j , ρ∗k)F0(ρ
∗
k)
]
= min
[
1,
F (λg2j , ρ
∗∗
k )
F (λg2j , ρ∗k)
]
= min
[
1,
∏
{g:ξg=k}
∏n2
j=1 p(λg2j |αg, βg, ρ∗∗k )∏
{g:ξg=k}
∏n2
j=1 p(λg2j |αg, βg, ρ∗k)
]
= min
1, ∏
{g:ξg=k}
n2∏
j=1
e−βgρ∗∗k λg2j (βgρ∗∗k )
αg
e−βgρ∗∗k λg2j (βgρ∗k)αg

= min
[
1, e
−∑{g:ξg=k}∑n2j=1 βgλg2j(ρ∗∗k −ρ∗k) · (ρ∗∗k
ρ∗k
)∑
{g:ξg=k} n2αg
]
Set the new value of ρ∗k to ρ
∗∗
k with this probability. Otherwise, let the new ρ
∗
k be the
same as the old value. If we have duplicated ρ∗k, delete it and combine ξg.
70
Bibliography
Anders, S., Huber, W. (2010). Differential expression analysis for sequence count data. Genome
Biology, 11, R106.
Benjamini, Y., Hochberg, Y.(1995). Controlling the false discovery rate: a practical and powerful
approach to multiple testing. J. R. Stat. Soc. B, 57, 289–300.
Blackwell, D., MacQueen, B. J.(1973). Ferguson Distributions Via Polya Urn Schemes. The Annals
of Statistics, 1 (2), 353–355.
Do, K. A. , Muller, P., Tang, F. (2005). A Bayesian Mixture Model For Differential Gene. Journal
of the Royal Statistical Society, Series C (Applied Statistics), 54, 627–644.
Escobar, M. D. (1994). Estimating Normal Means With a Dirichlet Process Prior. Journal of the
American Statistical Association, 89, 268–277.
Gelman A., Rubin D. B. (1992). Inference from iterative simulation using multiple sequences.
Statistical science. 7, 457–472.
Genovese, C., Wasserman, L. (2003). Bayesian and Frequentist Multiple Testing. Bayesian Statis-
tics, 7, 145–161.
Gilks, W. R. (1992). Adaptive Rejection Sampling for Gibbs Sampling. Applied Statistics, 41, 337–
348.
Green, P. J., Richardson, S. (2001). Modelling Heterogeneity With and Without the Dirichlet
Process. Scandinavian Journal of Statistics, 28, 355–375.
Hastings, W. K. (1970). Monte Carlo Sampling Methods Using Markov Chains and Their Applica-
tions. Biometrika, 57, 97–109.
71
Kalli, M., Griffin, J., Walker, S. (2011). Slice Sampling Mixture Models. Statistics and Computing,
1, 93–105.
Kvam, V. M., Liu, P., Si, Y. (2012). A Comparison of Statistical Methods for Detecting Differen-
tially Expressed Genes from RNA-Seq Data. American Journal of Botany, 99 (2), 248–256.
Law, C. W., Chen, Y., Shi, W., Smyth, G. K. (2014). Voom: precision weights unlock linear model
analysis tools for RNA-seq read counts. Genome Biol, 15, R29.
Li, P., Ponnala, L., Gandotra, N., Wang, L., Si, Y., Tausta, S. L., Kebrom, T., Provart, N., Patel,
R., Myers, C. R., Reidel, E., Turgeon, R., Liu, P., Sun, Q., Nelson, T., Brutnell, T. P. (2010).
The developmental dynamics of the maize leaf transcriptome. Nature Genetics, 42, 1060–1067.
Liu, F., Wang, C., Liu, P. (2015). A Semi-parametric Bayesian Approach for Differential Expression
Analysis of RNA-seq Data. J Agric Biol Environ Stat, 20 (4), 555–576.
Love M. I., Huber, W., Anders, S. (2014). Moderated estimation of fold change and dispersion for
RNA-Seq data with DESeq2. Genome Biology, 15 (12), 550.
McCarthy, D. J., Chen, Y. , Smyth, G. K. (2012). Differential expression analysis of multifactor
RNA-Seq experiments with respect to biological variation. Nucleic Acids Research, 40, 4288–
4297.
Neal, R. M. (2000). Markov Chain Sampling Methods for Dirichlet Process Mixture Models. Journal
of Computational and Graphical Statistics, 9 (2), 249–265.
Newton, M. A., Noueiry, A., Sarkar, D., Ahlquist, P. (2004). Detecting Differential Gene Expression
with a Semiparametric Hierarchical Mixture Method. Biostatistics, 5, 155–176.
Peart, M. J., Smyth, G. K., van Laar, R. K., Bowtell, D. D., Richon, V. M., Marks, P. A., Holloway,
A. J., Johnstone, R. W. (2005). Identification and functional significance of genes regulated
bystructurally different histone deacetylase inhibitors. Proceedings of the National Academy of
Sciences of the United States of America, 102, 3697–3702.
72
Robinson, M. D., Smyth, G. K. (2007). Moderated statistical tests for assessing differences in tag
abundance. Bioinformatics, 23, 2881–2887.
Robinson, M. D., Smyth, G. K. (2008). Small-sample estimation of negative binomial dispersion,
with applications to SAGE data. Biostatistics, 9, 321–332.
Robinson, M. D., McCarthy, D. J., Smyth, G. K. (2010). edgeR: a Bioconductor package for
differential expression analysis of digital gene expression data. Bioinformatics, 26, 139–140.
Si, Y., Liu, P. (2013). An Optimal Test with Maximum Average Power While Controlling FDR
with Application to RNA-seq Data. Biometrics, 69, 594–605.
Smyth, G. K. (2004). Linear models and empirical bayes methods for assessing differential expres-
sion in microarray experiments. Statistical Applications in Genetics and Molecular Biology, 3,
Article 3.
Soneson, C., Delorenzi, M. (2013). A comparison of methods for differential expression analysis of
RNA-seq data. BMC Bioinformatics, 14, 91.
Tausta, S. L., Li, P., Si, Y., Gandotra, N., Liu, P., Sun, Q., Brutnell, T. P., Nelson, T. (2014).
Developmental dynamics of Kranz cell transcriptional specificity in maize leaf reveals early onset
of C4-related processes. Journal of Experimental Botany, 65, 3543–3555.
Tierney, L. (1994). Markov Chains for Exploring Posterior Distributions. The Annals of Statistics,
22 (4), 1701–1728.
73
CHAPTER 4. A SEMI-PARAMETRIC BAYESIAN APPROACH FOR
DETECTION OF GENE EXPRESSION HETEROSIS WITH RNA-SEQ
DATA
A paper in preparation
Ran Bi, Peng Liu, Dan Nettleton
Abstract
Heterosis, also called hybrid vigor, refers to the improvements in the phenotype of hybrid offspring
relative to its two inbred parents. Although heterosis phenomenon is widely applied in agricul-
ture, the molecular mechanism of heterosis is still unknown. Recent advances in RNA-sequencing
technologies have provided an opportunity to understand phenotypic heterosis at the gene expres-
sion level. However, it is challenging to identify gene expression heterosis via comparing both
parental inbred lines and their hybrid offspring with RNA-seq count data for tens of thousands of
genes simultaneously. A major challenge is the so-called ”small n, large p” problem when tens of
thousands of hypotheses tests are conducted using data with only a few biological replicates. In
addition, detecting heterosis genes requires testing composite null hypotheses involving multiple
parameters instead of testing simple null hypotheses as in differential expression analysis. In this
manuscript, we aim to develop a powerful test to detect gene expression heterosis while controlling
false discovery rate. We model the count data from RNA-seq experiments with a Poisson-Gamma
mixture, and propose a Bayesian mixture modeling procedure with a Dirichlet process as the prior
for the distribution of fold changes between each parental line versus the hybrid offspring respec-
tively. The MCMC sampling scheme with Gibbs algorithm is utilized to provide posterior inference
to detect heterosis genes while controlling false discovery rate. Simulation results demonstrate that
our proposed method outperforms other methods used to detect gene expression heterosis.
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Key Words: Semi-parametric Bayesian; Gene expression; Heterosis; RNA-seq; Dirichlet process;
Posterior probability; MCMC.
4.1 Introduction
Heterosis, or hybrid vigor, describes the superior performance of a hybrid offspring compared
with its two inbred parents. Heterosis was scientifically documented by Darwin (1876) and has
been widely utilized in the breeding of agricultural crops by increasing development rates and grain
yields, such as rice (Yu et al., 1997), alfalfa (Riday and Brummer, 2002) and tomatoes (Krieger
et al., 2010).In China, hybrid rice is estimated to be planted on more than 50% of the total rice
growing area, and produces 10%-20% more yields than inbred varieties (Chen et al., 2007). However,
the genetic and molecular mechanism of heterosis remains unclear (Chen, 2013).
Researchers have speculated that the genes which are differentially expressed between hybrid off-
spring and its two inbred parents, or gene expression heterosis, might be responsible for phenotypic
heterosis (Song and Messing, 2003; Hubner et al., 2005). With the development of high-throughput
genomics technologies, such as microarray and RNA-Sequencing (RNA-seq), the expression levels
of tens of thousands of genes can be simultaneously measured for each sample. It allows the study
of gene expression heterosis by comparing expression levels between hybrid offspring and its two
inbred parents for all expressed genes. For each gene, it is of interest to test if it exhibits high-
parent heterosis (HPH), i.e., the mean expression level of the hybrid is greater than both parental
means, or low-parent heterosis (LPH), i.e., the mean expression level of the hybrid is less than both
parental means.
For both microarray and RNA-seq technologies, tens of thousands of genes are simultaneously
measured for their expression levels. However, due to the cost of such experiments, only a small
sample size can be afforded. This introduces the “small n, large p” problem, where n refers to
the sample size and p refers to the number of variables. The power for hypotheses testing in such
settings is often low after adjusting multiple testing errors. To utilize information from other genes,
hierarchical models and Bayesian methods have been proposed to borrow information across genes.
75
These strategies have been popularly adopted in differential expression analysis, such as the widely
applied moderated-t test for microarray data (Smyth, 2004) and edgeR (Robinson and Smyth, 2007,
2008; Robinson et al., 2010; McCarthy et al., 2012) or DESeq/DESeq2 (Anders and Huber, 2010;
Love et al., 2014) for RNA-seq data. Differential expression analysis aims to identify genes whose
expression levels change across treatments or conditions. Hence, the null hypothesis is no change,
and is a simple null case. However, for detecting HPH or LPH genes, the null hypotheses involves
the mean expression levels for three conditions in a composite null. Therefore, the well-developed
differential expression analysis methods are not directly applicable for detecting heteresis genes.
Only a few methods have been proposed to detect gene expression heterosis. Ji et al. (2014)
introduced an empirical Bayes framework to assess gene expression heterosis using microarray
data where gene expression measurements were modeled as continuous variables. They proposed a
normal hierarchical model for microarray data that allows borrowing information across genes to es-
timate means and variances. They applied the empirical Bayes procedure that first estimates model
hyperparameters, then obtains the posterior distributions for gene-specific parameters conditional
on those hyperparameters, and finally computes the posterior probabilities of heterosis. Nowadays,
RNA-seq technologies instead of microarray have been widely applied for gene expression studies.
Generally, RNA- seq count data are modeled with negative binomial (NB) distribution (Robinson
and Smyth, 2007, 2008; Robinson et al., 2010; McCarthy et al., 2012; Anders and Huber, 2010;
Love et al., 2014). Based on the work of Ji et al. (2014), Niemi et al. (2015) proposed an empirical
Bayes approach for estimating gene expression heterosis using RNA-seq count data based on a NB
hierarchical model. The method by Niemi et al. (2015) is based on the assumption that gene-
specific parameters are independent and arise from given parametric distributions. However, the
distributions of parameters across all genes are not guaranteed to follow the assumed parametric
distributions in practice. Empirical distributions of parameters could be irregular and varies among
different studies (Liu et al., 2015). Therefore, under these circumstances, it is hard to model the
empirical distribution of all genes by given parametric models.
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In order to avoid the dependence on parametric assumptions, we propose to use Bayesian non-
parametric methods. The Dirichlet process (DP) mixture modeling is arguably the most commonly
used Bayesian nonparametric method, and such modeling method has been used for differential ex-
pression analyses when comparing two different conditions. For instance, Do et al. (2005) built a
DP mixture model for the population of genes under two different conditions and applied to a mi-
croarray dataset. (Liu et al., 2015) chose the DP as a nonparametric prior to model the distribution
of fold changes between two treatment conditions (given reference condition) for RNA-seq data. Bi
and Liu (2018) modified the base distribution of the DP prior used in Liu et al. (2015), in order
to guarantee that the differential expression status being invariant regardless of which treatment
group is set to be the reference condition.
Building on the work of Liu et al. (2015), we model RNA-seq data using a Poisson-Gamma
mixture model, or equivalently, a NB model. We propose a method regarding the hybrid offspring
as the reference treatment, then construct a semi-parametric Bayesian modeling procedure for the
fold changes between the mean expression levels of hybrid versus each parent separately. Posterior
results are finally used for detection of gene expression heterosis while controlling false discovery
rate (FDR).
The article is organized as follows. Section 4.2 describes our proposed semi-parametric Bayesian
approach and the prior models. In Section 4.3, we present the MCMC sampling scheme for posterior
inference and FDR estimation. Section 4.4 provides an algorithm for improving computational
efficiency grounded on a data division. In Section 4.5, we generate several simulation studies based
on NB distributions, and compare the results of our approach to Niemi et al. (2015) method. In
Section 4.6, we analyze a real maize dataset and identify heterosis genes using our proposed method.
Section 4.7 summarizes our work and provides some discussion.
4.2 A Semi-parametric Bayesian Model
In this section, we first describe the framework of our semi-parametric Bayesian modeling, and
then introduce the prior models employed in our method.
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4.2.1 A Poisson-Gamma Mixture Model
We consider gene expression heterosis experiments that involves three genotypes: the hybrid
offspring genotype, and the two parental inbred lines. Although the offspring genotype is obtained
by crossing the two parental lines, plants for the three genotypes are grown together in the same
environment to provide samples for gene expression studies. Suppose that a completely randomized
design with independent biological replicates for each genotype has been employed for the gene ex-
pression heterosis experiments under study. For RNA-seq experiments with independent biological
replicates in each treatment (genotype) group, the NB distribution has been popularly applied to
model the RNA-seq count data (Robinson and Smyth, 2007, 2008; Robinson et al., 2010; McCarthy
et al., 2012; Anders and Huber, 2010; Love et al., 2014). Notice that the NB distribution has no
conjugate prior, we reparameterize the NB model by a Poisson-Gamma mixture model so that it
is much easier to obtain conjugate priors.
Suppose that an RNA-seq heterosis experiment measures G genes. Let Ygij denote the number
of reads mapped to gene g from biological replicate j of genotype i, where g = 1, . . . , G, i = 1, 2, 3,
(i = 1 denotes hybrid offspring, i = 2 denotes parental line 1, and i = 3 denotes parental line 2),
j = 1, . . . , ni, and ni is the number of biological replicates in treatment i. Then read count data
Ygij can be modeled using a Poisson-Gamma mixture model as below,
Ygij |λgij ∼ Poisson(Sijλgij),
λg1j |αg, βg ∼ Gamma(αg, βg),
λg2j |αg, βg, ρg1 ∼ Gamma(αg, βgρg1),
λg3j |αg, βg, ρg2 ∼ Gamma(αg, βgρg2),
where Sij is a normalization factor that adjusts for sequencing depths variation and potentially
other technical effects across the replicates, λgij is the conditional expression mean of jth replicate
of ith treatment for gene g, αg is the shape parameter which stands for the reciprocal of the
dispersion parameter for gene g, βg is the rate parameter for hybrid offspring, the product of βg
and ρg1 is the rate parameter for parental line 1, and the product of βg and ρg2 is for parental line 2.
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So the marginal mean of expression for the hybrid is αg/βg, while αg/(βgρg1) is the marginal mean
expression for parental line 1, and αg/(βgρg2) is for parental line 2. Here we set the first genotype
(hybrid offspring) as the reference treatment, thus the mean ratio of genotype 1 over genotype 2
(or genotype 1 over genotype 3) is ρg1 (or ρg2), which refers to the fold change between hybrid
offspring versus parental line 1 (or parental line 2) for gene g.
With our parameterization, the goal of detecting HPH genes is to detect genes with
ρg1 > 1 and ρg2 > 1 (4.1)
for each gene g. Similarly, the detection of LPH genes is to identify genes with
ρg1 < 1 and ρg2 < 1 (4.2)
for each gene g.
As shown in (4.1) and (4.2), under our parameterization, conditions for HPH and LPH are
expressed with two parameters instead of three means and hence simplifies the problem. In addition,
using the fold change parameters ρg1 and ρg2 makes interpretation easier too.
4.2.2 Prior Specification
Since our main focus is to test the hypotheses corresponding to fold changes ρg1 and ρg2, it is
very important to use appropriate prior distributions for these two parameters. To provide maximal
flexibility, we propose to use Bayesian nonparametric modeling with DP as the prior distributions
for the fold change parameters.
DP is a family of stochastic processes whose realizations are probability distributions, i.e., each
draw from a DP is a distribution. The formal definition of DP is as follows. Given a measurable
set Ω, a base probability distribution F0 and a positive real number M called the concentration
parameter, a random probability distribution F is generated by a DP if for any measurable partition
A1, . . . , Ak of Ω, the distribution of (F (A1), . . . , F (Ak)) is Dirichlet D(M ·F0(A1), . . . ,M ·F0(Ak)).
We denote this by F ∼ DP (M,F0). The parameters F0 and M play intuitive roles in the definition
of the DP. For any measurable subset B of Ω, the base distribution F0 is the mean of the DP, i.e.,
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E[F (B)] = F0(B). Besides, the concentration parameter M defines the variance as V ar[F (B)] =
F0(B)(1−F0(B))/(M + 1). The larger M is, the smaller the variance, and the DP will concentrate
more of its mass around the mean.
An intuitive view of DP is based on Chinese Restaurant Process (CRP). Imagine a Chinese
restaurant with an infinite number of round tables, each has infinite seats. A new customer comes
into the restaurant with two choices, one is sitting at an occupied table with probability propor-
tional to the number of customers already there, the other is sitting at a new table with probability
proportional to the concentration parameter M. After infinitely many customers sit in the restau-
rant, we could obtain a probability distribution over infinitely many tables, which is a random
sample of the probabilities of observations drawn from a DP with the concentration parameter M.
Throughout our mixture modeling procedure, we use a DP to model the fold change parameters.
Here we illustrate the DP modeling procedure for ρg1 (fold change between hybrid offspring and
parental line 1) as an example, the same procedure is applied to ρg2. Following Liu et al. (2015),
we use a mixture of a point mass and a Gamma distribution as the base distribution in the DP
prior for the distribution of the fold change parameters.
Therefore, the DP prior can be expressed as
ρg1|F i.i.d.∼ F,
F ∼ DP (M,F0), (4.3)
F0 ∼ p0δ{1} + (1− p0)Gamma(α0, β0),
for gene g, g = 1, . . . , G, where p0 is the proportion of non-differentially expressed genes between
the hybrid and parent 1, δ{x} denotes a point mass at x. We set p0 = 0.5 in this paper to give
no prior preference to either differential expression or non-differential expression between hybrid
offspring and parental line 1. The concentration parameter M in the DP priors is fixed as M = 1,
which is a common choice used in application (Do et al., 2005; Green and Richardson, 2001; Kalli
et al., 2011).
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We use an exponential distribution as the prior for αg to reduce the computational complexity
of the posterior distribution, and a Gamma distribution as the prior for βg because of its conjugacy,
αg ∼ Exp(r), (4.4)
βg ∼ Gamma(a0, b0), (4.5)
where r, a0, b0 and α0, β0 are hyperparameters. Also, we set r = 0.01, a0 = 0.1, b0 = 0.1,
α0 = 0.1, β0 = 0.1 so that the priors are not informative and the inference for αg and βg mainly
relies on the observed data. And we set the priors for αg’s, βg’s, ρg1’s and ρg2’s to be independent.
Because we apply nonparametric priors for the fold change parameters and parametric priors for
other parameters, the method we propose is a semi-parametric Bayesian approach.
4.3 Posterior Inference
After specifying the priors, the posterior distributions can be derived by multiplying the priors
by the likelihood function. Markov chain Monte Carlo (MCMC) methods (Tierney, 1994) are
usually employed to generate samples from the posterior distribution. We use an MCMC-based
sampling method in our proposed Bayesian mixture models. We also use Gibbs sampling method
which is the most common tool used to perform MCMC simulations for Bayesian hierarchical
models when conjugate priors are utilized.
4.3.1 Markov Chain Monte Carlo Simulation
For DP mixture modeling procedure, typical MCMC sampling schemes are based on integrating
F over its DP prior (4.3), where the sequence of ρg1’s follows a Polya urn scheme (Blackwell and
MacQueen, 1973; Escobar, 1994). The successive conditional distribution of ρg1 can be written as
ρg1|ρ−g1 ∼
1
G− 1 +M
∑
k 6=g
δ{ρk1} +
M
G− 1 +MF0, (4.6)
where ρ−g1 is the vector of (ρ11, . . . , ρG1) after deleting ρg1.
Then the most direct approach to sample from our model is to update each of the ρg1 iteratively.
However, this algorithm may not be very efficient since we cannot change ρg1 for more than one
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gene simultaneously. Thus it may take a long time to converge to the posterior distribution (Neal,
2000). Due to this computational efficiency issue of the MCMC algorithm, configuration indicators
are used here as in Liu et al. (2015). Let K denote the number of distinct values in the vector
(ρ11, . . . , ρG1) and assume the distinct values are ρ
∗
1, . . . , ρ
∗
K , respectively. Let ξ = (ξ1, . . . , ξG) be
the configuration indicators defined by
ξg = k iff ρg1 = ρ
∗
k = ρ
∗
ξg .
Therefore, the prior model for ρg1’s is reparameterized with ρ
∗
k’s and ξg’s as follows,
ρ∗k
i.i.d.∼ F0,
F0 ∼ p0δ{1} + (1− p0)Gamma(α0, β0),
(ξ1, . . . , ξG)|M ∼ CRP(M),
where priors for ρ∗k’s and ξg’s are independent, and CRP is short for Chinese Restaurant Process.
CRP is a random distribution with the full conditional distribution for ξg’s written as
ξg|ξl,M ∼
K(−g)∑
k=1
n
(−g)
k
G− 1 +M δ{k} +
M
G− 1 +M δ{K(−g)+1},
where K(−g) denotes the number of distinct values in the vector (ρ11, . . . , ρG1) after deleting ρg1,
and n
(−g)
k denotes the number of (ρ11, . . . , ρG1) who equal ρ
∗
k after deleting ρg1.
The MCMC sampling scheme uses Gibbs sampling algorithm to update each of the following
parameters: (1) λgij ’s, (2) βg’s, (3) αg’s, (4) ρg1’s and (5) ρg2’s, where the update of ρg1’s and ρg2’s
utilizes the configuration indicators as shown above.
The details on the full conditionals for all parameters are shown in the first part of Appendices
(Section 4.8.1). The posterior samples for both ρg1’s and ρg2’s are then used for further inference.
4.3.2 Bayesian FDR for Multiple Hypothesis Testing
In genomic studies, a large number of hypotheses are simultaneously tested, each relating to
a gene. Hence, multiple testing is commonly used in the analysis, which requires the controlling
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of multiple testing error. False discovery rate (FDR) (Benjamini and Hochberg, 1995), defined as
the expected proportion of false positives among the rejected hypotheses, has been the choice of
error criterion in RNA-seq data analysis. Within the Bayesian framework, one can estimate the
FDR with Bayesian FDR (Genovese and Wasserman, 2003; Newton et al., 2004) by using posterior
probability.
For each gene g, g = 1, . . . , G, we denote the posterior probability that the gth gene exhibits
HPH by P (ρg1 > 1, ρg2 > 1|Yg), while the posterior probability for gene g that exhibits LPH to be
P (ρg1 < 1, ρg2 < 1|Yg). P (ρg1 > 1, ρg2 > 1|Yg) and P (ρg1 < 1, ρg2 < 1|Yg) can be estimated by the
proportion of the posterior samples obtained from MCMC for gene g that satisfy the HPH or LPH
conditions, i.e.,
HPH : vˆg = Pˆ (ρg1 > 1, ρg2 > 1|Yg) = 1
N
N∑
m=1
I(ρmg1 > 1, ρ
m
g2 > 1|Yg),
LPH : vˆg = Pˆ (ρg1 < 1, ρg2 < 1|Yg) = 1
N
N∑
m=1
I(ρmg1 < 1, ρ
m
g2 < 1|Yg),
where N is the number of posterior samples. We conclude HPH or LPH if the estimated posterior
probability 1− vˆg is smaller than a critical value c∗. The critical value c∗ can be chosen so that the
FDR is controlled at a target level γ, for example, 0.05, i.e.,
c∗ = sup{c : F̂DR(c) < γ},
where
F̂DR(c) =
∑G
g=1(1− vˆg)I(1− vˆg < c)∑G
g=1 I(1− vˆg < c)
.
In general, for any c ∈ [0, 1], the Bayesian FDR can be calculated by
B̂FDR(c) =
∑G
g=1(1− vˆg)I(1− vˆg < c)∑G
g=1 I(1− vˆg < c)
.
4.4 Data Division
The method we proposed is based on the MCMC sampling scheme that updates parameters
iteratively among genes. Not surprisingly, such procedure is quite time consuming, especially when
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the total number of genes is huge. In order to improve the computational efficiency, we consider
a strategy that divides the raw dataset into several small datasets, applies our proposed method
independently to the smaller datasets using parallel computing, and then combines the posterior
samples together for further inference. Assume we have G genes, and we randomly divide them into
m groups, so that each group has more or less equal number of genes. We evaluate performance of
our proposed method with and without this data division strategy in simulation studies.
4.5 Simulation Studies
In this section, we use simulations to study the performance of our proposed semi-parametric
approaches, SBA (without data division) and SBA div (with data division), and compared them to
the empirical Bayes method by Niemi et al. (2015) (eBayes Laplace and eBayes Normal, depending
on the parametric prior assumption). To mimic the distributions of real RNA-seq dataset, we
generated gene-specific mean and dispersion parameters from a maize dataset (Tausta et al., 2014)
for an experiment that compared gene expression between bundle sheath and mesophyll cells of
corn plants. Two sets of simulation studies (A and B) were conducted, and they differed by how
the fold change parameters were generated. For each simulation study, 32 independent RNA-seq
datasets were simulated from NB distributions with given mean and dispersion parameters, each
dataset contained 3000 genes, 3 genotype groups and 3 replicates per genotype. For our proposed
method, we burned in the MCMC sampler for 3000 iterations, followed by another 5000 iterations
to calculate the estimated posterior probabilities. Convergence was checked via Gelman-Rubin
criteria (Gelman and Rubin, 1992). The test performances of different methods were evaluated by
averaging results from the 32 datasets.
4.5.1 Simulation A
We used the maize dataset from Tausta et al. (2014) to estimate the gene-specific mean from
one treatment group, along with the dispersion parameters estimated across two treatments. We
randomly sampled 3000 pairs of mean and dispersion parameters out of all 27,819 pairs without
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replacement, which would be used as the true mean expression level for the hybrid (µg) and the
true dispersion parameter (φg) for gene g = 1, . . . , 3000. The RNA-seq read count data for the
hybrid offspring were generated from NB(µg, φg) for gene g. Then 1500 out of the 3000 genes
were randomly selected, and ρg1 for these genes were set to be 1, which means that count data
for parental line 1 were also drawn from NB(µg, φg). The remaining 1500 genes were simulated to
have fold changes ρg1 set to be 4, 8, 0.25, or 0.125, thus we had 375 genes for each ρg1 value. Then
the count data for parental line 1 were drawn from NB(µgρg1, φg). The count data for parental
line 2 were generated similarly while ρg2 was generated independent of ρg1.
4.5.2 Simulation B
Similar to Simulation A, we generated 3000 genes from NB(µg, φg), where pairs of µg and φg
are sampled from the estimates from the maize dataset by Tausta et al. (2014). Still, 1500 out of
3000 genes were randomly selected to have fold changes ρg1 = 1 between hybrid and parental line
1. For the remaining 1500 genes, instead of setting ρg1 to be one of the values 4, 8, 0.25 and 0.125,
we simulated ρg1 from a two-component mixture of lognormal distributions,
log(ρg1) ∼ 0.5Normal(log(4), 1) + 0.5Normal(−log(4), 1).
The fold changes between the hybrid and parent 2, ρg2, were generated in the same way independent
of ρg1.
4.5.3 Simulation Results for Detecting Gene Expression Heterosis
To evaluate the test performance without the influence of different normalization methods, we
used the same normalization factors for all methods. Specifically, we set all normalization factors
to be 1.
The performances of different methods in terms of ranking heterosis genes were evaluated with
the receiver operating characteristic (ROC) curve, i.e., the plot of the true positive rate (TPR)
versus false positive rate (FPR), which was generated based on ranking genes using the poste-
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rior probabilities for each method. The area under curve (AUC) was also calculated. A better
performing method would have a higher ROC curve and a larger value of AUC.
The ROC curves resulting from Simulations A and B are shown in Figure 4.1. For each level
of FPR, the TPRs were averaged over 32 simulated datasets. We plotted the curves over the
FPR values between 0 and 0.1 because we are most interested in small range of FPR values. The
AUC values representing the percentage of the total area 0.1 in the range of FPR < 0.1 were
also calculated. The average values and standard deviations of the AUC across the 32 simulated
datasets are reported in the legends. As indicated in Figure 4.1, our proposed methods (SBA and
SBA div) generated higher ROC curves and greater AUC values than the empirical Bayes method
proposed by Niemi et al. (2015), under both simulation settings A and B. Here SBA div is the
method that we randomly divided the 3000 genes into 5 groups, with 600 genes in each group, then
applied our SBA method independently to the 5 groups.
We also evaluated the estimation of FDR based on subsection 4.3.2 using the posterior prob-
abilities for each method. FDR plots for Simulations A and B are presented in Figure 4.2. Our
proposed methods (SBA and SBA div) controlled FDR well, while the FDR was not controlled for
the empirical Bayes method by Niemi et al. (2015).
In Figure 4.2, the FDR curves for our proposed methods are below the Y = X line, indicating
that our methods are conservative. For further study of the FDR control, we checked the actual
FDR, the number of declared heterosis genes, and the number of truly declared heterosis genes for
each nominal level of FDR. The results for HPH or LPH in Simulations A and B are presented in
Table 4.1 and Tables 4.4 - 4.6 in the second part of Appendices 4.8.2 respectively. The empirical
Bayes methods declared more truly heterosis genes than our methods when controlling FDR at a
desired level. However, they also generated much more false positives than desired, and resulted in
liberal actual FDR.
Based on the simulation results above, our proposed methods generated higher ROC curves
comparing with the empirical Bayes method by Niemi et al. (2015). Furthermore, our methods
controlled FDR, hence provided more reliable lists of genes exhibiting HPH or LPH at a desired
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Figure 4.1 ROC curves resulting from Simulations A and B. For each level of FPR, the
TPRs were averaged across the 32 simulated datasets. The percentage anno-
tated for each method is the average AUC, represented as the percentage of
the total area 0.1 in the range of FPR < 0.1, and the percentage in each set of
parentheses is the standard deviation of the estimated AUC.
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Figure 4.2 Plots of the actual FDR versus the nominal level of FDR. When we controlled
FDR at each nominal level, the proportion of false discoveries among the de-
clared heterosis genes was calculated for each dataset, and the actual FDR was
calculated by averaging such proportions over 32 simulated datasets. The gray
dash-dotted lines correspond to the Y = X line.
88
T
ab
le
4.
1
R
es
u
lt
s
fo
r
H
P
H
in
S
im
u
la
ti
on
A
.
N
om
in
al
L
ev
el
M
et
h
o
d
A
ct
u
al
N
u
m
b
er
of
D
ec
la
re
d
N
u
m
b
er
of
D
ec
la
re
d
T
ru
ly
T
ot
al
N
u
m
b
er
of
o
f
F
D
R
F
D
R
H
et
er
os
is
G
en
es
H
et
er
os
is
G
en
es
H
et
er
os
is
G
en
es
0
.0
1
S
B
A
0.
00
18
49
5
49
4
61
3
S
B
A
d
iv
0.
00
21
49
4
49
3
eB
a
ye
s
L
a
p
la
ce
0.
01
75
56
7
55
7
eB
a
ye
s
N
o
rm
a
l
0.
02
28
57
6
56
3
0
.0
5
S
B
A
0.
01
29
56
2
55
5
61
3
S
B
A
d
iv
0.
01
16
56
1
55
5
eB
a
ye
s
L
a
p
la
ce
0.
10
04
65
7
59
1
eB
a
ye
s
N
o
rm
a
l
0.
11
45
67
2
59
5
0
.1
S
B
A
0.
04
20
60
9
58
3
61
3
S
B
A
d
iv
0.
04
05
60
7
58
3
eB
a
ye
s
L
a
p
la
ce
0.
18
29
73
6
60
1
eB
a
ye
s
N
o
rm
a
l
0.
20
18
75
6
60
4
0
.2
S
B
A
0.
13
05
69
4
60
3
61
3
S
B
A
d
iv
0.
12
97
69
2
60
2
eB
a
ye
s
L
a
p
la
ce
0.
31
50
88
9
60
9
eB
a
ye
s
N
o
rm
a
l
0.
33
52
91
7
61
0
89
level of FDR. All in all, our proposed methods worked better than Niemi et al. (2015) empirical
Bayes method under both simulation settings.
4.5.4 Number of Groups Divided
In this subsection, we studied how SBA div method works as the number of groups m varies. If
we randomly divide the G = 3000 genes into m groups, m = 5, 10, or 25, the ROC curves and FDR
plots are shown in Figures 4.3 and 4.4. In Simulation A, the results based on different m’s did not
differ too much, indicating that we could choose a relatively large m to receive more computational
efficiency. In Simulation B, smaller m led to slightly better results, which was as expected. All
divisions controlled FDR well across all simulation settings.
4.5.5 Computational Time
Table 4.2 presents the computational time needed for each method. The computational time
for each simulation was calculated on a cluster node with two 8-core 2.6GHz Intel Haswell E5-
2640 v3 processors. Our SBA method with random division (SBA div) and Niemi et al. (2015)
eBayes methods (eBayes Laplace and eBayes Normal) could be parallelized to increase efficiency,
the parallelization was done across 16 cores. We could notice that the computational time based on
data division of our proposed method (SBA div) was comparable to Niemi et al. (2015) empirical
Bayes method. As the number of divisions increased, the computational time decreased. However,
as indicated in Figure 4.1 and 4.3, larger number of divisions led to slightly worse results, but was
still better than the empirical Bayes method.
4.6 Real Data Analysis
We used our proposed SBA methods to analyze the maize dataset (Paschold et al., 2012) of
RNA-seq gene expression in parental lines B73 and Mo17 and the hybrid genotype (B73×Mo17).
We kept genes with average count at least one and at most two zero read counts for each genotype
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Figure 4.3 ROC curves resulting from Simulations A and B for different data divisions. For
each level of FPR, the TPRs were averaged across the 32 simulated datasets.
The percentage annotated for each method is the average AUC, represented
as the percentage of the total area 0.1 in the range of FPR < 0.1, and the
percentage in each set of parentheses is the standard deviation of the estimated
AUC.
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Figure 4.4 Plots of the actual FDR versus the nominal level of FDR for different data
divisions. When we controlled FDR at each nominal level, the proportion
of false discoveries among the declared heterosis genes was calculated for each
dataset, and the actual FDR was calculated by averaging such proportions over
32 simulated datasets. The gray dash-dotted lines correspond to the Y = X
line.
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Table 4.2 Computational time needed for each method.
Method Simulation A Simulation B
SBA 90.6 mins 163.1 mins
SBA div5 45.2 mins 56.5 mins
SBA div5 parallel 9.9 mins 12.0 mins
SBA div10 39.8 mins 43.8 mins
SBA div10 parallel 4.6 mins 5.3 mins
SBA div25 37.0 mins 39.1 mins
SBA div25 parallel 3.4 mins 3.7 mins
eBayes Laplace 40.5 mins 40.7 mins
eBayes Laplace parallel 3.8 mins 3.7 mins
eBayes Normal 39.8 mins 39.7 mins
eBayes Normal parallel 3.0 mins 3.0 mins
across the four replicates (same filtration criterion as in Niemi et al. (2015)), thus 28,943 genes
were left for gene expression heterosis analysis.
Table 4.3 provides the number of heterosis genes detected from different methods when con-
trolling FDR at level 0.1 or 0.05. We could notice that the eBayes laplace and eBayes normal
methods detected more LPH genes than our proposed methods, which might not be reliable given
our simulation results that FDR was not controlled for their methods.
Table 4.3 Number of heterosis genes detected when controlling FDR at different levels.
Heterosis FDR SBA SBA div5 SBA div10 SBA div16 eBayes laplace eBayes normal
HPH 0.1 27 31 30 30 28 35
HPH 0.05 12 13 12 14 8 9
LPH 0.1 7 9 6 10 75 82
LPH 0.05 0 4 0 4 23 12
Although the eBayes laplace and eBayes normal methods detected nearly the same number of
HPH genes when controlling FDR at levels 0.1 or 0.05, the lists of HPH genes detected by empirical
Bayes method (Niemi et al., 2015) were quite different from what our method identified. Figures
4.5 shows the venn diagrams of detected HPH genes when controlling at different FDR levels. For
example, when controlling FDR at level 0.1, only 9 genes were detected to exhibit HPH by all three
methods, 16 genes were detected to exhibit HPH only by our SBA method, 28 genes were detected
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by either eBayes laplace or eBayes normal methods. Again, the HPH genes detected from Niemi
et al. (2015) might not be reliable due to their failure of FDR control based on our simulation
results. Without knowing the true heterosis genes at the moment, more biological experiments are
needed to validate these results.
Figure 4.5 Real data analysis results. The Venn diagram on the left shows the results of
detected HPH genes from our SBA method, eBayes laplace and eBayes normal
methods when FDR was controlled at level 0.1; the Venn diagram on the right
shows the corresponding results when FDR was controlled at 0.05.
4.7 Discussion
Heterosis refers to the improvements in the phenotype of hybrid offspring compared with its
two inbred parents, and such phenomenon has been widely applied in agriculture. Gene expression
heterosis is hypothesized to help account for phenotypic heterosis, such as grain yields increment.
Thus identifying heterosis genes is a crucial issue, and may have a potentially strong impact on
biology and genetics. Existing method for detecting gene expression heterosis based on RNA-seq
data require parametric assumption (Niemi et al., 2015). We proposed a semi-parametric Bayesian
approach to model the RNA-seq data, and employed the MCMC sampling scheme to generate
posterior samples for detection of gene expression heterosis. Our method provides a more flexible
way which avoids the dependence on parametric assumptions. From the simulation studies, we
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demonstrate that our proposed methods outperform Niemi et al. (2015) empirical Bayes method,
in terms of both ranking heterosis genes and FDR control. Therefore, our methods offer reliable
ways for the detection of gene expression heterosis for RNA-seq experiments.
Throughout the process of building our semi-parametric Bayesian modeling framework, we
consider the two inbred parents as independent, and model the fold changes between the hybrid
offspring and each parental line, ρg1 and ρg2, separately. Consider parental line 1 as an example,
we set the hybrid offspring as the reference condition, and use DP as the prior for the distribution
of fold changes between the hybrid and parental line 1 for each gene. In a typical heterosis study
design involving one hybrid and two parents, the hybrid offspring is naturally selected as reference,
so that the fold changes ρg1 and ρg2 can be interpreted as effects of each parental line on the hybrid.
If there are biological knowledge that ρg1 and ρg2 may be correlated, the two parameters may be
modeled jointly.
The DP priors we imposed for the distribution of fold changes depend on the base distribution F0
and the concentration parameter M . We used a mixture of a point mass and a Gamma distribution
as the base distribution F0 because the Gamma distribution ensures conjugacy. The point mass
distribution part is due to the high frequency of estimated fold changes that lie in the small range
around 1 based on real data. A common choice of the concentration parameter M in the DP priors
that are widely used in application is M = 1 (Do et al., 2005). We also checked the simulation
results with different M values (M being 0.2, 0.5, 2, 5, 10 or 20), and the results remained almost
the same for various values of M .
Although our proposed semi-parametric Bayesian method provide a reliable approach for the
detection of gene expression heterosis, computational complexity might be an issue. In order to
improve the efficiency, we also provide an algorithm based on a division of the data. The choice
of m is a trade off between efficiency and accuracy. According to the simulation results, larger
number of divisions m led to slightly worse results, but still outperformed the current empirical
Bayes method with comparable computational time.
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4.8 Appendices
4.8.1 Generate Full Conditional Distributions
Details on how we generate the full conditionals for all parameters are shown as below.
(1) Draw samples of λgijs from their full condition distributions:
p(λg1j |·) ∝ p(Yg1j |λg1j)p(λg1j |αg, βg)
∝ e−S1jλg1j (S1jλg1j)Yg1jλαg−1g1j e−(λg1jβg)
∝ λ(Yg1j+αg−1)g1j e−λg1j(S1j+βg),
p(λg2j |·) ∝ p(Yg2j |λg2j)p(λg2j |αg, βg, ρg1)
∝ e−S2jλg2j (S2jλg2j)Yg2jλαg−1g2j e−(λg2jβgρg1)
∝ λ(Yg2j+αg−1)g2j e−λg2j(S2j+βgρg1),
p(λg3j |·) ∝ p(Yg3j |λg3j)p(λg3j |αg, βg, ρg2)
∝ e−S3jλg2j (S3jλg2j)Yg3jλαg−1g3j e−(λg3jβgρg2)
∝ λ(Yg3j+αg−1)g3j e−λg3j(S3j+βgρg2).
Thus, λgij ’s are drawn based on
λg1j |· ∼ Gamma(Yg1j + αg, S1j + βg),
λg2j |· ∼ Gamma(Yg2j + αg, S2j + βgρg1),
λg3j |· ∼ Gamma(Yg3j + αg, S3j + βgρg2).
(2) Draw samples of βg’s from their full conditional distributions:
p(βg|·) ∝ pi(βg)
n1∏
j=1
p(λg1j |αg, βg)
n2∏
j=1
p(λg2j |αg, βg, ρg1)
n3∏
j=1
p(λg3j |αg, βg, ρg2)
∝ βa0−1g e−βgb0 ·
n1∏
j=1
e−λg1jβgβαgg ·
n2∏
j=1
e−λg2jβgρg1(βgρg1)αg ·
n3∏
j=1
e−λg3jβgρg2(βgρg2)αg
∝ β(n1+n2+n3)αg+a0−1g e−βg(
∑n1
j=1 λg1j+
∑n2
j=1 λg2jρg1+
∑n3
j=1 λg3jρg2+b0).
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Thus, βg’s are drawn from
βg|· ∼ Gamma
(
αg(n1 + n2 + n3) + a0,
n1∑
j=1
λg1j +
n2∑
j=1
λg2jρg1 +
n3∑
j=1
λg3jρg2 + b0
)
(3) Obtain full conditional distributions of αg’s:
p(αg|·) ∝ pi(αg)
n1∏
j=1
p(λg1j |αg, βg)
n2∏
j=1
p(λg2j |αg, βg, ρg1)
n3∏
j=1
p(λg3j |αg, βg, ρg2)
∝ e−rαg ·
n1∏
j=1
λ
αg−1
g1j β
αg
g
Γ(αg)
·
n2∏
j=1
λ
αg−1
g2j (βgρg1)
αg
Γ(αg)
·
n3∏
j=1
λ
αg−1
g3j (βgρg2)
αg
Γ(αg)
∝ e−rαg · β
αg(n1+n2+n3)
g ρ
αgn2
g1 ρ
αgn3
g2
[Γ(αg)]n1+n2+n3
·
3∏
i=1
ni∏
j=1
λ
αg−1
gij .
There is no closed-form full conditional distribution for αg. If the conditional posterior
distribution for αg, p(αg|·) is a log-concave function with respect to αg, then we could draw
posterior samples based on adaptive rejection sampling method (Gilks, 1992).
log p(αg|·) =− rαg + αg(n1 + n2 + n3)log(βg) + αgn2log(ρg1) + αgn3log(ρg2)
− (n1 + n2 + n3)log Γ(αg) +
3∑
i=1
ni∑
j=1
(αg − 1)log(λgij),
then the first derivative of log p(αg|·) is
∂ log p(α|·)
∂ αg
=− r + (n1 + n2 + n3)log(βg) + n2log(ρg1) + n3log(ρg2)
− (n1 + n2 + n3)∂ log Γ(αg)
∂ αg
+
3∑
i=1
ni∑
j=1
log(λgij),
the second derivative of log p(αg|·) is
∂2 log p(αg|·)
∂ α2g
= −(n1 + n2 + n3)∂
2 log Γ(αg)
∂ α2g
.
We could derive that
d2 log Γ(x)
d2x
=
∞∑
k=0
1
(x+ k)2
> 0.
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Therefore,
∂2 log p(αg|·)
∂ α2g
< 0,
i.e., p(αg|·) is log-concave.
(4) Obtain posterior samples for ρg1’s by getting the Markov chain for (ξ1, . . . , ξG) and (ρ
∗
1, . . . , ρ
∗
K)
as follows:
(i) Update the configuration vector (ξ1, . . . , ξG).
• If ξ = ξl for some l 6= g,
p(ξg = ξ|ξ−g, rest) = cn(−g)ξ Πn2j=1p(λg2j |αg, βg, ρ∗ξ)
= cn
(−g)
ξ Π
n2
j=1
β
αg
g (ρ∗ξ)
αg
Γ(αg)
λ
αg−1
g2j exp(−βgρ∗ξλg2j).
• Otherwise,
p(ξg 6= ξl for all l 6= g|ξ−g, rest)
= cM
∫
Πn2j=1p(λg2j |αg, βg, ρ)F0(ρ)dρ
= cM
∫ ∞
0
[
Πn2j=1
λ
αg−1
g2j exp(−βgρλg2j)(βgρ)αg
Γ(αg)
· (1− p0)ρ
α0−1exp(−β0ρ)βα00
Γ(α0)
]
dρ
+ cM
∫ ∞
0
[
Πn2j=1
λ
αg−1
g2j exp(−βgρλg2j)(βgρ)αg
Γ(αg)
· p0δ{1}
]
dρ
= cM(1− p0) β
α0
0
Γ(α0)
β
n2αg
g
[Γ(αg)]n2
Πn2j=1λ
αg−1
g2j
∫ ∞
0
ρn2αg+α0−1exp
{
− (βg n2∑
j=1
λg2j + β0
)
ρ
}
dρ
+ cMp0Π
n2
j=1
{
β
αg
g
Γ(αg)
λ
αg−1
g2j exp(−βgλg2j)
}
= cM(1− p0) β
α0
0
Γ(α0)
β
n2αg
g
[Γ(αg)]n2
Πn2j=1λ
αg−1
g2j ×
Γ(n2αg + α0)(
β0 + βg
∑n2
j=1 λg2j
)n2αg+α0
+ cMp0Π
n2
j=1
{
β
αg
g
Γ(αg)
λ
αg−1
g2j exp(−βgλg2j)
}
.
Here c is a common proportionality constant to ensure that the probabilities add up to
1.
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(ii) Update (ρ∗1, . . . , ρ∗K).
p(ρ∗k|.) ∝ Π{g:ξg=k}Πn2j=1p(λg2j |αg, βg, ρg1) · F0(ρ∗k)
∝ Π{g:ξg=k}Πn2j=1p(λg2j |αg, βg, ρ∗k) · F0(ρ∗k)
∝ Π{g:ξg=k}Πn2j=1
λ
αg−1
g2j exp(βgρ
∗
kλg2j)(βgρ
∗
k)
αg
Γ(αg)
×
{
p0δ{1} + (1− p0)
(ρ∗k)
α0−1exp(−β0ρ∗k)βαg0
Γ(α0)
}
∝ p0exp
{
−
( ∑
{g:ξg=k}
n2∑
j=1
βgλg2j
)}
·
{
Π{g:ξg=k}Π
n2
j=1
λ
αg−1
g2j β
αg
g
Γ(αg)
}
δ{1}
+ (1− p0)(ρ∗k)
∑
{g:ξg=k}
∑n2
j=1 αg+α0−1 · exp
{
−
( ∑
{g:ξg=k}
n2∑
j=1
βgλg2j + β0
)
ρ∗k
}
·
{
Π{g:ξg=k}Π
n2
j=1
λ
αg−1
g2j β
αg
g
Γ(αg)
}
· β
α0
0
Γ(α0)
∝ p0exp
{
−
( ∑
{g:ξg=k}
n2∑
j=1
βgλg2j
)}
δ{1}
+ (1− p0) β
α0
0
Γ(α0)
·
Γ
(
n2
∑
{g:ξg=k} αg + α0
)
(∑
{g:ξg=k}
∑n2
j=1 βgλg2j + β0
)n2∑{g:ξg=k} αg+α0
∝ p0exp
{
−
( ∑
{g:ξg=k}
n2∑
j=1
βgλg2j
)}
δ{1}
+ c0Gamma
(
n2
∑
{g:ξg=k}
αg + α0,
∑
{g:ξg=k}
n2∑
j=1
βgλg2j + β0
)
,
where c0 = (1− p0) β
α0
0
Γ(α0)
· Γ(n2
∑
{g:ξg=k} αg+α0)(
β0+
∑
{g:ξg=k}
∑n2
j=1 βgλg2j
)n2∑{g:ξg=k} αg+α0 .
(5) The procedure for obtaining posterior samples for ρg2’s is similar to ρg1’s.
4.8.2 Table Results for Simulations A and B
For each nominal level of FDR, the actual FDR, the number of declared heterosis genes, and
the number of truly declared heterosis genes for LPH in Simulation A, HPH and LPH in Simulation
B are reported in Tables 4.4 - 4.6.
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CHAPTER 5. RiboZIP, A STATISTICAL METHOD FOR DETECTION OF
DIFFERENTIAL TRANSLATIONS WITH PAIRED RIBO-SEQ AND
RNA-SEQ DATA
A paper in preparation
Ran Bi, Pulkit Kanodia, W. Allen Miller, Stephen Howell, Peng Liu
Abstract
Although deep sequencing based ribosome profiling (Ribo-seq) has been widely used to quantify
genome-wide translation, statistical methods are still under development to reliably detect genes
with changes in translational efficiency. To study translational efficiency, Ribo-seq experiments
are typically carried out together with RNA-seq experiments with samples paired between the two
experiments. However, recently proposed Ribo-seq analysis methods ignore the pairing structure
in the experimental design. Another characteristic of Ribo-seq data is that a large portion of the
measurements are zero counts, and this calls for zero-inflated models. In addition, tens of thousands
of genes are measured simultaneously for each of a small number of samples in ribosome profiling
studies. Hence, it is one of the “small n, large p” problems. To deal with all these challenges,
we propose a statistical method that we call RiboZIP to identify differentially translated genes
(DTGs). More specifically, we model the Ribo-seq data with a zero-inflated Poisson (ZIP) model,
and adopt a Bayesian hierarchical modeling procedure to assess differential translation while taking
the paring between mRNA and Ribo-seq samples into account. The MCMC sampling scheme is
utilized for posterior inference to detect DTGs while controlling false discovery rate. Simulation
results demonstrate that our proposed method outperforms other existing methods used for ribo-seq
data analysis.
Keywords: Ribo-seq; RNA-seq; Differential translation; Zero-inflated Poisson; Bayesian; MCMC.
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5.1 Introduction
Protein synthesis (translation) is an energy intensive and pivotal process in regulating gene
expression. Translational control of gene expression is critical for maintaining cellular and organ-
ismal homeostasis, controlling growth and development, and to respond quickly to various biotic
and abiotic stresses (Hershey et al., 2012; Munoz and Castellano, 2012; Kelen et al., 2009; Gebauer
and Hentze, 2004; Echevarria-Zomeno et al., 2013; Merchante et al., 2017; Kong and Lasko, 2012;
Sonenberg and Hinnesbusch, 2007). Translation deregulation can result in a wide range of diseases
such as Parkinson’s disease, Alzheimer’s disease, anemia, autistic spectrum disorder, and cancer
(Taymans et al., 2015; Bottley and Kondrashov, 2013; Morimoto et al., 2007; Ludwig et al., 2014;
Alvarez-Dominguez et al., 2017; Kelleher and Bear, 2008; Ruggero, 2013; Silvera et al., 2010; Hol-
land, 2004). In animal and plant viral disease, the host’s translation machinery is hijacked by the
virus to preferentially translate viral RNA and modulate host’s mRNA translation to make cellular
conditions more suitable for virus replication (Reid et al., 2018; Stern-Ginossar et al., 2018). There-
fore, understanding the molecular mechanism of translational control and deciphering the role and
mechanism of translationally regulated proteins is crucial in understanding cellular processes and
disease.
With the advancement of next-generation sequencing (NGS), high-throughput techniques such
as RNA sequencing (RNA-seq) has been widely used to assess gene expression by using the steady-
state mRNA levels as a proxy for protein abundance. However, this does not take into consideration
the post-transcriptional modifications of mRNAs, translational recoding and translational regula-
tion (Sonenberg and Hinnesbusch, 2007; Baek et al., 2008; Selbach et al., 2008; Hinnebusch et al.,
2016; Namy et al., 2004). mRNA levels do not always correlate well with protein levels (de Godoy
et al., 2008). The rate of protein synthesis has been shown to be a better predictor of protein abun-
dance than measurements of mRNA level (Ingolia et al., 2009). Therefore, using techniques that
quantify translation rate in conjunction with RNA sequencing can provide a better approximation
of protein expression.
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Ribosome profiling, also known as ribo-seq, provides quantitative measure of ribosome occu-
pancy and speed of translation elongation in vivo with single nucleotide resolution (Ingolia et al.,
2009). It involves deep sequencing of ribosome protected footprints (RPFs) obtained by ribonu-
clease (RNase) digestion of translation-arrested polyribosomes. It is a modification of RNA-seq
that allows one to essentially detect the position and amount of every translating (80S) ribosome
on every mRNA in the cell. Briefly, a translation-arrested cell lysate is digested with RNase to
degrade all mRNA that is not protected by a translating ribosome. The resulting RPFs, along
with randomly fragmented total RNA from the same initial lysate to be used for normalization,
are sequenced by Illumina sequencing, and then mapped to the reference genome or transcriptome.
RPFs, usually 28-30 nt. long, represent the mRNA region occupied by the translating ribosome
(Ingolia et al., 2009; Steitz, 1969; Wolin and Walter, 1988). Consequently, the vast majority of
RPFs map within an open reading frame (ORF) (Ingolia et al., 2009). The positions and numbers
of RPFs on each mRNA indicate the abundance of ribosomes at each position in each mRNA.
Highly translated mRNAs and ribosome pause sites generate more RPFs. When comparing the
Ribo-seq data with RNA-seq data that measures the abundance of transcripts (mRNAs), we can
gain insights on translational efficiency. Studies of translational efficiency across different treat-
ments allow us to understand how translation process is regulated. In fact, one of the major goals
of the analysis for Ribo-seq data is to study translationally-regulated differential gene expression by
identifying which genes exhibit changes in translational efficiency across treatments (Ingolia et al.,
2011; Andreev et al., 2015; Irigoyen et al., 2016; Michel and Baranov, 2013; Juntawong et al., 2014;
Ingolia, 2014, 2016; Hsu et al., 2016; Xu et al., 2017; Lintner et al., 2017).
Similar to other NGS methods, ribo-seq requires extensive bioinformatics and statistical anal-
ysis. In recent years, several bioinformatics tools have been developed to analyze ribo-seq datasets
(O’Connor et al., 2016; Xiao et al., 2016; Zhong et al., 2017; Zhang et al., 2017; Calviello and
Ohler, 2017; Xu et al., 2018; Xiao et al., 2018; Chung et al., 2015; H Backman and Girke, 2016).
These tools can be used to determine triplet periodicity of RPFs, identify true RPFs with high
confidence, identify translation start and stop sites and ribosomal pause sites, identify novel ORFs
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de novo and to statistically evaluate differentially translated genes (DTGs). Calviello and Ohler
(2017) summarize some concepts involved in ribo-seq data analysis, functions of recently developed
ribo-seq analysis tools and their limitations.
For a given mRNA species, the abundance of RPFs measured by ribo-seq depends on the trans-
lation rate and the mRNA expression level as well. Thus ribo-seq experiments are typically done
together with RNA-seq experiments that measure the abundance of transcripts. Each biological
sample provides two sets of measurements, RPF from ribo-seq experiment and mRNA from RNA-
seq experiment. Hence, the observations are paired between ribo-seq and RNA-seq, and a method
that integrates both RPF and mRNA abundances is needed to search for DTGs. A straight-
forward method takes the ratio of ribo-seq measurement and RNA-seq measurement to quantify
translational efficiency for each sample. Or, we can use statistical models that incorporate the
experimental design and conduct hypothesis test to search for DTGs.
Tools such as RiboDiff (Zhong et al., 2017), xtail (Xiao et al., 2016) and babel (Olshen et al.,
2013) have been developed for ribo-seq analysis. RiboDiff (Zhong et al., 2017) is a statistical analysis
tool for detecting genes with changes in translational efficiency across treatments. It assumes RNA-
seq and RPF read counts both follow Negative Binomial (NB) distributions, then uses generalized
linear models (GLM) to estimate the dispersion parameters of of RNA-seq and RPF measurements
separately, and performs a statistical test for differential translation efficiency. xtail (Xiao et al.,
2016) is another pipeline that proposed to quantify the magnitudes and statistical significances of
differential translations, which also adopts NB distributions to model the read counts of both mRNA
and RPF. xtail applies two parallel pipelines to measure the differential translation by quantifying
between the mRNA and RPF changes or between the RPF-to-mRNA ratios in two conditions.
Besides RiboDiff and xtail, most of the ribo-seq analysis strategies utilize NB distribution to model
RPF data. However, some of these tools do not handle pairing information between mRNA and
RPF data. Both the RiboDiff and xtail methods are based on the assumption that RNA and
RPF replicates are independent of each other, which ignores the pairing signal contributed from a
pair of mRNA and RPF. babel (Olshen et al., 2013) is an analytical tool for assessing differential
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translations with ribosome profiling data while taking paring information into account. babel is
based on an errors-in-variables regression model. It uses the NB distribution as well, and draws
inference using a parametric boostrap approach.
Researchers have also been using methods developed for RNA-seq data analysis, such as edgeR
(Robinson and Smyth, 2007, 2008; Robinson et al., 2010; McCarthy et al., 2012) and DESeq2
(Love et al., 2014), for detection of DTGs (Li et al., 2017; Juntawong et al., 2018). Similar to
RiboDiff, xtail, and babel, both edgeR and DESeq2 are also based on NB models. However, due
to the energy intension of translation process, the mRNA transcribed from a gene in a cell may
not be translated into protein until the protein is required by the cell, thus results in an excess of
zeros in RPF samples. Because of this, the observed frequency of zeros is in excess of what would
reasonably be expected in NB distribution. Therefore, an appropriate statistical model should take
into consideration of the excess of zeros.
In addition, for genomic data analysis, tens of thousands of genes are simultaneously tested,
which requires multiple testing precedures that control the number of testing errors. False discovery
rate (FDR) (Benjamini and Hochberg, 1995) has been the choice of error criterion in genomic
studies. However, differential translation analysis for ribo-seq data while controlling FDR is lack
of study, most of the available methods suffer from high FDR.
To deal with all these challenges in ribo-seq data analaysis, we propose a zero-inflated Poisson
(ZIP) model (Lambert, 1992) to cope with the excess of zeros for the RPF count data. To account
for the reason that gives rise to the extra zero read counts, we apply a mixture model with a point
mass at zero and a Poisson distribution for the count data from RPF. The component of point
mass at zero is associated with a probability that related to the sequencing depth. The component
of the Poisson distribution models the count of reads mapped to each gene.
Due to the high cost of experimental materials and sequencing, many of the previous ribosome
profiling studies only employ a small number of replicates, in which cases the power of statistical
inference is limited. Therefore, Bayesian approach is a natural way in terms of borrowing informa-
tion across genes to mitigate the effects of small sample sizes during estimation, and is becoming
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increasingly popular in statistical genomics (Do et al., 2005; Hardcastle and Kelly, 2010; Wu et al.,
2012). We adopt a Bayesian hierarchical modeling pipeline to assess differential translations while
taking the paring information between mRNA and RPF into account.
The article is organized as follows. Section 5.2 describes our proposed method. In Section
5.3, we generate several simulation studies, and compare our proposed method to some popular
methods used for differential translation analysis of ribo-seq data. In Section 5.4, we analyze a
real dataset using our proposed method. Section 5.5 summarizes our results and provides some
discussion.
5.2 Method
5.2.1 Bayesian Modeling Pipeline
Suppose that the experiment measures G genes. Let Ygijk denote read count data from gene
g, ith protocol, jth treatment, and kth biological replicate, where i = 1, 2 correspond to RPF
sample and mRNA sample respectively. Note that each biological replicate provides two samples,
one generating ribo-seq measurements and the other generate whole transcriptome (mRNA-seq)
measurements. Here we consider a comparison between two conditions, and assume n replicates in
each condition, i.e., j = 1, 2, k = 1, . . . , n.
In the development of our modeling framework, we use zero-inflated Poisson distribution to
model RPF count data Yg1jk, for dealing with the excess of zeros . Let Zg1jk be independently
distributed with a binary probability mass function having parameter pg1jk. Zg1jk is used to
specify which mixture component the observed count data Yg1jk comes from. Take the Yg1jk’s to
be independent with conditional distributions given Zg1jk = 1 that are Poisson distribution with
parameter λg1jk. The distribution of Yg1jk can be expressed as
Zg1jk|pg1jk ind∼ Bernoulli(pg1jk)
Yg1jk|Zg1jk, λg1jk ind∼

0, if Zg1jk = 0
Poisson(λg1jk), if Zg1jk = 1.
(5.1)
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The parameter pg1jk is the probability of Yg1jk coming from Poisson part, which may vary depending
on the sequencing depth and gene g. Thus we consider a logistic relation modeled as follows,
logit(pg1jk) = βg · S1jk, (5.2)
where S1jk is the normalization factor that adjusts for sequencing depths variation and potentially
other technical effects across the replicates.
For RNA-seq read count data Yg2jk, we assume it follows a regular Poisson distribution with
true expression mean parameter λg2jk, i.e.,
Yg2jk ∼ Poisson(λg2jk).
For both mRNA and RPF samples, λgijk represents the expression mean of k
th replicate of jth
treatment in ith protocol of gene g. We can express expectations on read counts λgijk as a function
of normalization factor Sijk, baseline quantity related to RPF abundance λg in the first treatment,
a quantity ugi that relates the protocol difference between mRNA and RPF, a quantity tgj that
relates the fold change between two treatments, a quantity wgij that captures the effect of the
treatment on translation, and a quantity bgjk that relates to the pairing signal between RNA and
RPF. In particular, the expected expression mean λgijk is modeled as below,
λgijk = Sijk · λg · ugi · tgj · wgij · bgjk, (5.3)
where Sijk is the normalization factor of k
th replicate of jth treatment in ith protocol; λg is the
normalized expression mean baseline for i = j = 1 (RPF sample in the first condition); ugi is
the fold change between two protocols with ug1 = 1; tgj is fold change between two treatments
with tg1 = 1; wgij is the fold change between the translation efficiency of two treatments, with
wg11 = wg12 = wg21 = 1; bgjk denotes the one-to-one correspondence between RPF and mRNA
samples, which is considered to be random. Note that the expression (5.3) is equivalent to a log-
linear model if we express both sides in log scale, and the term wgij corresponds to the interaction
between protocol and treatment, which is of main interest.
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Here we calculate the normalization factor Sijk in the same way as RiboDiff method (Zhong
et al., 2017),
Sijk = median
g:Ygijk>0
(
Ygijk + 1
n
√
Πnk=1(Ygijk + 1)
)
,
where they calculated the ratios of observed count in a given library to the geometric mean for
each gene, and the normalization factor is determined by the median of these ratios whose count is
greater than zero. They added one to the count value to avoid zero of the geometric mean across
all replicates in the denominator.
Differential translation can be characterized by the dissimilarity between the changes in mRNA
and RPF expressions across the two conditions. This is equivalent to determining whether the
parameter wg22 in our model (5.3) differs significantly from 1. And the corresponding hypothesis
test is
Hgw0 : wg22 = 1 vs. H
g
w1 : wg22 6= 1 (5.4)
for each gene g. Often times, biologists are also interested in the differential expression analysis
for RPF data between the two treatments. This corresponds to testing whether the parameter tg2
differs significantly from 1.
We assume a hierarchical model for the gene-specific parameters (βg, λg, ug2, tg2, wg22, bgjk) men-
tioned in equations (5.2) and (5.3). It is worth noticing that the model (5.3) we proposed is equiv-
alent to a generalized linear mixed model with log link, but our expression makes the conjugate
priors more obvious. Since in our paper, the simple null hypotheses we are most interested in are
wg22’s H
g
w0 : wg22 = 1 and tg2’s H
g
t0 : tg2 = 1, so a mixture of a point-mass at 1 and a Gamma
distribution (due to conjugacy) is used as the hierarchical model for wg22 and tg2. Again, we use
Gamma distribution as the prior distribution for λg, ug2 and bgjk because of their conjugacy,
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βg|ηβ, σ2β iid∼ N(ηβ, σ2β)
Baseline: λg|αλ, γλ iid∼ Gamma(αλ, γλ)
Protocol: ug2|αu, γu iid∼ Gamma(αu, γu)
Treatment: tg2|pit1, αt, γt iid∼ pit1δ{1} + (1− pit1)Gamma(αt, γt) (5.5)
Translation Efficiency: wg22|piw1, αw, γw iid∼ piw1δ{1} + (1− piw1)Gamma(αw, γw)
Pairing: bgjk|αb iid∼ Gamma(αb, αb).
For computational convnience, we assume all the gene-specific parameters in (5.5) to be indepen-
dent.
To formulate our problem of interest more clearly, we introduce latent variables Zgt and Zgw
to denote which mixture component the treatment effect tg2 or translational efficiency change wg22
come from,
Zgt ∼ Bernoulli(1− pit1),
Zgw ∼ Bernoulli(1− piw1), (5.6)
where pit1 and piw1 denote the chance that treatment and translation efficiency effects equal to 1.
Then the treatment and differential translation effects can be reparameterized as below,
Treatment: tg2 = (1− Zgt) + Zgt · t˜g2,
Translation Efficiency: wg22 = (1− Zgw) + Zgw · w˜g22, (5.7)
where
t˜g2|αt, γt iid∼ Gamma(αt, γt),
w˜g22|αw, γw iid∼ Gamma(αw, γw). (5.8)
Thus, for each gene g, our main focus becomes
Hgw0 : Zgw = 0 vs. H
g
w1 : Zgw = 1
and Hgt0 : Zgt = 0 vs. H
g
t1 : Zgt = 1. (5.9)
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5.2.2 Markov Chain Monte Carlo Simulation
There are (11 + 2G) unknown parameters of interest in our model,
Θ = {ηβ, σ2β, αλ, γλ, αu, γu, αt, γt, αw, γw, αb, tg2,wg22}.
The data likelihood function with observed data Y = {Y1111, Y1112, . . . , YG222} is
L(Θ|Y ) =ΠGg=1Π2j=1Π2k=1
{
[1− pg1jk](1−Zg1jk) · [pg1jk · fPoi(yg1jk;λg1jk)]Zg1jk
}
×ΠGg=1Π2j=1Π2k=1 {fPoi(yg2jk;λg2jk)}
×ΠGg=1
{
fN(βg; ηβ, σ
2
β)
}
×ΠGg=1 {fGamma(λg;αλ, γλ)}
×ΠGg=1 {fGamma(ug2;αu, γu)}
×ΠGg=1
{
[pit1]
(1−Zgt) · [(1− pit1)fGamma(tg2;αt, γt)]Zgt
}
×ΠGg=1
{
[piw1]
(1−Zgw) · [(1− piw1)fGamma(wg22;αw, γw)]Zgw
}
×ΠGg=1Π2j=1Πnk=1 {fGamma(bgjk;αb, αb)} . (5.10)
Here we propose a fully Bayesian analysis for the parameter estimation. For all unknown
parameters in (5.5), due to either conjugacy or to reduce the complexity of computation of the
posterior distribution, we assume independent non-informative priors as follows,
ηβ ∼ N(0, 104)
σ2β ∼ IG(0.001, 0.001)
αλ, αu, αt, αw, αb
iid∼ Exp(0.01)
γλ, γu, γt, γw
iid∼ Gamma(0.1, 0.1)
pit1, piw1
iid∼ Unif(0, 1). (5.11)
After specifying the prior distributions, data will be used to update these prior distributions
to obtain the posterior distributions for inference. Posterior inference in our proposed model is
implemented by using Markov Chain Monte Carlo (MCMC) simulation (Tierney, 1994). Gibbs
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sampling (Geman and Geman, 1984) is the most commonly used tool to perform MCMC simula-
tions for Bayesian hierarchical models. We applied MCMC Gibbs sampling method with Rjags to
implement posterior inference. Details on how we generate the full conditionals for all parameters
are shown in the Appendix (Section 5.6).
From Bayesian inference, our null hypothesis or any quantities of interest could be easily ob-
tained from the posterior distribution. For example, our null hypothesis of differential translation
could be assessed through the posterior probability pg = Pr(Zgw = 0|Y ) for each gene g. In addi-
tion to the simple hypothesis testing problem, we could also applied our method to do other kinds
of hypothesis testing, such as to test whether the fold change is within a certain interval or not.
5.2.3 Bayesian FDR Control
In ribo-seq studies, a large number of hypotheses are simultaneously tested, each relating to
a gene. Hence, multiple testing procedures that control the number of false significant results is
essential. False discovery rate (FDR) (Benjamini and Hochberg, 1995), defined as the expected
proportion of false positives among the rejected hypotheses, has been the choice of error criterion
in genomic studies.
The Bayesian version of FDR is an alternative way to estimate the FDR within the Bayesian
framework. It has been proposed and discussed by several authors including Genovese and Wasser-
man (2003) and Newton et al. (2004). The Bayesian FDR can be obtained by using posterior
probabilities of the null hypothesis. More specifically, for the analysis of translational efficiency
change, for each gene g, g = 1, . . . , G, we denote the posterior probability that gth null hypothesis
is true by vg = P (wg22 ∈ ∆0|Yg). If we are interested in detecting differential translated genes,
with ∆0 = {1}, P (wg22 ∈ ∆0|Yg) is the posterior probability that gth gene is not differentially
translated. P (wg22 ∈ ∆0|Yg) can be estimated by the proportion of the posterior samples obtained
from MCMC for gene g that falls into the null set ∆0, i.e.,
vˆg = Pˆ (wg22 ∈ ∆0|Yg) = 1
N
N∑
m=1
I(wmg22 ∈ ∆0|Yg),
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where N is the number of posterior samples. Then the posterior probability which the gth gene
is differentially translated is estimated through 1 − vˆg. We reject Hgw0 if the estimated posterior
probability vˆg is smaller than a critical value c
∗. The critical value c∗ is chosen based on controlling
the FDR below a target level γ, for example, 0.05, i.e.,
c∗ = sup{c : F̂DR(c) < γ},
where
F̂DR(c) =
∑G
g=1 vˆgI(vˆg < c)∑G
g=1 I(vˆg < c)
.
So the Bayesian FDR controlled at level γ can be calculated by
B̂FDR(γ) =
∑G
g=1 vˆgI(vˆg < c
∗)∑G
g=1 I(vˆg < c
∗)
.
5.3 Simulation Studies
In this section, we conduct several simulation studies to evaluate our proposed method, and
compare its performance with some current approaches for differential translation analysis of ribo-
seq data. Those methods include 1) methods that are designed for ribosome profiling, such as
RiboDiff (Zhong et al., 2017), xtail (Xiao et al., 2016) and babel (Olshen et al., 2013); 2) edgeR
(Robinson et al., 2010) and DESeq2 (Love et al., 2014) with a generalized linear model (GLM)
setting that consists a block term (fixed) which takes care of the pairing information between RPF
and mRNA data; 3) gene-wise generalized linear mixed model (GLMM) which considers block
effect as random. We will focus on the translational efficiency change between two treatments in
the following simulation studies, the analysis for treatment effect of RPF samples can be easily
obtained with the same strategy.
For each simulation setting, 32 independent datasets were simulated with each dataset contain-
ing 5,000 genes, 2 treatment groups and n replicates for each treatment group in each protocol,
where n is either 2, 4 or 10. For our proposed method, we burned in the MCMC sampler for 30,000
iterations, followed by another 20,000 iterations to draw 2000 samples at every 10 iterations. Con-
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vergence was checked via Gelman-Rubin criteria (Gelman and Rubin, 1992). The test performances
of different methods were evaluated by averaging results from the 32 datasets.
5.3.1 Simulation A
The datesets for Simulation A were simulated based on our model (5.1), (5.2), (5.3) and (5.5).
The true values of the simulation parameters are as follows:
(ηβ, σ
2
β) = (0.5, 0.5
2)
(αλ, γλ) = (9.974, 0.526)
(αu, γu) = (9, 3)
(αt, γt) = (1.44, 1.2)
(αw, γw) = (4, 2)
αb = 2
pit1 = piw1 = 0.5 or 0.8,
where the true values for αλ and γλ were estimated from a real ribo-seq dataset. Normalization
factors Sijk were also estimated from the real dataset based on RiboDiff method.
Given the number of replicates per group (n), and the proportion of non-DTGs, the procedure
we used to simulate one dataset is as follows. For each gene g, g = 1, . . . , 5000,
1. Generated latent variables Zgt and Zgw from Bernoulli distributions for gene g,
Zgt ∼ Bernoulli(1− pit1)
Zgw ∼ Bernoulli(1− piw1).
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2. Generated parameters (βg, λg, ug2, tg2, wg22, bgjk) as below,
βg ∼ N(ηβ, σ2β)
Baseline: λg ∼ Gamma(αλ, γλ)
Protocol: ug2 ∼ Gamma(αu, γu)
Treatment: tg2 ∼ (1− Zgt) + Zgt ·Gamma(αt, γt)
Translation Efficiency: wg22 ∼ (1− Zgw) + Zgw ·Gamma(αw, γw)
Pairing: bgjk ∼ Gamma(αb, αb).
3. Obtained pg1jk and mean count λgijk based on the generated parameters in Step 1 and 2,
logit(pg1jk) = βg · S1jk
λgijk = Sijk · λg · ugi · tgj · wgij · bgjk,
4. For RPF samples, we simulated latent variable Zg1jk from Bernoulli distribution with param-
eter pg1jk, and pseudo count data Y
′
g1jk from Poisson distribution with parameter λg1jk, then
the product of Zg1jk and Y
′
g1jk would be our simulated count data for RPF samples.
5. For mRNA samples, we simulated count data Yg2jk directly from Poisson distribution with
mean λg2jk.
5.3.2 Simulation B
The procedure to generate a simulated dataset in Simulation B is the same as that in Simulation
A, except the true values for parameters (ηβ, σ
2
β). When (ηβ, σ
2
β) = (0.5, 0.5
2) as in Simulation A,
there are about 37-40% zeros of all numerical values in RPF samples. Here in Simulation B, we
consider (ηβ, σ
2
β) = (10, 1
2), which results in a very low proportion of zero counts in RPF samples
(2-3%). Figure 5.1 gives a view of the distribution for pg1jk for Simulation A and B separately.
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Figure 5.1 Histograms of pg1jk for Simulation A and B separately.
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5.3.3 Simulation C
In this simulation, we generated both RPF and mRNA count data from NB distribution, as
most of the other ribosome profiling analysis methods did. We referred to the simulation settings
in Zhong et al. (2017) (Supplementary Section F), the procedure for simulating one dataset is as
follows.
1. The mean counts µg for two treatments of both RPF and mRNA data were drawn from
NB(µ, φ) for gene g, where µ = 124 for RPF and µ = 499 for mRNA, while dispersion
parameter φ = 1.
2. For each mean count µg in each protocol, we generated n count values as n replicates from
NB(µg, φg), where φg = f(µg) = 0.1/µg + 0.0001.
3. Randomly selected 2,500 genes out of the 5,000 to have TE changes in two treatments by
multiplying the fold difference FC to the mean count of the target genes. Among the 2,500
genes, half of them had fold increase FCI simulated from Gamma(α, 2) + 1, half of them had
fold decrease FCD = 1/FCI . There are five sub-simulations in total:
(a) mean count had a fold change only for RPF count, with α = 0.8;
(b) mean count had a fold change only for mRNA count, with α = 0.6;
(c) mean count had a fold change only for RPF count, with α = 1.5;
(d) mean count had a fold change only for mRNA count, with α = 1.5;
(e) mean count had a fold change for RPF with α = 0.8 and for mRNA with α = 0.6.
4. For the target genes, the count data in the second treatment for protocol having fold change
were drawn from NB(µg · FC, φg).
The five sub-simulations in Zhong et al. (2017) did not generate excess of zero counts in RPF
samples. Also, the RPF and mRNA data were generated independently. Thus, in addition of these,
we added three more sub-simulations to the fold change settings in (e).
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(f) Generated a pairing effect bgjk from Gamma(2, 2), then the count data for each protocol were
draw from NB(µ∗g · bgjk, φg), where µ∗g is the product of mean count and fold difference.
(g) In this sub-setting, we added less zero-inflation in RPF samples. We generated βg from
N(5, 12), then simulated latent variable Zg1jk from Bernoulli distribution with parameter
pg1jk that related to βg as in our model. The RPF count data for this sub-setting was the
product of Zg1jk and the RPF data simulated in (f). RNA-seq count data remained the same
as in (f).
(h) For this sub-setting, we considered more zero counts in RPF samples. The data generation
steps were the same as in (f), except that βg were drawn from N(0.5, 0.5
2).
5.3.4 Simulation Results
To evaluate the test performance without the influence of different normalization methods, we
applied the same normalization step as RiboDiff (Zhong et al., 2017) to all the methods.
The performances of different methods in terms of ranking DTGs were evaluated in the receiver
operating characteristic (ROC) curve, which plots the true positive rate (TPR) versus false positive
rate (FPR). It was generated based on either the posterior probabilities or p values for each method,
with the area under the curve (AUC) calculated. A better performing method would have a higher
ROC curve and a larger value of AUC.
ROC curves resulting from Simulations A and B with proportion of non-DTGs pit1 = piw1 = 0.5
or 0.8, and various numbers of replicates per group n = 2, 4 or 10 are shown in Figure 5.2 and 5.3.
For each level of FPR, the TPRs were averaged over 32 simulated datasets. We plotted the curves
over the FPR values between 0 and 0.1 because we are most interested in small range of FPR values.
The AUC values representing the percentage of the total area 0.1 in the range of FPR < 0.1 were
also calculated, with average values and standard deviations of the AUC across the 32 simulated
datasets reported in the legends of Figure 5.2 and 5.3. When sample size increases from 2 to 4 to
10, the AUC value increases for all method under both Simulations A and B, as expected. When
we compare between Simulations A and B, the ROC curves indicated that our proposed method
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(RiboZIP in the plots) has greater advantage over other methods in more zero-inflation (Simulation
A) cases, which is also as expected.
Figure 5.4 gives the ROC curves for the eight situations in Simulation C. Not surprisingly, in
cases (a) and (c), our RiboZIP method performed slightly worse than edgeR, DESeq2, xtail and
GLMM, because the differential translation effect was confounded in the treatment effect of the
RPFs, in such cases our method might not estimate the differential translation effect well. However,
while in all other cases, our RiboZIP method outperformed other methods. Also, we could observe
the phenomenon that our method has greater advantage while more zeros were observed in RPF
count data while comparing C(f) through C(h).
To sum up, in all simulation scenarios, Figure 5.2 - 5.4 demonstrated that our RiboZIP method
generated the highest (or among the highest) ROC curves and largest (or among the largest) AUC
values among all methods under all simulation settings.
In addition to the ability of correctly ranking truly DTGs, we also evaluated the estimation
of FDR for our RiboZIP method based on subsection 5.2.3 using the posterior probabilities, and
for other non-Bayesian methods via Benjamini and Hochberg (Benjamini and Hochberg, 1995)
procedure. FDR plots for Simulations A and B with proportion of non-DTGs pit1 = pit2 = 0.5 or
0.8, and various numbers of replicates per group n = 2, 4 or 10 are presented in Figure 5.5 and
5.6, where our proposed RiboZIP method controlled FDR well in all simulation settings. Other
methods were either conservative or liberal. Figure 5.7 gives the FDR plots for the eight situations
in Simulation C, where in such NB distribution cases, our proposed method controlled FDR better
than all other methods.
Based on all the simulation results, we conclude that our proposed RiboZIP method generated
the highest ROC curves and the least false positives while comparing with other methods. Further-
more, our RiboZIP method controlled FDR close to the nominal level the best, thus provided more
reliable lists of DTGs at a desired FDR level. All in all, our proposed RiboZIP method outperforms
other methods under all simulation settings, especially for handling excess of zero counts in RPF
samples and pairing information between RPF and mRNA scenarios.
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Figure 5.2 ROC curves resulting from Simulations A for different proportions of non-DTGs
and various number of replicates per group. For each level of FPR, the TPRs
were averaged across the 32 simulated datasets. The percentage reported in
the legend is the average AUC for each method, representing the percentage of
the total area 0.1 in the range of FPR < 0.1, and the percentage in each set of
parentheses is the standard deviation of the estimated AUC.
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Figure 5.3 ROC curves resulting from Simulations B for different proportions of non-DTGs
and various number of replicates per group. For each level of FPR, the TPRs
were averaged across the 32 simulated datasets. The percentage reported in
the legend is the average AUC for each method, representing the percentage of
the total area 0.1 in the range of FPR < 0.1, and the percentage in each set of
parentheses is the standard deviation of the estimated AUC.
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Figure 5.4 ROC curves resulting from Simulation C.
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Figure 5.5 Plot of the actual FDR versus the nominal level of FDR for Simulation A.
The proportion of false discoveries among the declared DTGs was calculated
for each dataset when we controlled FDR at nominal levels, and the actual
FDR was calculated by averaging such proportions over 32 simulated datasets
at each nominal FDR level. The grey lines correspond to the Y = X line.
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Figure 5.6 Plot of the actual FDR versus the nominal level of FDR for Simulation B.
The proportion of false discoveries among the declared DTGs was calculated
for each dataset when we controlled FDR at nominal levels, and the actual
FDR was calculated by averaging such proportions over 32 simulated datasets
at each nominal FDR level. The grey lines correspond to the Y = X line.
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Figure 5.7 FDR plots resulting from Simulation C.
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5.4 Real Data Analysis
In this section, we analyze a real ribo-seq dataset published by Su et al. (2015), which is the
same dataset used in xtail (Xiao et al., 2016). It studies the interferon gamma (IFN-γ) treatment
in human primary macrophages. The study consists of 26,271 genes, two treatments (mock and
IFN-γ), and two replicates per treatment in each protocol. Among the 26,271 genes of 8 samples,
there are about 38.1% zeros of all numerical values in RPF samples and 25.7% zeros in mRNA
samples. 5,058 out of 26,271 genes have zero count for all RNA samples. Without the 5,058 genes,
there still exist about 23.8% zeros in the remaining genes of RPF samples, while only 8% zeros in
mRNA samples. We kept genes with at least one count per million (CPM) in at least two samples
for RNA-seq data, thus 13,699 out of genes were left for further analysis.
We applied our RiboZIP method, RiboDiff, xtail, babel, GLMM, edgeR, and DESeq2 to the
filtered dataset. Table 5.1 provides the number of DTGs detected from different methods when
controlling FDR at level 0.05. Our RiboZIP method detected all genes as DTGs when FDR is
controlled at 0.05. This makes sense because the posterior probabilities produced in our method is
the estimated probability that differential translation effect exactly equals to 1, which is not likely
to be true in reality. When we look at the estimated translational fold change for each gene g from
RiboZIP, which was calculated by the average of posterior samples for wg22, most of the genes have
quite small fold changes, which may not be our focus. One great advantage of Bayesian inference
is that any quantities of interest could be easily obtained from the posterior samples. To detect
genes with biological significance, we aimed to detect DTGs with at least 1.5 fold change, then
our RiboZIP method identified 1,130 genes with FDR controlled at 0.05, among them, 978 genes
are translationally up-regulated while 152 genes are down-regulated. If we are most interested in
at least 2 fold change, then only 178 genes would be identified as DTGs while controlling FDR at
0.05, 150 genes of which are translationally up-regulated while 28 genes are down-regulated.
The numbers of detected DTGs for our RiboZIP method (FC > 2 or < 1/2), xtail, and babel
when controlling FDR at level 0.05 are shown in Figure 5.8. Among the three methods, babel
identified the least DTGs, while xtail identified the most. Only 31 genes were detected to be
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Table 5.1 Number of DTGs detected when controlling FDR at 0.05.
Methods DTGs up-regulated down-regulated
RiboZIP 13699 9414 4285
RiboZIP (FC > 1.5 or FC < 1/1.5) 1130 978 152
RiboZIP (FC > 2 or FC < 1/2) 178 150 28
RiboDiff 0 0 0
xtail 295 222 73
babel 70 37 33
GLMM 6058 4650 1408
edgeR 634 510 124
DESeq2 326 264 62
differentially translated by all three methods. 117 genes were detected by both RiboZIP and xtail,
but not by babel, which may due to the conservative control of FDR based on our simulation studies.
Figure 5.8 The Venn diagram for detected DTGs from our RiboZIP method (testing FC
> 2 or < 1/2), xtail, and babel, while controlling FDR at 0.05.
If we change the test of interest for our RiboZIP method to FC > 1.5 or < 1/1.5, then our
method covers the majority of genes detected by xtail (Figure 5.9). Besides, it identified 827 more
genes that were not detected by either xtail or babel, which might be reliable since our simulation
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results demonstrate that our proposed method is much more powerful than xtail and babel in the
case that RPF count data consists a lot of zeros.
Figure 5.9 The Venn diagram for detected DTGs from our RiboZIP method (testing FC
> 1.5 or < 1/1.5), xtail, and babel, while controlling FDR at 0.05.
5.5 Discussion
The step of translation is being increasingly recognized as a crucial step in gene expression.
Ribosome profiling has become a standard method to quantify the rates of mRNA translations.
However, the differential translation analysis from ribo-seq data is still underdeveloped. Existing
methods for detecting DTGs suffer from high FDR, fail to handle the pairing information between
RPF and mRNA data, and ignore the excess of zero counts in RPF samples. We proposed a zero-
inflated Poisson (ZIP) model to deal with extra zeros in RPF samples, and adopted a Bayesian
hierarchical modeling framework to assess differential translation while taking the paring informa-
tion between mRNA and RPF samples into account. From the simulation studies, we demonstrate
that our proposed method outperforms existing ribo-seq differential translation analysis tools such
as RiboDiff (Zhong et al., 2017), xtail (Xiao et al., 2016) and babel (Olshen et al., 2013), in terms of
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both ranking of DTGs and FDR control. Therefore, our method offers a reliable way for differential
translation analysis of ribosome profiling data.
In the first step of our model, we follow the normalization method proposed in RiboDiff (Zhong
et al., 2017) to calculate the normalization factor Sijk, in order to make our method comparable with
them, in regardless of the influence from different normalization methods. One could choose other
normalization methods, such as methods commonly used for RNA-seq including upper-quartile
(Bullard et al., 2010), TMM (Robinson et al., 2010), method proposed in DESeq (Anders and
Huber, 2010), etc.
In this manuscript, we only reported the simulation results for testing differential translation.
However, the posterior samples for other parameters in our model or any quantities of interest
related to our parameters could also be extracted out for posterior inference. For example, we
could do the differential expression (DE) analysis only for RPF count data directly by testing
Hgt0 : tg2 = 1 for each gene g. The resulting ROC curves and FDR plots for testing tg2 (which are
omitted here) are as the same patterns as for testing wg22, indicating that our RiboZIP method
outperforms other methods in terms of both ROC curves and FDR control, especially when RPF
samples have an excess of zero counts. We could also test whether the translational fold change is
within a certain interval or not as indicated in the real data analysis (5.4). Besides, we could do DE
analysis only for mRNA count data as well, the quantity of interest in such case is Hg0 : tg2 ·wg22 = 1.
5.6 Appendix: Full Conditional Distributions
The posterior distribution of the parameters Θ is the product of the likelihood by the prior
distribution of the parameters.
(1) For parameter ηβ, we assume non-informative prior
ηβ ∼ N(a0, b20),
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where a0 = 0, b
2
0 = 10
4. Then the full conditional distribution of ηβ can be written as
f(ηβ|·) ∝ ΠGg=1
{
fN(βg; ηβ, σ
2
β)
}× fN(ηβ; a0, b20)
∝ exp
−
G∑
g=1
(βg − ηβ)2
2σ2β
 exp
{
−(ηβ − a0)
2
2b20
}
,
thus
ηβ|· ∼ N(m, v),
where v =
[
G
σ2β
+ 1
b20
]−1
, m = v ·
[∑G
g=1 βg
σ2β
+ a0
b20
]
.
(2) For parameter σ2β, we consider conjugate prior
σ2β ∼ IG(c0, d0),
where c0 = d0 = 0.001. Then the full conditional distribution of σ
2
β can be written as
f(σ2β|·) ∝ ΠGg=1
{
fN(βg; ηβ, σ
2
β)
}× fIG(σ2β; c0, d0)
∝ (σ2β)−G2 exp
−
G∑
g=1
(βg − ηβ)2
2σ2β
 · (σ2β)−c0−1 exp
{
− d0
σ2β
}
∝ (σ2β)−G2 −c0−1 exp
{
−
1
2
∑G
g=1(βg − ηβ)2 + d0
σ2β
}
,
thus
σ2β|· ∼ IG
G
2
+ c0,
1
2
G∑
g=1
(βg − ηβ)2 + d0
 .
(3) For parameter αλ, we consider prior
αλ ∼ Exp(e0),
where e0 = 0.01. Then the full conditional distribution of αλ can be written as
f(αλ|·) ∝ ΠGg=1 {fGamma(λg;αλ, γλ)} × fExp(αλ; e0)
∝ ΠGg=1
{
γαλλ
Γ(αλ)
λαλ−1g
}
× exp{−e0αλ}
∝ exp{−e0αλ} ·
γαλGλ
[Γ(αλ)]G
·ΠGg=1λαλ−1g .
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There is no closed-form full conditional distribution for αλ. If f(αλ|·) is a log-concave function
with respect to αλ, then we could draw posterior samples based on adaptive rejection sampling
method (Gilks, 1992).
logf(αλ|·) = −e0αλ + αλG · log(γλ)−G · logΓ(αλ) +
G∑
g=1
(αλ − 1)log(λg),
then the first derivative of logf(αλ|·) is
∂logf(αλ|·)
∂αλ
= −e0 +G · log(γλ)−G · ∂logΓ(αλ)
∂αλ
+
G∑
g=1
log(λg),
the second derivative of logf(αλ|·) is
∂2logf(αλ|·)
∂α2λ
= −G · ∂
2logΓ(αλ)
∂α2λ
< 0,
i.e. f(αλ|·) is log-concave.
(4) For parameter γλ, we consider conjugate prior
γλ ∼ Gamma(f0, g0),
where f0 = g0 = 0.1. Then the full conditional distribution of γλ can be written as
f(γλ|·) ∝ ΠGg=1{fGamma(λg;αλ, γλ)} × fGamma(γλ; f0, g0)
∝ ΠGg=1
{
γαλλ · exp(−γλλg)
}× γf0−1λ · exp(−g0γλ)
∝ γαλG+f0−1λ · exp
−γλ ·
 G∑
g=1
λg + g0
 ,
thus
γλ|· ∼ Gamma
αλG+ f0, G∑
g=1
λg + g0
 .
(5) For parameter αu, we consider prior
αu ∼ Exp(e0),
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where e0 = 0.01. Then the full conditional distribution of αu can be written as
f(αu|·) ∝ ΠGg=1 {fGamma(ug2;αu, γu)} × fExp(αu; e0)
∝ ΠGg=1
{
γαuu
Γ(αu)
uαu−1g2
}
× exp{−e0αu}
∝ exp{−e0αu} · γ
αuG
u
[Γ(αu)]G
·ΠGg=1(ug2)αu−1.
There is no closed-form full conditional distribution for αu,
logf(αu|·) = −e0αu + αuG · log(γu)−G · logΓ(αu) +
G∑
g=1
(αu − 1)log(ug2),
the first derivative of logf(αu|·) is
∂logf(αu|·)
∂αu
= −e0 +G · log(γu)−G · ∂logΓ(αu)
∂αu
+
G∑
g=1
log(ug2),
the second derivative of logf(αu|·) is
∂2logf(αu|·)
∂α2u
= −G · ∂
2logΓ(αu)
∂α2u
< 0,
i.e. f(αu|·) is log-concave, then we could draw posterior samples based on adaptive rejection
sampling method.
(6) For parameter γu, we consider conjugate prior
γu ∼ Gamma(f0, g0),
where f0 = g0 = 0.1. Then the full conditional distribution of γu can be written as
f(γu|·) ∝ ΠGg=1{fGamma(ug2;αu, γu)} × fGamma(γu; f0, g0)
∝ ΠGg=1 {γαuu · exp(−γuug2)} × γf0−1u · exp(−g0γu)
∝ γαuG+f0−1u · exp
−γu ·
 G∑
g=1
ug2 + g0
 ,
thus
γu|· ∼ Gamma
αuG+ f0, G∑
g=1
ug2 + g0
 .
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(7) For parameter αt, we consider prior
αt ∼ Exp(e0),
where e0 = 0.01. Then the full conditional distribution of αt can be written as
f(αt|·) ∝ ΠGg=1{fGamma(tg2|Zgt = 1, αt, γt)} × fExp(αt; e0)
∝ ΠGg=1
{(
γαtt
Γ(αt)
tαt−1g2
)I(Zgt=1)}
× exp{−e0αt}
∝ exp{−e0αt} ·
(
γαtt
Γ(αt)
)∑G
g=1 I(Zgt=1)
· exp

G∑
g=1
(αt − 1)log(tg2)I(Zgt = 1)
 .
There is no closed-form full conditional distribution for αt,
logf(αt|·) = −e0αt +
 G∑
g=1
I(Zgt = 1)
αtlog(γt)−
 G∑
g=1
I(Zgt = 1)
 logΓ(αt)
+
G∑
g=1
(αt − 1)log(tg2)I(Zgt = 1),
the first derivative logf(αt|·) is
∂logf(αt|·)
∂αt
= −e0 +
 G∑
g=1
I(Zgt = 1)
 log(γt)−
 G∑
g=1
I(Zgt = 1)
 ∂logΓ(αt)
∂αt
+
G∑
g=1
I(Zgt = 1)log(tg2),
the second derivative of logf(αt|·) is
∂2logf(αt|·)
∂α2t
= −
 G∑
g=1
I(Zgt = 1)
 · ∂2logΓ(αt)
∂α2t
< 0,
i.e. f(αt|·) is log-concave, then we could draw posterior samples based on adaptive rejection
sampling method.
(8) For parameter γt, we consider conjugate prior
γt ∼ Gamma(f0, g0),
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where f0 = g0 = 0.1. Then the full conditional distribution of γt can be written as
f(γt|·) ∝ ΠGg=1{fGamma(tg2|Zgt = 1, αt, γt)} × fGamma(γt; f0, g0)
∝ ΠGg=1
{
(γαtt · exp(−γttg2))I(Zgt=1)
}
× γf0−1t · exp(−g0γt)
∝ γαt
∑G
g=1 I(Zgt=1)+f0−1
t · exp
−γt ·
 G∑
g=1
tg2I(Zgt = 1) + g0
 ,
thus
γt|· ∼ Gamma
αt G∑
g=1
I(Zgt = 1) + f0,
G∑
g=1
tg2I(Zgt = 1) + g0
 .
(9) For parameter αw, we consider prior
αw ∼ Exp(e0),
where e0 = 0.01. Then the full conditional distribution of αw can be written as
f(αw|·) ∝ ΠGg=1{fGamma(wg22|Zgw = 1, αw, γw)} × fExp(αw; e0)
∝ ΠGg=1
{(
γαww
Γ(αw)
wαw−1g22
)I(Zgw=1)}
× exp{−e0αw}
∝ exp{−e0αw} ·
(
γαww
Γ(αw)
)∑G
g=1 I(Zgw=1)
· exp

G∑
g=1
(αw − 1)log(wg22)I(Zgw = 1)
 .
There is no closed-form full conditional distribution for αw,
logf(αw|·) = −e0αw +
 G∑
g=1
I(Zgw = 1)
αwlog(γw)−
 G∑
g=1
I(Zgw = 1)
 logΓ(αw)
+
G∑
g=1
(αw − 1)log(wg22)I(Zgw = 1),
the first derivative logf(αw|·) is
∂logf(αw|·)
∂αw
= −e0 +
 G∑
g=1
I(Zgw = 1)
 log(γw)−
 G∑
g=1
I(Zgw = 1)
 ∂logΓ(αw)
∂αw
+
G∑
g=1
I(Zgw = 1)log(wg22),
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the second derivative of logf(αw|·) is
∂2logf(αw|·)
∂α2w
= −
 G∑
g=1
I(Zgw = 1)
 · ∂2logΓ(αw)
∂α2w
< 0,
i.e. f(αw|·) is log-concave, then we could draw posterior samples based on adaptive rejection
sampling method.
(10) For parameter γw, we consider conjugate prior
γw ∼ Gamma(f0, g0),
where f0 = g0 = 0.1. Then the full conditional distribution of γw can be written as
f(γw|·) ∝ ΠGg=1{fGamma(wg22|Zgw = 1, αw, γw)} × fGamma(γw; f0, g0)
∝ ΠGg=1
{
(γαww · exp(−γwwg22))I(Zgw=1)
}
× γf0−1w · exp(−g0γw)
∝ γαw
∑G
g=1 I(Zgw=1)+f0−1
w · exp
−γw ·
 G∑
g=1
wg22I(Zgw = 1) + g0
 ,
thus
γw|· ∼ Gamma
αw G∑
g=1
I(Zgw = 1) + f0,
G∑
g=1
wg22I(Zgw = 1) + g0
 .
(11) For parameter Zgt, g = 1, . . . , G, we independently sample from
f(Zgt = 1|·) ∝ fGamma(tg2|Zgt = 1, αt, γt)fBernoulli(Zgt = 1|pit1)
∝ (1− pit1)fGamma(tg2|Zgt = 1, αt, γt)
f(Zgt = 0|·) ∝ pit1δ{1},
thus
Zgt|· ∼ Bernoulli
(
(1− pit1)fGamma(tg2|Zgt = 1, αt, γt)
(1− pit1)fGamma(tg2|Zgt = 1, αt, γt) + pit1δ{1}
)
.
(12) For parameter Zgw, g = 1, . . . , G, we independently sample from
f(Zgw = 1|·) ∝ fGamma(wg22|Zgw = 1, αw, γw)fBernoulli(Zgw = 1|piw1)
∝ (1− piw1)fGamma(wg22|Zgw = 1, αw, γw)
f(Zgw = 0|·) ∝ piw1δ{1},
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thus
Zgw|· ∼ Bernoulli
(
(1− piw1)fGamma(wg22|Zgw = 1, αw, γw)
(1− piw1)fGamma(wg22|Zgw = 1, αw, γw) + piw1δ{1}
)
.
(13) For parameter pit1, we sample from
f(pit1|·) ∝ ΠGg=1(pit1)(1−Zgt)(1− pit1)Zgt
∝ (pit1)
∑G
g=1(1−Zgt)(1− pit1)
∑G
g=1 Zgt ,
thus
pit1| · Beta
 G∑
g=1
(1− Zgt) + 1,
G∑
g=1
Zgt + 1
 .
(14) For parameter piw1, we sample from
f(piw1|·) ∝ ΠGg=1(piw1)(1−Zgw)(1− piw1)Zgw
∝ (piw1)
∑G
g=1(1−Zgw)(1− piw1)
∑G
g=1 Zgw ,
thus
piw1| · Beta
 G∑
g=1
(1− Zgw) + 1,
G∑
g=1
Zgw + 1
 .
(15) For parameter αb, we consider prior
αb ∼ Exp(e0),
where e0 = 0.01. Then the full conditional distribution of αb can be written as
f(αb|·) ∝ ΠGg=1Π2j=1Πnk=1fGamma(bgjk;αb, αb)× fExp(αb; e0)
∝ ΠGg=1Π2j=1Πnk=1
{
ααbb
Γ(αb)
b[gjk]
αb−1exp(−αbbgjk)
}
× exp{−e0αb}
∝ exp{−e0αb} ·
(
ααbb
Γ(αb)
)2nG
· (ΠGg=1Π2j=1Πnk=1bgjk)αb−1 · exp
−αb
G∑
g=1
2∑
j=1
n∑
k=1
bgjk
 .
There is no closed-form full conditional distribution for αb, thus we use Metropolis-Hastings
to update αb.
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(16) For parameter λg, g = 1, . . . , G, we have
λg11k = S11k · λg · bg1k
λg12k = S12k · λg · tg2 · bg2k
λg21k = S21k · λg · ug2 · bg1k
λg22k = S22k · λg · ug2 · tg2 · wg22 · bg2k.
We independently sample λg from
f(λg|·) ∝ Π2j=1Πnk=1{fPoisson(yg1jk|Zg1jk = 1, λg1jk)}
×Π2j=1Πnk=1{fPoisson(yg2jk;λg2jk)} × fGamma(λg;αλ, γλ)
∝ Πnk=1 {exp [yg11k · log(S11kλgbg1k)− S11kλgbg1k]}I(Zg11k=1)
×Πnk=1 {exp [yg12k · log(S12kλgtg2bg2k)− S12kλgtg2bg2k]}I(Zg12k=1)
×Πnk=1 {exp [yg21k · log(S21kλgug2bg1k)− S21kλgug2bg1k]}
×Πnk=1 {exp [yg22k · log(S22kλgug2tg2wg22bg2k)− S22kλgug2tg2wg22bg2k]}
× λαλ−1g exp(−γλλg)
∝ exp
log(λg) ·
2∑
i=1
2∑
j=1
n∑
k=1
ygijk

× exp
{
−λg ·
n∑
k=1
∆k
}
× λαλ−1g exp(−γλλg)
∝ (λg)
∑2
i=1
∑2
j=1
∑n
k=1 ygijk+αλ−1 · exp
{
−λg ·
[
n∑
k=1
∆k + γλ
]}
,
thus
λg|· ∼ Gamma
 2∑
i=1
2∑
j=1
n∑
k=1
ygijk + αλ,
n∑
k=1
∆k + γλ
 ,
where
∆k = S11kbg1kI(Zg11k = 1) + S12ktg2bg2kI(Zg12k = 1)
+ S21kug2bg1k + S22kug2tg2wg22bg2k.
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(17) For parameter ug2, g = 1, . . . , G, we independently sample from
f(ug2|·) ∝ Π2j=1Πnk=1{fPoisson(yg2jk;λg2jk)} × fGamma(ug2;αu, γu)
∝ Πnk=1 {exp [yg21k · log(S21kλgug2bg1k)− S21kλgug2bg1k]}
×Πnk=1 {exp [yg22k · log(S22kλgug2tg2wg22bg2k)− S22kλgug2tg2wg22bg2k]}
× (ug2)αu−1exp(−γuug2)
∝ exp
log(ug2) ·
2∑
j=1
n∑
k=1
yg2jk

× exp
{
−ug2 ·
n∑
k=1
[S21kλgbg1k + S22kλgtg2wg22bg2k]
}
× (ug2)αu−1exp(−γuug2)
∝ (ug2)
∑2
j=1
∑n
k=1 yg2jk+αu−1 · exp
{
−ug2 ·
[
n∑
k=1
(S21kλgbg1k + S22kλgtg2wg22bg2k) + γu
]}
,
thus
ug2|· ∼ Gamma
 2∑
j=1
n∑
k=1
yg2jk + αu,
n∑
k=1
(S21kλgbg1k + S22kλgtg2wg22bg2k) + γu
 .
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(18) For parameter tg2, g = 1, . . . , G, we independently sample from
f(tg2|Zgt = 0, ·) ∝ Πnk=1{fPoisson(yg12k|Zg12k = 1, λg12k)}
×Πnk=1{fPoisson(yg22k|λg22k)} × f(tg2|Zgt = 0)
∝ δ{1}
f(tg2|Zgt = 1, ·) ∝ Πnk=1{fPoisson(yg12k|Zg12k = 1, λg12k)}
×Πnk=1{fPoisson(yg22k|λg22k)} × fGamma(tg2|Zgt = 1, αt, γt)
∝ Πnk=1 {exp [yg12k · log(S12kλgtg2bg2k)− S12kλgtg2bg2k]}I(Zg12k=1)
×Πnk=1 {exp [yg22k · log(S22kλgug2tg2wg22bg2k)− S22kλgug2tg2wg22bg2k]}
× (tg2)αt−1exp(−γttg2)
∝ exp
{
log(tg2) ·
2∑
i=1
n∑
k=1
ygi2k
}
× exp
{
−tg2 ·
n∑
k=1
[S12kλgbg2kI(Zg12k = 1) + S22kλgug2wg22bg2k]
}
× (tg2)αt−1exp(−γttg2)
∝ (tg2)
∑2
i=1
∑n
k=1 ygi2k+αt−1 · exp
{
−tg2 ·
[
n∑
k=1
(S12kλgbg2kI(Zg12k = 1) + S22kλgug2wg22bg2k) + γt
]}
,
thus
tg2|Zgt = 0, · ∼ δ{1}
tg2|Zgt = 1, · ∼ Gamma
(
n∑
k=1
ygi2k + αt,
n∑
k=1
[S12kλgbg2kI(Zg12k = 1) + S22kλgug2wg22bg2k] + γt
)
.
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(19) For parameter wg22, g = 1, . . . , G, we independently sample from
f(wg22|Zgw = 0, ·) ∝ Πnk=1{fPoisson(yg22k;λg22k)} × f(wg22|Zgw = 0)
∝ δ{1}
f(wg22|Zgw = 1, ·) ∝ Πnk=1{fPoisson(yg22k;λg22k)} × fGamma(wg22|Zgw = 1, αw, γw)
∝ Πnk=1 {exp [yg22k · log(S22kλgug2tg2wg22bg2k)− S22kλgug2tg2wg22bg2k]}
× (wg22)αw−1exp(−γwwg22)
∝ exp
{
log(wg22) ·
n∑
k=1
yg22k
}
× exp
{
−wg22 ·
n∑
k=1
S22kλgug2tg2bg2k
}
× (wg22)αw−1exp(−γwwg22)
∝ (wg22)
∑n
k=1 yg22k+αw−1 · exp
{
−wg22 ·
[
n∑
k=1
S22kλgug2tg2bg2k + γw
]}
,
thus
wg22|Zgw = 0, · ∼ δ{1}
wg22|Zgw = 1, · ∼ Gamma
(
n∑
k=1
yg22k + αw,
n∑
k=1
S22kλgug2tg2bg2k + γw
)
.
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(20) For parameter bg1k, g = 1, . . . , G, k = 1, . . . , n, we independently sample from
f(bg1k|·) ∝ fPoisson(yg11k|Zg11k = 1, λg11k)
× fPoisson(yg21k|λg21k)× fGamma(bg1k;αb, αb)
∝ {exp [yg11k · log(S11kλgbg1k)− S11kλgbg1k]}I(Zg11k=1)
× {exp [yg21k · log(S21kλgug2bg1k)− S21kλgug2bg1k]}
× (bg1k)αb−1exp(−αbbg1k)
∝ exp
{
log(bg1k) ·
2∑
i=1
ygi1k
}
× exp {−bg1k · [S11kλgI(Zg11k = 1) + S21kλgug2]}
× (bg1k)αb−1exp(−αbbg1k)
∝ (bg1k)
∑2
i=1 ygi1k+αb−1 · exp {−bg1k · [S11kλgI(Zg11k = 1) + S21kλgug2 + αb]} ,
thus
bg1k|· ∼ Gamma
(
2∑
i=1
ygi1k + αb, S11kλgI(Zg11k = 1) + S21kλgug2 + αb
)
.
(21) For parameter bg2k, g = 1, . . . , G, k = 1, . . . , n, we independently sample from
f(bg2k|·) ∝ fPoisson(yg12k|Zg12k = 1, λg12k)
× fPoisson(yg22k|λg22k)× fGamma(bg2k;αb, αb)
∝ {exp [yg12k · log(S12kλgtg2bg2k)− S12kλgtg2bg2k]}I(Zg12k=1)
× {exp [yg22k · log(S22kλgug2tg2wg22bg2k)− S22kλgug2tg2wg22bg2k]}
× (bg2k)αb−1exp(−αbbg2k)
∝ exp
{
log(bg2k) ·
2∑
i=1
ygi2k
}
× exp {−bg2k · [S12kλgtg2I(Zg12k = 1) + S22kλgug2tg2wg22]}
× (bg2k)αb−1exp(−αbbg2k)
∝ (bg2k)
∑2
i=1 ygi2k+αb−1 · exp {−bg2k · [S12kλgtg2I(Zg12k = 1) + S22kλgug2tg2wg22 + αb]} ,
146
thus
bg2k|· ∼ Gamma
(
2∑
i=1
ygi2k + αb, S12kλgtg2I(Zg12k = 1) + S22kλgug2tg2wg22 + αb
)
.
(22) For parameter βg, g = 1, . . . , G, we have
f(βg|·) ∝ Π2j=1Πnk=1
[
1
1 + S
βg
1jk
]I(Zg1jk=0) [ Sβg1jk
1 + S
βg
1jk
]I(Zg1jk=1)
× fN(βg; ηβ, σ2β)
∝ Π
2
j=1Π
n
k=1S
βgI(Zg1jk=1)
1jk
Π2j=1Π
n
k=1(1 + S
βg
1jk)
× exp
{
−(βg − ηβ)
2
2σ2β
}
.
There is no closed-form full conditional distribution for βg, thus we use Metropolis-Hastings
to update βg.
(23) For parameter Zg1jk, g = 1, . . . , G, j = 1, 2, k = 1, . . . , n, we independently sample from
f(Zg1jk = 1|·) ∝ pg1jkfPoisson(yg1jk;λg1jk)
f(Zg1jk = 0|·) ∝ (1− pg1jk)δ{0},
thus
Zg1jk|· ∼ Bernoulli
(
pg1jkfPoisson(yg1jk;λg1jk)
pg1jkfPoisson(yg1jk;λg1jk) + (1− pg1jk)δ{0}
)
.
(24) For parameter pg1jk, g = 1, . . . , G, j = 1, 2, k = 1, . . . , n, we independently sample from
f(pg1jk|·) ∝ (pg1jk)1−Zg1jk · (1− pg1jk)Zg1jk ,
thus
pg1jk|· ∼ Beta(2− Zg1jk, Zg1jk + 1).
147
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